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ABSTRACT 
The intermolecular ruthenium hydride catalyzed coupling of internal alkynes with 
subsequent insertion of olefin acceptors is described. This approach utilizes a vinyl silicon tether 
to provide complete regiocontrol, a stereoselective anti-exo-dig cyclization which affords a 
tetrasubstituted olefin with a new vinylsilane, and a highly functionalized Z,E diene motif. 
Subsequent studies for a highly selective intramolecular trans-silylvinylation of internal alkynes 
catalyzed by RuHCl(CO)(SIMes)(PPh3) is reported. The use of methyl vinyl ketone as an additive 
increased the efficiency of this transformation. This process was expanded upon using ethylene 
gas as an additive and provides a net 5-exo-dig trans-silylvinylation of internal alkynes. Ethylene 
decreased reaction times and promoted altered selectivity at increased pressure. Furthermore, the 
chemoselectivity was attenuated when alkyl substituted alkynes afforded silylvinylation at 80 psi 
of ethylene. Terminal alkynes were utilized in this transformation at increased ethylene pressure 
and produced syn-silylvinylation products. 
 
 
 
 
Imidazo[4,5-c]pyridines were synthesized in three steps utilizing a palladium catalyzed 
amidation-cyclization strategy. N-Aryl substrates were synthesized using copper catalyzed 
amidation of 3-amino-N-Boc-4-chloropyridine. Complementary protocols for the selective 
chlorination of imidazo[4,5-c]pyridines at C2 and C7 positions were also developed. An improved 
protocol for the synthesis of imidazo[4,5-b]pyridines and pyrazines using palladium catalyzed 
amidation of 2-chloro-3-aminopyridines is described. The process utilizes Xantphos and a binary 
solvent system comprised of 1,4-dioxane and tert-amyl alcohol. The improved conditions were 
extended to provide a method for the regioselective coupling of polychlorinated aminopyridines. 
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1.0  RUTHENIUM HYDRIDE CATALYZED SILYLVINYLATION OF ALKYNES: 
INTRODUCTION 
Transition metal catalyzed reactions have become some of the most valuable tools in 
organic synthesis. Organometallic complexes are frequently used in cross-coupling reactions to 
form new bonds that are described as efficient and selective. The protocols for metal catalyzed 
coupling reactions have been developed extensively and are based on the work of several pioneers 
including the 2010 Nobel Laureates Richard Heck, Akira Suzuki, and Ei-ichi Negishi. Several well 
known cross coupling methods used to form new carbon-carbon bonds include: Suzuki–Miyaura,1 
Heck,2 Negishi,3 Stille,4 Kumada,5 Sonogashira,6 and Hiyama (Figure 1).7 These modern cross 
coupling techniques often require each component to contain a functional group that can 
participate readily in the cross coupling. The participating partners are generally halides or pseudo-
halides which are matched with an organometallic species.8 In most cases alkynes are transformed 
into an activated alkene species when functionalized dienes are desired. Well defined 
functionalized conjugated dienes are prevalent in natural products (Figure 2). The palladium cross-
coupling methods used to generate these moieties often have toxic byproducts such as tin.  
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Figure 1: Examples of Cross-Coupling Reactions to Form Conjugated Dienes 
 
 
Figure 2: Natural products that contain diene motif 
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 Ruthenium catalyzed coupling reactions on the other hand, have become a reliable method 
for the construction of new carbon-carbon bonds.9 One major advantage of ruthenium catalysis is 
that no pre-activation of either coupling partner is required. Ruthenium catalyzed cross coupling 
reactions frequently convert alkynes and alkenes into dienes. The formation of conjugated dienes 
by ruthenium catalysis can proceed through several different mechanisms. Watanabe10 and Trost8, 
9 have have developed ruthenium catalyzed reactions which proceed through metallacycle 
intermediates (Scheme 1, Equation 1), while Grubbs,11 Diver12, 13 and many others have 
demonstrated the effectiveness of ruthenium vinyl carbenes (Scheme 1, Equation 2). 12-18 
Moreover, Murai revealed the use of a ruthenium dihydrido complex in C-H functionalization 
chemistry (Scheme 1, Equation 3).19 These methods have been thoroughly explored and continue 
to evolve. Alternative ruthenium hydride methods20 that do not require a directing group have not 
been as extensively examined for the synthesis of dienes. Ruthenium hydride catalyzed coupling 
of alkynes and alkenes can lead to highly substituted dienes of great synthetic value.21  
Scheme 1: Ruthenium Catalyzed Formation of Conjugated Dienes 
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Examples of intramolecular transformations to form conjugated dienes using ruthenium 
hydrides were reported by Mori.22 In the presence of catalytic amounts of RuHCl(CO)(PPh3)3, 
Mori demonstrated the intramolecular transformation of enynes to dienes. Mechanistically, Mori 
proposed a three step sequence which proceeds via 1) hydrometallation of the alkyne, 2) 
carbometallation of the alkene and 3) subsequent -hydride elimination (Scheme 2). Mori 
demonstrated the utility of this transformation in the synthesis of carbepanem skeletons. This 
process showed excellent functional group compatibility.23 
Scheme 2: Mori’s Examples of Intramolecular Transformations 
  
Selected Examples R R1 Time (h) Yield (%) 
1 Me (CH2)3Ph 9 62 
2 Ph Et 18 57 
3 4-MeO-Ph Et 18 82 
4 4-Me-Ph Et 18 67 
5 4-CF3-Ph Et 18 53 
 
Other groups have produced 1,3 dienes utilizing ruthenium hydride catalysts through 
intermolecular transformations of alkynes with alkenes. Yi reported a hydrovinylation of alkynes 
using [(PCy3)2(CO)(Cl)Ru=CHCH=C(CH3)2]
+BF4
- (1.14) and ethylene gas (Scheme 3).24 The 
substrate compatibility for Yi’s hydrovinylation was limited to symmetrical internal alkynes. 
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When terminal alkynes were subjected to these conditions chemoselectivity was an issue and a 
mixture of products 1.16 and 1.17 were observed. 
Scheme 3: Hydrovinylation Reaction with Selected Examples 
 
Entry R R1 Ratio (1.16:1.17) Time (h) Yield (%) 
1 Ph Ph 98:2 5 91 
2 n-Pr n-Pr 98:2 7 90 
3 H p-Tol 74:26 2 95 
4 H SiEt3 94:6 2 82 
5 H CH2CH2OH 92:8 2 57 
  
When electron deficient internal alkynes (1.18) were subjected a [2+2] reaction 
predominated and compound 1.19 was isolated in 70% yield (Scheme 4). The reaction with 
norbornene also produced a cyclobutene ring 1.20 under similar conditions. Yi hypothesized the 
formation of the hydrovinylation products 1.16 or 1.17 can occur via sequential insertion of alkyne 
and ethylene to metal-hydride and metal-vinyl species. The hypothesis was tested using ruthenium-
vinyl species 1.21 and ruthenium-hydride 1.23.  
Scheme 4: Yi’s [2+2] Reaction with Electron Deficient Alkynes 
  
The reaction of 1.21 and ethylene in C6D6 produced a 1:1 mixture of 1.22 and 1.23(Scheme 
5). This suggests that these three ruthenium complexes (1.14, 1.21 and 1.23) proceed through a 
common intermediate (1.24) in the hydrovinylation reaction.   
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Scheme 5: Evidence for Ruthenium Hydride Mechanism in Yi’s Hydrovinylation 
 
Yi’s hydrovinylation of symmetrical internal alkynes using ruthenium hydride 1.23 
provides excellent reactivity but chemoselectivity was an issue. Furthermore, there were no 
unsymmetrical internal alkynes tested lending the reader to believe they were not compatible or 
provided a mixture of regioisomers. 
Marciniec utilized ruthenium hydride 1.23 to couple terminal alkynes with vinyl boronates 
(Scheme 6).25 Marciniec also observed a selectivity issue. The reaction proceeded to deliver a 
mixture of stereoisomers (1.27, 1.28) along with boronate (1.29) and alkyne dimerization (1.30) 
as byproducts. Internal alkynes were not investigated leaving room for improvement in this area. 
However, the products obtained were interesting and possessed dual functionality at the 1 and 4 
positions of the 1,3-diene motif. 
Scheme 6: Marciniec’s Vinyl Boronate Coupling with Selected Examples 
 
 
Entry R Ratio (E:Z:1.29:1.30) 
1 SiEt3 83:14:0:3 
2 TMS 40:5:0:55 
3 SiMe2Ph 75:25:0:0 
4 GeEt3 44:14:23:21 
5 Cy 82:18:0:0 
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 Plietker investigated the coupling of alkynes with acrylates and acrylamides (Scheme 7).26 
The reaction was stereo and regioselective when using terminal alkynes resulting in (Z)-A with a 
57% isolated yield. When symmetrical internal alkynes were subjected to these conditions 
stereoselectivity was reduced. When unsymmetrical internal alkynes were examined the 
regioselectivity also became an issue. 
Scheme 7: Plietker’s Ruthenium Hydride Coupling 
 
Entry R1 R2 A:B Z:E Yield (%) 
1 Ph H 99:1 98:2 57 
2 Pr Pr - 91:9 76 
3 C5H11 Me 50:50 91:9 65 
4 Ph C3H7 11:89 98:2 83 
 
Ruthenium hydrides show promise as catalysts in the synthesis of dienes, however, they 
do not seem to be broadly applicable in the transformation of unsymmetrical internal alkynes. 
Plietker reported a single example that showed high levels of regiocontrol (Scheme 8). In this case 
the presence of the propargylic benzyl ether provided a possible coordination to the metal that 
could facilitate a regioselective delivery of the hydride. Despite excellent regiocontrol, 
stereoselectivity was still poor with 1.31 obtained as a 2:1, Z:E ratio and regioisomer 1.32 was not 
formed in this reaction.   
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Scheme 8: Hypothesis for Plietker’s Observed Regiochemistry 
  
 
The limitations in selectivity with unsymmetrical internal alkynes suggested a deficit in 
these methods. However, as demonstrated in the example above, selectivity can be impoved by 
preorganizing substrates. Connecting a linker or temporary silicon tether to an alcohol at the 
homopropargylic position was envisioned to provide a solution to control both regio and 
stereoselectivity.27   
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1.1 INTERMOLECULAR RUTHENIUM HYDRIDE CATALYZED COUPLINGS 
1.2.1 Ruthenium Hydride Coupling of Alkynes and Acrylates 
Initial investigations using ruthenium hydride catalysis from the Clark group were 
conducted by Dr. Shasha Liu and Dr. Jinbo Zhao.28 It was discovered that a vinyl silicon moiety 
attached to an alcohol at the homo-propargyl position could assist the delivery of ruthenium across 
an alkyne π system (Figure 3). Mechanistically, the ruthenium hydride is delivered across the vinyl 
moiety followed by the loss of ethylene (Figure 4). The initial hypothesis for addition to the alkyne 
was a syn addition of a silyl ruthenium intermediate (Id). Contrary to the hypothesis the product 
observed showed an interesting anti-exo-dig-addition to the alkyne (Ie). The anti isomer obtained 
was verified by 1D and 2D experiments conducted by Liu et al.28 
 
 
Figure 3: Silicon Tethered Coupling Approach 
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Figure 4: Mechanistic Proposal 
The observed anti addition process was unpredicted due to the rarity of a direct trans 
addition to alkynes. Other groups have observed trans addition to alkynes (Scheme 9). Trost,29 
Denmark,30 and Chang31 have observed anti-hydrosilylation products using some ruthenium 
catalysts. Direct trans-addition across alkynes has also been observed by Fu32, 33 and Mori34 using 
rhodium, and Murakami35 using gold. Lastly, Yamamoto observed a trans-carbosilylation using 
Lewis acid catalysts.36, 37   
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Scheme 9: Literature Examples of Trans-addition to Alkynes 
 
The initial work conducted by the Clark group utilized ruthenium hydride catalysts to 
couple unsymmetrical internal alkynes with alkenes (Figure 5). The reaction was found to work 
well with acrylates and on large scale. A screen of acrylates revealed bulkier acrylates such as L-
menthol acrylate produced the highest yields in this reaction. This could be a result of varying 
volatility with the smaller acrylates such as methyl and ethyl acrylate. The reaction conditions 
were amenable to the use of various aryl substituted alkynes, while alkyl substituted alkynes 
proved to be a bit more sensitive. Alkyl alkynes provided lower yields and produced a mixture of 
stereoisomers. The alkyl alkynes required a large excess of acrylates for full conversion to dienes, 
and so lower boiling acrylates were used to facilitate the isolation of product. Several olefin 
coupling partners were examined under these conditions but only acrylates worked well (Figure 
5).  
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Figure 5: Ruthenium Hydride Catalyzed Alkyne-Acrylate Coupling 
 
While screening catalysts for the acrylate coupling, specifically 
RuHCl(CO)(SIMes)(PPh3), 1.35 (Scheme 10, i.e. ethylene transfer) was discovered as a 
byproduct. New endeavors were undertaken to selectively produce the ethylene transfer reaction. 
Unreactive olefin coupling partners from previous studies were also desired. Conditions were 
examined in an attempt to couple acrylamides. As aforementioned, the acrylate coupling was 
optimized and the reaction performed the best at 85°C. Since the standard conditions did not work 
for acrylamides the more reactive complex RuHCl(CO)(SIMes)(PPh3) was examined. This 
complex promoted partial coupling with acrylamides along with some ethylene transfer (Scheme 
10). Increasing the reaction temperature to 110 °C in toluene allowed for full conversion of 1.33 
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and provided a 3:1 mixture of acrylate incorporated (1.34) to vinylated ene (1.35) products. In an 
effort to reduce the byproduct formation some additives were examined. Lewis acid additives were 
believed to coordinate to the acrylamide lowering the LUMO and making the requisite conjugate 
addition easier. Lewis acid additives could also prevent the amide carbonyl from coordinating to 
the ruthenium. However, additives such as MgCl2, AlCl3 and CuCl did not improve the reaction; 
in fact, they were deleterious and shut down reactivity.  
 
Scheme 10: Acrylamide Coupling Example 
 
While there were many other possibilities and combinations that could be attempted in 
order to improve this reaction, no further work was conducted. Instead the acrylamide coupling 
reaction protocol was implemented to couple acrylates with difficult alkynes (Scheme 11). 
Alkynes that were previously unreactive or demonstrated poor conversion were deemed difficult 
substrates. The methyl substitution pattern of alkyne 1.36 made for a surprisingly low yielding 
(<10%) reaction with RuHCl(CO)(PCy3)2 (Scheme 11). However, using 
RuHCl(CO)(SIMes)(PPh3) the product (1.37) was delivered in 52% yield and could be readily 
separated from the vinylated byproduct (1.38).  
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Scheme 11: Acrylate Coupling with Difficult Substrate 
 
At the outset of this project several coupling partners were desired that could produce 
bifunctional dienes. A selective coupling between vinyl silicon tethered alkynes and other vinyl 
metalloid (germanes, silanes, boronates and tin) species was envisioned. Additional investigations 
into coupling vinyl boronates and in selectively achieving an intramolecular vinyl transfer reaction 
will be discussed in the following chapters of this thesis.  
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1.2.2 Stereo- and Regioselective Formation of Silyl-Dienyl Boronates  
Vinyl boronates38-40 and vinyl silanes41 are considered valuable reagents and are often used 
as synthetic intermediates in catalytic transformations.25, 42 The Suzuki-Miyaura cross-coupling 
with organoboranes is perhaps the most utilized transition metal catalyzed C-C bond forming 
reaction.43, 44 Alternatively, organosilanes have been utilized efficiently in Fleming-Tamao 
oxidations45 and Hiyama couplings.46 Given the significant use of vinyl boronates and vinyl 
silanes, a great deal of effort has been applied to incorporate these functionalities into complex 
molecules. Methods used to prepare vinyl silanes and vinyl boronic esters include hydroboration47 
or hydrosilylation29 of alkynes, metal catalyzed addition of diboron reagents,48-50 olefin metathesis 
with vinyl boronates11, 51, 52 and silaboration chemistry (Scheme 12).53-56  
Scheme 12: Known Preparations of Vinyl Boronates and Vinyl Silanes 
 
 
The successful application of the ruthenium hydride methodology, recently developed in 
the Clark lab,28 to the coupling of unsymmetrical internal alkynes and vinyl boronates would 
diversify this category of valuable intermediates. The coupling would deliver regio- and 
stereodefined silyl-dienylboronates with varied functional handles at the 1 and 4 position of a diene 
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scaffold (Scheme 12, 1.40). Marciniec has previously prepared bifunctional dienes of a similar 
nature from silyl-acetylenes and vinyl boronates; however, a mixture of stereoisomers and alkyne 
dimerization was obtained (Scheme 12).25 In addition to complex vinyl silanes and boronates this 
approach would also produce tetra-substituted olefins and Z,E diene systems. Tetra-substituted 
olefins are valuable intermediates which are a considerable challenge to obtain stereo and 
regioselectively.57 Despite their prevalence in natural product scaffolds, Z, E diene motifs are also 
quite difficult to obtain.58-60 This coupling method provides a straightforward solution to both 
challenges.  
Scheme 13: Vinyl Boronate Coupling with Alkynes 
 
 
This study began by examining alkyne 1.33 and vinyl boronate 1.39a using the standard 
conditions from the acrylate coupling methodology.28 Ruthenium hydride catalysts were evaluated 
and RuHCl(CO)(PCy3)2 was chosen due to the highest crude yield and minimal byproduct (1.41a) 
formation (Table 1). 
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Table 1: Initial Catalyst Screen for Vinyl Boronate 1.39a Coupling 
 
Entry Catalyst Crude Yield 1.40 (%)a Crude Yield 1.41a(%)a 
1d RuHCl(CO)(PCy3)2 87 9 
2c,d RuHCl(CO)(SIMes)(PPh3) 23 12 
3b,d RuHCl(CO)(Pi-Pr3)2 69 4 
4b RuHCl(CO)(Pt-Bu2Me)2 55 14 
5d RuHCl(CO)(Pn-BuAd2)2 Not determined 32 
6b RuH(OSiPh3)(CO)(Pt-Bu2Me)2 17 0 
    
a Determined by 1H NMR vs. mesitylene internal standard. b Starting material observed after 9 hours. c Reaction 
complete after 2 hours. d Reaction run by Lauren Kaminsky.  
 
 
A solvent screen with varying temperatures was also performed (Table 2). Toluene and 
1,4-dioxane were suitable solvents for this reaction at 85C providing crude yields of 72% and 
78% respectively (entries 7, 8). When DCE was used as the solvent at 85C the reaction was 
complete in 9 h and produced the highest crude yield of 87% (entry 6). Lowering the reaction 
temperature required longer reaction times and produced lower yields (entries 1-5). However, at 
reduced temperature the amount of dimer byproduct (1.41a) was reduced. In DCE at 85C the 
vinyl boronate to alkyne ratio was examined (entries 11, 12). This ratio played a crucial role in the 
reaction. With 1.2, 1.5 and 2.0 equivalents of boronate the crude yields by 1H NMR were 62, 65 
and 87 percent respectively. This effect is presumably due to dimerization (1.41a) of the vinyl 
boronate which consumes the boronate prior to the desired coupling. 
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Table 2: Solvent and Equivalents Screen with 1.39a 
 
Entry Solvent Equiv. 1.39a Temp. (°C) Time (h) Crude Yield 1.40 (%)a,d Crude Yield 1.41a (%)a 
1b DCM 2 45 7 27 0 
2b DCE 2 60 15 53 1 
3b DCE 2 70 15 65 2 
4b THF 2 70 9 64 0 
5c MeCN 2 70 9 No reaction - 
6c DCE 2 85 9 87 9 
7c PhMe 2 85 5.5 72 (53) 1 
8c 1,4-dioxane 2 85 5.5 78 (59) 3 
9 DMF 2 105 9 No reaction - 
10 b PhCF3 2 105 9 45 0 
11c DCE 1.5 85 9 66 3 
12c DCE 1.2 85 9 63 2 
       
a Determined by 1H NMR vs. mesitylene internal standard. b Starting material observed after designated reaction time. 
c Reaction run by Lauren Kaminsky. d Isolated yield reported in parenthesis. 
 
Product isolation was difficult with nearly 20 percent loss from the observed crude yields 
(Table 2, entries 7, 8). This result was most probably due to boronate hydrolysis upon exposure to 
silica gel. Attempting to deactivate the silica gel with triethylamine, trimethylchlorosilane, or boric 
acid61 showed no increase in isolated yield. Using neutral alumina provided similar results to silica 
gel. Several additional vinyl boronates were explored in an attempt to improve product isolation 
(Table 3). Careful examination of the literature revealed several promising candidates that were 
commercially available or readily prepared (Scheme 14).  
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Scheme 14: Approach to Vinyl Boronate Couplings 
 
Table 3: Vinyl Boronate Screen 
Entry Boronate Time (h) Crude yield (%) Isolated Yield (%) 
1 1.39a 5.5 72 53 
2 1.39b 5 75 55 
3 1.39c 3 70 55 
4 1.39d 9 No reaction - 
5 1.39e 9 No reaction - 
 
Pinacol boronate 1.39c was easily prepared but highly volatile with a tendency to 
polymerize.62 Standard reaction conditions using 1.39c and alkyne substrate 1.33 delivered a crude 
1H NMR yield of 70%, which was lower than observed with the neopentyl boronate 1.39a. Burke 
and coworkers introduced MIDA compound 1.39d,63 while Molander and coworkers produced 
compound 1.39e.64 These are both air stable solids that have repeatedly demonstrated their 
usefulness in cross coupling chemistry;64 however, these two reagents did not function in the 
desired reaction. We found that the most successful boronate was the hexylene glycol derived 
1.39b. Compound 1.39b was easily prepared from readily available materials in multigram 
quantities following the procedure of Whiting.62 
Scheme 15: Preparation of Vinyl Boronate 1.39b 
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The ruthenium hydride catalyzed coupling reaction was conducted using alkyne 1.33 and 
boronate 1.39b. Boronate dimer 1.41b was found to co-elute with the products during isolation 
and some fractions had to be discarded. In order to minimize the formation of boronate dimer, 
solvent and temperature were once again evaluated (Table 4). Toluene, DCE and 1,4-dioxane 
performed well at 85 C (entries 1-3). Refluxing THF (entry 4) gave no dimer but required a longer 
reaction time with compromised (58%) product yield. No reactivity was observed in refluxing 
acetonitrile (entry 5) presumably due to solvent coordination to the ruthenium. Additional 
temperatures were also explored with toluene. Lowering the temperature lead to longer reaction 
times and decreased the amounts of both dimer and product being formed (entry 6). Increasing the 
temperature to 100 C gave a 78% crude yield of 1.42 but also increased the amount of dimer 
1.41b (entry 7). Toluene at 85 C proved optimal for the reaction (entry 2) with regard to both 
reaction time and amount of dimer formation. Dimer 1.41b was independently synthesized using 
these optimized reaction conditions to verify its structure (Scheme 15). Once again two equivalents 
of vinyl boronate to alkyne were observed to be the most beneficial ratio of reactants for the 
reaction.  
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Table 4: Solvent and Equivalents Screen With 1.39b 
 
entry solvent equiv. 1.39b temp (°C) time (h) yield 1.42 (1.41b)a 
1 b DCE 2 85 5 75 (5) 
2 b PhMe 2 85 3.5 75 (3) 
3 b 1,4-dioxane 2 85 4 67 (3) 
4 b THF 2 70 7 58 (0) 
5b MeCN 2 70 7 No reaction 
6 DCE 2 70 7 77 (2) 
7 PhMe 2 70 7 63 (1) 
8 PhMe 2 60 10 59 (1) 
9 DCE 2 60 10 59 (1) 
10 PhMe 2 100 3 78 (5) 
11 PhMe 1.5 100 7 57 (3) 
12 PhMe 1.2 100 7 58 (4) 
a percent yield determined by crude 1H NMR versus mesitylene as an internal standard b reaction run by Lauren 
Kaminsky 
 
Scheme 16: Independent Synthesis of Boronate Dimer 1.41b 
 
 
 
A catalyst screen was conducted in an attempt to impede the formation of 1.41b while 
potentially increasing the amount of 1.42 (Table 5).65 The overall goals for the proper catalyst were 
to retain reactivity with appropriate selectivity and short reaction time. Ruthenium-phosphine 
complexes with various steric and electronic properties were prepared and tested. Ruthenium 
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hydride complex RuHCl(CO)(PCy3)2 was shown to be superior to analogous hydride catalysts 
(entry 1). RuHCl(CO)(Pi-Pr3)2 demonstrated good yield of product (72 %) but required longer 
reaction times. The remaining electron rich bisphosphine complexes (Table 5, entries 3-5) 
catalyzed the reaction with reasonable times but at compromised yield and increased dimer 
formation. RuHCl(CO)[Pi-Pr2(3,5-bis(trifluoromethyl)phenyl)]2 with electron deficient phosphine 
ligands, exhibited poor catalytic activity in the coupling. After significant development, standard 
reaction conditions were implemented and used in a substrate scope. The standard conditions were 
as follows; 5 mol % RuHCl(CO)(PCy3)2 with 2 equivalents of 1.39b in toluene (0.5M in alkyne) 
at 85 C.  
 
Table 5: Ruthenium Hydride Catalyst Screen with 1.39b 
entry catalyst time (h) yield 1.42 (%)a dimer (1.41b)a 
1b RuHCl(CO)(PCy3)2 3.5 75 3 
2b RuHCl(CO)(Pi-Pr3)2 8 72  4 
3 RuHCl(CO)(Pt-Bu2Me)2 5 67   10 
4b RuHCl(CO)(Pt-Bu2Cy)2 2 61   11 
5b RuHCl(CO)(PCy2t-Bu)2 8 60   6 
6c RuHCl(CO)(PR3)2 8 15 0 
 
a
 percent yield determined by crude 1H NMR versus mesitylene as an internal standard. b reaction run by Lauren 
Kaminsky. c PR3 = (3,5-bis(trifluoromethyl)phenyl)diisopropylphosphine 
 
Mechanistically (Figure 6), the hypothesis is that dissociation of one phosphine ligand from 
RuHCl(CO)(PCy3)2 reveals a 14-electron ruthenium species (I). Once the active catalytic species 
is produced, substrate coordination, hydroruthenation of the vinyl silane (II) and -silyl transfer 
occur to deliver silyl ruthenium intermediate (III). Considering the presence of two vinyl metalloid 
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species in the reaction (vinyl boronate and tethered vinyl silicon), it is assumed that since dimer 
formation can be inhibited by changes in reaction conditions that the vinyl silicon is more reactive 
than the vinyl boron leading to preferential hydroruthenation of the vinyl silicon tethered alkyne 
substrate. At this stage an intramolecular silyl-ruthenation of the alkyne provides vinyl ruthenium 
(IV). In view of the trans addition product obtained, the silyl-ruthenation of the alkyne can occur 
from a direct trans-addition29, 30 or cis-addition followed by isomerization.28 The isomerization 
can occur through a polarization of the olefinic bond and formation of a zwitterionic species. At 
the zwitterionic stage free rotation allows for the trans orientation to be attained. Intermolecular 
insertion of the vinyl boronate and -hydride elimination liberates the product and regenerates the 
active hydride catalyst. A similar mechanistic possibility is depicted to show the formation of 
boronate dimer (1.41). 
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Figure 6: Vinyl Boronate Coupling Mechanistic Hypothesis 
With optimized conditions in hand, a study of substrate scope was conducted, and the 
reaction worked well with various alkyne substrates (Table 6). Racemic alkyne substrates were 
prepared in one of two ways: propargyl Grignard addition to aldehydes or ketones, or anionic 
acetylide epoxide openings. These two methods produced homopropargyl alcohols which were 
silylated using chloro dimethyl vinyl silane in the presence of imidazole and DMAP at 0 °C. The 
substrate scope began with altering alkyl functionality at R1 and maintaining a phenyl ring at the 
alkyne terminus. Homopropargylic alkyl functionality was well tolerated with methyl (1.42, 55%), 
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n-heptyl (1.57, 60%), cyclohexyl (1.58, 60%) and dihydrocinnamyl (1.59, 58%) providing dienes 
1.42, 1.57-1.59 in good yields. Tertiary homopropargylic tethered alcohols also performed well 
generating dienes 1.60 (65%) and 1.61 (55%) efficiently. Aryl substituents at the homopropargyl 
position, phenyl (1.62, 54% and 1.63, 63%), biphenyl (1.64, 57%) and para-nitro (1.65, 60%) also 
worked well. Next, aryl substitution on the pendant alkyne was examined. It was observed that 
ortho substitution (i.e.2-chlorophenyl-) did not participate in the reaction, presumably due to steric 
crowding. Fortunately, aryl substituents bearing meta substitution worked well and gave 3,5-xylyl 
substrate 1.66 in 57% yield. Altering the electronic structure of the aryl group at the para position 
it was observed that methyl (1.67, 55%) and the electron donating methoxy group (1.68, 68%) 
provided higher yields than an electron withdrawing acetyl group(1.70, 45%). Fluorine 
substitution was also compatible and diene 1.69 was obtained in 59% yield. Dienes 1.62 and 1.64 
were synthesized on a 2 mmol scale and the isolated yields obtained were within ± 3% of those 
conducted at 0.3 mmol.  
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Table 6: Silyl Dienylboronate Substrates 
 
 
    
1.42, 55%a 
 
1.57, 60% a 1.58, 60% a 1.59, 58% a 
    
1.60, 65% 
 
1.61, 55% a 
 
1.62, 54% 
 
1.63, 63% 
    
1.64, 57% a 1.65, 60% 
 
1.66, 57% a 1.67, 55% a 
   
 
1.68, 68% 1.69, 59% 1.70, 45%  
 
a reactions conducted by Lauren Kaminsky 
With the isolated yields of dienes 1.42, and 1.57-1.70 under 70% a few substrates with the 
pinacol boronate 1.39c were inspected (Table 7). These substrates produced a lower crude yield 
but the dienes proved more stable to isolation with minimal product loss during chromatography. 
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Going back to the drawing board ruthenium catalysts were investigated in order to identify, 
solvents and temperature then finally vinylboronate 1.39c equivalents that could provide the best 
results. 
As previously observed with boronates 1.39a and 1.39b, ruthenium catalyst 
RuHCl(CO)(PCy3) performed the best compared to the other ruthenium hydride sources examined. 
RuHCl(CO)(Pt-Bu2Me)2 provided very similar results but greater amounts of dimer (1.41c) were 
observed and this hydride source was disregarded. It was decided that 5 mol % RuHCl(CO)(PCy3)2 
would be used for the remainder of the evaluation. 
Table 7: Catalyst Screen for Vinyl Boronate Coupling with 1.39c  
 
 
entry catalyst time (h) yield 1.71 (%)a dimer (1.41c)a 
1 RuHCl(CO)(PCy3)2 3 70 3 
2 RuHCl(CO)(SIMes)(PPh3) 1 21 4 
3 RuHCl(CO)(Pi-Pr3)2 3 53  10 
4 RuHCl(CO)(Pt-Bu2Me)2 3 71 12 
5 RuHCl(CO)(Pt-Bu2Cy)2 1 43 34 
6 RuHCl(CO)(PPh3)3 10 0 8 
a
 percent yield determined by crude 1H NMR versus mesitylene as an internal standard 
 
As seen in Table 8, lower temperatures required longer reaction times and diminished 
yields were observed (Table 8, entries 1-4). The reaction in DCE heated to 85 °C was superior to 
other solvents at the same temperature, and this solvent was chosen along with two equivalents of 
1.39c as the standard conditions. Attempting the reaction using vinyl boronate 1.39c as solvent 
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(1.0M in alkyne) proved unsuccessful, as the dimerization product 1.41c was observed in a nearly 
equal ratio to the desired product 1.71 (entry 10). 
 
Table 8: Solvent, Temperature and Equivalents Screen with 1.39c 
 
entry solvent equiv. 1.39c temp (°C) time (h) yield 1.71 (1.41c)a 
1  DCM 2 50 24 No reaction 
2  DCE 2 70 8 60 (3) 
3  THF 2 70 8 42 (4) 
4  DCE:THF (1:1) 2 70 14 60 (9) 
5 1,4-dioxane 2 85 3 57 (5) 
6 DCE 2 85 3 70 (3) 
7 DME 2 85 3 59 (0) 
8 PhMe 2 85 3 56 (5) 
9 DCE 1.2 85 5 54 (2) 
10 - Neat (1.0M) 85 3 38 (20) 
11 1,4-dioxane 2 100 3 66 (7) 
12b DCE 2 85 6 60 (3) 
      
a percent yield determined by crude 1H NMR versus mesitylene as an internal standard b 1.39c and alkyne 1.33 were 
added as a 0.5M solution in DCE to reaction via syringe pump over 1 h. 
 
 
In regard to Scheme 17, the isolated yield of diene 1.71 using the pinacol boronate 1.39c 
was consistent with diene 1.42 using the hexylene glycol boronate 1.39b; however, dienes 1.72-
1.74 displayed increased isolated yields of 7-18% when compared to 1.60-1.62, respectively. 
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Scheme 17: Ruthenium Hydride Coupling Substrate Scope Using Vinyl Boronate 1.39c 
 
The silyl-dienyl boronates obtained from these reactions could be further manipulated into 
more diverse molecules by the use of various metal-catalyzed coupling methods (Scheme 18).41, 
46 Suzuki coupling66 with diene 1.62 or 1.74 and iodobenzene produced 1.75 in comparable yields 
with retention of configuration. Iodo-deboration52 of the same dienes provided silyl-dienyl iodide 
1.76 in 60% and 66% isolated yields, respectively. Iodide 1.76 was subsequently used as a coupling 
partner under Sonogashira6 conditions to afford dienyne 1.77 in 88 % yield.  
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Scheme 18: Synthetic Derivatization of Silyl-dienyl Boronates 
 
a reactions conducted by Lauren Kaminsky 
 
After significant examination, suitable conditions67 were established for the tandem silyl-
boration of alkyne 1.33 and in-situ Suzuki coupling of diene 1.62 with 4-iodotoluene (Scheme 19). 
This protocol provided diene 1.78 in 54% isolated yield over two steps. With identical conditions 
and diene 1.74 Suzuki coupled product 1.78 was obtained in a 55% isolated yield over two steps. 
  
31 
 
 
Scheme 19: Tandem Hydride Coupling-Suzuki Coupling 
 
a reaction conducted by Lauren Kaminsky  
 
Attempts to form the Z,Z dienyl bromide52 from diene 1.62 were not successful and gave a 
complex mixture with mostly proto-desilylation. Several other reactions were attempted for 
derivatization that resulted in undesired transformations. For example, diene 1.74 was treated with 
methyl lithium in an attempt to form the borate complex in situ (Scheme 20).68 Once the borate 
complex is formed the addition of iodine should induce a migratory insertion of the methyl group, 
followed by NaOH mediated deiodoboration. However, when this protocol was subjected to 
silyldienyl-boronate 1.74, methyl lithium was selective for the vinyl silicon moiety and we 
observed a new vinyl trimethyl silane by proton NMR.  
Scheme 20: Borate Complex Formation and Migratory Insertion of Methyl Group 
 
The formation of silyl-dienyl boronates by a trans-silylation protocol with internal alkynes 
and vinyl boronates has been successfully demonstrated. Highly substituted dienes were formed 
in a single step and were transformed into more complex diene products by Suzuki couplings and 
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iodo-deboration. The vinyl iodide was transformed under Sonagashira coupling conditions to 
produce a diene-yne. The silyl-dienylboronate motif will be explored further toward the synthesis 
of more complex molecules and natural products. 
Our initial reports of intermolecular ruthenium hydride catalyzed couplings using alkynes 
and olefin acceptors was rewarding. We developed a stereo and regioselective approach toward 
conjugated dienes through an anti-exo-dig cyclization. The products have an exocyclic diene with 
a tetrasubstituted double bond containing four different substituents. Other similar protocols used 
to form tetrasubstituted olefins from alkynes have been reported in the literature.69-72 However, 
processes like silylformylation occur via syn addition to the alkyne.73,74-77 There are a select few 
examples that provide anti addition products to alkynes and the silylvinylation of internal alkynes 
using ruthenium hydrides now fits in this category.29, 78, 79 
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1.2 ETHYLENE TRANSFER 
1.3.1 Intramolecular Silylvinylation 
The unexpected discovery of an ethylene transfer reaction occurred during the preliminary 
screening of ruthenium hydride catalysts (Scheme 21). A terminal diene 1.35 was observed in a 
nearly 1:1 ratio with acrylate incorporation when RuHCl(CO)(SIMes)PPh3 was used as the hydride 
source. Given the novelty and atom economy of the process we sought to optimize conditions to 
obtain vinylated product (1.35).  
Scheme 21: Reaction Discovery and Proposed Ethylene Transposition 
 
 
We anticipated that the exclusion of a coupling partner in a sealed environment would 
produce a smooth intramolecular ethylene transfer. The reaction was stirred for 14 h at 85 °C in a 
sealed tube using DCE as solvent and only 70 percent conversion of alkyne was observed (Scheme 
22). Under these conditions we observed for the first time a cycloisomerization byproduct (1.79) 
along with desired diene product (Z-1.35). The cycloisomerization of substituted enynes was 
unanticipated; however, the process has been reported previously using ruthenium hydrides.22 The 
byproducts were easily separated by column chromatography and independently characterized.  
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Scheme 22: Ethylene Transposition and Cycloisomerization Byproduct 
 
 
In retrospect, the intermolecular couplings were complete in less than 9 hours. Taking this 
into consideration led us to the assumption that olefin additives may be required for this reaction 
to go to completion (Table 9). We chose to screen primarily electron deficient olefin additives due 
to the inherent lack of reactivity that we had previously observed in the intermolecular coupling. 
As shown in Table 9, using no additive (entry 1) produced better results than many other additives. 
Acrylamides and acyclic vinyl ketones afforded full conversion and high yield of the product with 
an excellent ratio of (Z)-1.35 to 1.79 (entry 7-8). The use of cyclohexanone as an additive suggests 
that 4-coordination to the ruthenium may not be a requirement (entry 9). We also examined 
using ethylene (entry 10), however, a mixture of inseparable stereoisomers of 1.35 were obtained. 
Methyl vinyl ketone (MVK) was chosen as the additive as it provided the highest ratio of (Z)-1.35 
to 1.79, and its volatility facilitated its removal from the reaction mixture. 
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Table 9: Screen of Additives for Ethylene Transposition 
 
Entry Additive Crude yielda (%) Ratiob (Z:1.79) 
1 - 70 3.1:1 
2 
 
50 1.9:1 
3  55 4.5:1 
4  Trace - 
5  77 3.8:1 
6  76 3.7:1 
7  100 5.8:1 
8  100 5.7:1 
9 cyclohexenone 80 3:1 
10c C2H4(g) 1 atm 100 17:1 
    
  aYield based on remaining 1.33 by 1H NMR versus mesitylene as an internal standard. Reactions conducted by 
JinboZhao and Shasha Liu. bRatio of (Z)-1.35 and 1.79 was determined by 1H NMR versus mesitylene as an internal 
standard. c 1.35 was obtained as a mixture of isomers (10:1, Z:E) as observed by 1H NMR. Reaction conducted by 
Robert J Wilson 
 
The initial catalyst screen during the acrylate study revealed ruthenium hydride complex 
RuHCl(CO)(SIMes)(PPh3) bearing an NHC ligand to be the only complex to provide vinylated 
product (Z)-1.35. With this complex in the presence of MVK, alkyne 1.33 was successfully 
transformed and (Z)-1.35 and 1.79 were observed in an 85:15 ratio (Table 10, entry 1). Altering 
this complex by one degree of unsaturation to the NHC backbone [RuHCl(CO)(IMes)(PPh3), entry 
2] or phosphine exchange [RuHCl(CO)(SIMes)(PCy3), entry 3] offered little improvement in 
conversion and yield for this reaction. Attempts to generate the active NHC complex in situ from 
commercially available RuHCl(CO)(PPh3)3 and SIMes
.HCl did not provide any reaction.  
Assessment of catalyst loading and MVK concentration was also investigated to further optimize 
this reaction. In a 1:1 ratio of MVK to RuHCl(CO)(SIMes)(PPh3), 83% conversion was attained 
in only 5 hours. Addition of 10 mol % MVK (2:1 ratio, MVK:RuHCl(CO)(SIMes)(PPh3)) 
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provided the best results for both yield and product ratio ((Z)-1.35:1.79). Interestingly, it was found 
that the loading of complex RuHCl(CO)(SIMes)(PPh3) could be decreased when a high 
concentration of MVK was maintained. This came at the expense of reaction time and the 
possibility of less than full conversion. The current hypothesis is that the additive protects the 
ruthenium catalyst from decomposition.80, 81 Several solvents worked well in this reaction 
including toluene and 1,2-dichloroethane (DCE). Unfortunately a full solvent screen was not 
conducted. DCE was used first and excellent yields were obtained. Later on it was discovered that 
1,4-dioxane could be used as a chelating solvent that also worked as the additive with many of the 
substrates. 
Table 10: Catalyst Screen for Ethylene Transpostion 
 
Entry RuH (5 mol %) MVK (mol %) Time (h) Conv. (%) ratio ((Z)-1.35:1.79) 
1 RuHCl(CO)(SIMes)(PPh3) 10 5 100 85:15 
2 RuHCl(CO)(IMes)(PPh3) 10 12 65 54:10 
3 RuHCl(CO)(SIMes)(PCy3) 20 23 45 25:4 
4 RuHCl(CO)(Pt-Bu2Me)2 20 24 50 1:18 
5 RuHCl(CO)(PPh3)3 10 24 No reaction - 
 
The substrate scope of this reaction was also examined (Table 11) using 5 mol % catalyst 
RuHCl(CO)(SIMes)(PPh3), and 10 mol % MVK. Alkynes bearing a phenyl group at the terminus 
were examined first.  Dienes Z-1.35 and Z-1.88-1.92 were produced from the corresponding 
phenyl alkynes. These substrates performed very well, delivering products in good yields (64-
80%) with ratios of ethylene transfer to cycloisomerization consistently around 5:1 and 10:1 (ratios 
in parenthesis). Both electron rich functionality Z-1.93 and electron withdrawing functionality Z-
1.95 and Z-1.96 were well tolerated. Compound Z-1.96 was crystallized and the structure as 
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depicted was verified through X-ray diffraction. All other structures have been determined through 
NOESY experiments or by analogy. Compound Z-1.94 which bears a fluorine moiety was 
prepared in 71% yield. A 3,5-xylyl moiety at the alkyne provided diene Z-1.97 in 73% yield. Bulky 
ortho substituents such as chlorine and 1-naphthyl were well tolerated and afforded Z-1.98 in 73% 
yield and Z-1.99 in 63% yield respectively. These structures (Z-1.98 and Z-1.99) appear as 
mixtures of atropisomers by proton NMR.  Alkynes 1.84 and 1.85 which possess both propargylic 
and homopropargylic functionality provided >30:1 ratios of products Z-1.101 and Z-1.102 in 64% 
and 65% yield, respectively. Compound Z-1.38, which represents a trans relationship at the 
propargyl and homopropargyl positions also provided an excellent ratio of 15:1 in 61% yield. Six-
membered oxo-silylcycles could also be formed efficiently regardless of Thorpe-Ingold factors.82 
Compounds Z-1.103 and Z-1.104 were obtained in 59% and 74% yields, respectively. Of note, 
seven-membered ring product Z-1.105 was formed in 53% yield using this methodology. Ojima 
et al. have observed that forming seven-membered rings using rhodium catalyzed silylformylation 
proceeds to give a mixture of products with only trace amounts of the desired product observable 
by 1H NMR and GC-MS.83, 84 In our case, the corresponding eight-membered ring was not 
observed in the 1H NMR of the crude reaction mixture.   
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Table 11: Scope of Silylvinylation Using MVK with Aryl-Substituted Alkynesa,b 
 
 
 
aYields represent only isolated vinylation products Z. bRatios in parenthesis represent the ratio of vinylation product 
Z to cycloisomerization product as determined by 1H NMR of the crude reaction mixture. cStructure verified by Dr. 
Nadia Marino via X-ray crystallography . dReactions conducted by Robert J Wilson, all others conducted by Shasha 
Liu and Jinbo Zhao 
 
A primary goal of the silylvinylation project was to attain stereo, regio and 
chemoselectivity for alkynes bearing alkyl groups. Alkyl groups appended to diene motifs are 
more prevalent than aryl moieties in natural products. Our efforts to convert alkyl bearing alkyne 
substrates with these transposition conditions formed only cycloisomerization products (Table 12). 
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Cycloisomerization was the only outcome regardless of the alkyl substituent attached to the alkyne 
(1.129-1.132).  
 
Table 12: Diene Formation with Alkyl-Substituted Alkynesa 
 
a reactions conducted by Shasha liu and Jinbo Zhao 
The undesired cycloisomerization proved troublesome and a new method was required to 
avoid this result. Since the concentration and ratio of additive to catalyst played a favorable role 
in this ethylene transposition we sought to compare these results with the use of ethylene gas. 
Previously, an isomeric olefin mixture was observed when ethylene gas was utilized as an additive. 
This was originally observed as a deleterious effect and ethylene was disregarded as the additive 
of choice. It was predicted that increasing the amount of additive to exponentially greater quantities 
would produce more efficient catalytic turnover and possibly reduce or eradicate the 
cycloisomerization byproduct.  
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1.3.2 Silylvinylation Using Ethylene Gas as an Additive 
Alkenes are one of the most useful functional groups because they are tolerant to many 
conditions and known to undergo a variety of transformations.85 Ethylene is the simplest alkene 
that is made in enormous quantities with nearly 150 million lbs produced daily.86 It is also an 
economical resource ideal for vinylation chemistry as only one hydrogen atom is lost during the 
process.85 Ethylene has been utilized in numerous organic transformations including Mizoroki–
Heck reactions,87, 88 enyne metathesis17 and hydrovinylation (Scheme 23).24, 89, 90 Our previous 
screen of additives for silylvinylation revealed ethylene as an interesting choice. As a gas the 
excess additive quickly dissipates and is no longer a concern in the reaction mixture. The use of 
ethylene gas as an additive provided us with more rapid conversion to product but at the expense 
of stereocontrol. Using ethylene warranted a more thorough investigation for the silylvinylation of 
alkynes. The silylvinylation of internal alkynes delivers a well-defined tetra-substituted olefin, a 
new vinyl group and vinylsilane of significantly increased complexity.42 Vinyl silicon species are 
of particular interest due to their use in carbon-carbon bond forming reactions41, 46 allowing for 
further synthetic manipulations.  
Scheme 23: Examples of Ethylene used in Organic Transformations 
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Our main goal for this study was to improve the ethylene insertion process and to expand our 
repertoire of alkynes to include alkyl substituted substrates. Secondary goals included eradication 
of cycloisomerization byproducts (i.e. 1.79), reduction of catalyst loading and decreasing reaction 
times.   
Based on the product formation observed previously, we suggest a mechanism which can 
illustrate the ruthenium hydride catalyzed vinylation of internal alkynes (Figure 7). Phosphine 
dissociation from complex RuHCl(CO)(SIMes)(PPh3) provides ruthenium complex A which 
undergoes olefin insertion to provide alkyl-ruthenium B. Silane B liberates ethylene while the 
silicon transfers to ruthenium to give silyl-ruthenium intermediate C. Although we do not favor a 
direct trans-addition across the alkyne pi-system, the process has been observed by others (vida 
supra, section 1.2.1). Our mechanistic proposal suggests that cis-metallation (C to D) is followed 
by isomerization (D to E) and is supported by empirical data (vida infra). Subsequent insertion of 
ethylene into vinyl ruthenium E and beta-hydride elimination of F liberates the product and 
regenerates ruthenium hydride A to complete the catalytic cycle. We anticipated that the addition 
of ethylene to the reaction would increase the conversion of alkyne by silylvinylation in preference 
to the undesired cycloisomerization. Additionally, the use of ethylene could provide some 
understanding of the mechanism of this reaction; our hypothesis being that increasing the amount 
of ethylene in the reaction would trap proposed cis-isomer D prior to isomerization to trans-isomer 
E. Using ethylene-d4 we observed incorporation of exogenous ethylene into the product (Scheme 
24). This outcome affirms that the ethylene being added to the system can be incorporated into the 
product. Another aspect of this study was to obtain silylvinylation of internal alkyl substituted 
alkynes. Previously, ethylene transposition of these alkynes provided solely cycloisomerization 
products presumably through intermediates G and H (Figure 7). 
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Figure 7: Mechanistic Hypothesis for Ethylene Addition to Alkynes 
Scheme 24: Isotopic Labeling Experiment 
 
Table 13: Catalyst Screen for Silylvinylation under 1 Atmosphere Ethylene 
 
 
entry catalyst time (h) Conversion Z:1.79:E yield Z-1.35 (%)a 
1 RuHCl(CO)(SIMes)(PPh3) 1 100 18:1:2 91 
2* RuHCl(CO)(PCy3)2 7 89 55:4:1 55  
3* RuHCl(CO)(Pt-Bu2Cy)2 7 43 1:0:0 23   
4* RuHCl(CO)(Pt-Bu2Me)2 7 33 6:1:0 18   
5*c RuHCl(CO)PR3 7 29 1:0:0 11   
 
aYield determined by 1H NMR vs mesitylene internal standard. *5 mol % catalyst was used. 
c PR3 = (3,5-bis(trifluoromethyl)phenyl)diisopropylphosphine. 
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This investigation began by reacting alkyne 1.33 with 1 mol% of 
RuHCl(CO)(SIMes)(PPh3) under an atmosphere (balloon) of ethylene in 1,2-dichloroethane 
(DCE) at 80 °C. A rapid (1 h) reaction was observed that produced silylvinylation product 1.35 as 
a 9:1 mixture of Z and E isomers (Table 13, entry 1). The observed result supports the claim that 
syn-metallation (i.e. formation of D) followed by isomerization occurs to give E which proceeds 
to the silylvinylation products observed. Further examination of catalysts revealed that complex 
RuHCl(CO)(SIMes)(PPh3) was the optimum ruthenium hydride catalyst and in many cases 1 mol 
% was sufficient to provide the desired products. Alternatively, ruthenium hydride complexes that 
bear two large phosphine ligands instead of the NHC, do provide some of the silylvinylation 
products. These complexes (Table 13, entries 2-5) required higher catalytic loadings and longer 
reaction times. It was observed that the more electron rich complexes afforded higher conversion 
and larger quantities of product (Table 13). Presumably RuHCl(CO)(SIMes)(PPh3) is superior due 
to the greater donating ability of the NHC91 and the enhanced lability of the less basic PPh3 
ligand.92 The bis phosphine complexes also provided less desired product than 
RuHCl(CO)(SIMes)(PPh3). Other solvents such as toluene and 1,4-dioxane were also found to be 
suitable for this reaction at 80 °C. 
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Scheme 25: Substrate Scope for Silylvinylation Using Ethylene Gas 
 
aRatios determined by 1H NMR using mesitylene as an internal standard. Products were isolated as a mixture of Z/E 
isomers. bReaction conducted by Lauren Kaminsky. cReaction conducted by Ijaz Ahmed. 
 
 The substrate scope was examined using complex RuHCl(CO)(SIMes)(PPh3) in 
DCE at 80 °C (Scheme 25). The substrates were developed by keeping the aryl group constant and 
altering groups at the homo-propargyl and propargyl positions. The reaction tolerated methyl and 
cyclohexyl groups at the homo-propargyl position and gave 1.135 and 1.136 in 80% and 70% 
yield, respectively. Aryl groups were also well tolerated and 1.137 was formed in 65% yield. 
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Multiple substitutions at the homopropargyl position afforded 1.138 in 69% and 1.139 in 76% 
yield. Previously, using MVK as an additive, only partial conversion to diene 1.140 was observed; 
here 1.140 was rapidly produced in 67% yield. Products 1.141 (78%) and 1.142 (70%) demonstrate 
that the reaction works well with substitution in the syn or anti relationship at the propargyl and 
homopropargyl locants. Next, variation of the aryl moiety at the alkyne terminus was examined. 
As anticipated, para-substitution was well tolerated with the 4-fluorophenyl providing 1.143 in 
69% yield as essentially a single isomer. Chlorines were also amenable to these reaction conditions 
giving 1.144 in 70% yield. The ortho-chloro substituent did not hamper the efficiency of the 
reaction, nor did ortho-substituted groups like 1-naphthyl which gave 1.145 in 71% yield. The 3,5-
xylyl moiety afforded 1.146 in 74% yield without difficulty. Electronics of the aryl group was also 
examined using 4-anisole and 4-acetophenone derivatives which provided 1.147 in 73% yield and 
1.148 in 64% yield. Interestingly, although the yields are comparable, the ratio of isomers was 
substantially different in these cases. Finally, six membered oxasilacycle 1.149 was formed in 82% 
yield under these conditions. 
 
  The aryl substrates provided excellent selectivity for silylvinylation versus 
cycloisomerization (≥20:1) compared to previous results (5-8:1, section 1.3.1). With these results 
it was envisioned that higher concentration of ethylene (increased pressure) would further reduce 
or eliminate the cycloisomerization byproducts. Using alkyne 1.33 the amount of ethylene was 
systematically increased by 20 psi. The amount of the (E) isomer (syn-addition product) observed 
increased as a function of pressure. As speculated, the cycloisomerization byproduct was not 
observed over the pressure range studied (Table 14). To ascertain whether the pressure or 
concentration was influencing the outcome, a control experiment with increased argon pressure 
46 
 
 
was conducted. At 80 psi of argon the reaction was retarded and approximately 23% conversion 
with only 11% of the (Z) isomer observed by 1H NMR. This supports the hypothesis that increased 
ethylene concentration thwarts isomerization and produces greater quantities of syn-silylvinylation 
or the (E) isomer. To the best of our knowledge increased ethylene pressure has not been shown 
to overcome inherent selectivity of a substrate for stereocontrol.  
Table 14: Sequential Increase of Ethylene Pressure 
 
entry pressurea ratio (Z:E)b 
1 balloon 9:1c 
2 20 psi 6:1 
3 40 psi 2.5:1 
4 60 psi 1:1.4 
5 80 psi 1:1.7 
6 80 psi (Ar(g)) 1:0d 
aReactions were pressurized at room temperature prior to heating. bDetermined by 1H NMR. cCycloisomerization 
was observed for the standard reaction. d23% conversion and 11% Z observed. 
  The silylvinylation pressure study also revealed an interesting electronic trend. The E:Z 
ratio of silylvinylation products was influenced by the electronics of the alkyne (Table 15). 
Electronic neutral and weakly withdrawing alkynes gave ~1:2 ratio of Z:E (entry 1 and 2 
respectively). Electron rich alkynes (entry 3) produce the Z isomer as the major product, while 
electron deficient alkynes provide the E isomer (entry 4). Increasing the ring size from five to six 
surprisingly yielded a 25:1 ratio of Z:E (entry 5). These preliminary results warrant further 
examination i.e. higher pressures and increased reaction times, to determine the intrinsic electronic 
preference.  
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Table 15: Electronic Differentiation of Alkyne Terminus at 80 psi Ethylene 
 
entry substrate time (h) conv. (%) ratio (Z:E) yield (%)a  
1 Ar = Ph 4 100 1:1.7 (99)b 
2 Ar = 4-F 4 100 1:1.3 85 
3 Ar=4-OMe 6 100 3:1 91 
4 Ar = 4-Ac 24 100 1:7 86 
5 Ar = Ph, n= 2 24 100 25:1 72 
aYield in parenthesis determined by 1H NMR with mesitylene as an internal standard. b Reaction by Lauren 
Kaminsky 
The study continued by examining substrates that had previously proceeded via 
cycloisomerization (i.e. alkyl-substituted alkynes, section 1.3.1) or were aberrant at lower ethylene 
pressure. To our delight, excellent results were obtained when alkyl-substituted alkynes were 
employed in this reaction (Figure 8).  
 
Figure 8: Reactions of internal alkyl alkynes at 80 psi. 
 Structures are depicted as the major isomer. Ratio (Z:E) determined by 1H NMR and confirmed by nOe or 
NOESY experiments. 
 
Methyl substituted dienes 1.150 and 1.151 were formed in 84% yield, both favoring the 
syn-addition as the major product. Increasing the alkyl chain by one carbon to ethyl gave 1.152 in 
79% yield; adding three carbons gave n-butyl 1.153 in 69% yield, and further extension to n-hexyl 
provided 1.154 in 83% yield. In the later three cases, anti-addition products were the 
predominantly observed. Given the similar steric environment existing around these alkyl groups, 
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we suggest that the observed product ratios are due to the subtle increase in electron donating 
ability of these substrates.  
Scheme 26: Synthetic Elaboration of Dienes 
 
a reaction conducted by Lauren Kaminsky 
 
  It was considered essential to demonstrate the synthetic utility of these systems. Fleming–
Tamao oxidation45 under neutral conditions provided only slow decomposition of diene 1.137. 
Utilizing basic conditions (Scheme 26, eq. 1) afforded α,β-epoxy ketone 1.155 in 70% yield. 
Presumably, the excess basic peroxide facilitates a Michael addition into the newly formed α,β-
unsaturated ketone (i.e. 1.156). In order to avoid this undesired Michael addition acidic conditions 
were explored. Propionic anhydride, KHF2, and peroxide were added to the silane in DMF, and 
enone 1.156 was obtained in 85% isolated yield as a single isomer (eq. 2). These complementary 
methods provided access to -hydroxy-ketones in good yield. Several attempts to utilize the vinyl 
silyl moiety in Hiyama–Denmark93 chemistry resulted in undesired reactions. It was discovered 
that one of the undesired products was in fact a Heck product (1.157). When diene 1.137 was 
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subjected to the palladium catalyzed conditions using [(C3H5)PdCl]2, CuI, KF·2H2O, and 4-
iodotoluene in DMF at room temperature compound 1.157 was observed in low yield. After some 
experimentation the reaction of diene 1.137 with Pd(OAc)2, K2CO3, and 4-iodotoluene in DMF at 
80 C afforded 1.157 in 64% yield (eq. 3). We are currently exploring conditions that will 
selectively couple the silicon with Aryl halides to directly access all carbon tetrasubstituted olefins. 
Additionally, Tamao oxidation was particularly useful with compound 1.150 which was 
successfully converted into enone 1.158 (eq. 4). In fact, introducing an E/Z olefin mixture into the 
reaction was of no consequence as compound 1.158 was isolated in 73% yield as a single double 
bond isomer.  
  
Other transformations were conducted which provided diene decomposition or less than 
optimal yields. Reactions such as cyclopropanation and ozonolysis quickly destroyed the diene 
and no discernable products were obtained. Other chemical transformations such as Wacker 
oxidations94, Pauson–Khand reactions95 and Hiyama-Denmark46, 96, 97 reactions either provided no 
reaction, slow decomposition or small quantities of undesired products (Scheme 27).  
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Scheme 27: Unsuccessful Derivatization 
 
Olefin cross metathesis was attempted with a few Grubbs type catalysts and several olefins 
including acrylic acid, acrylates, acrylamides, N-hydroxy-acrylamides, allyl alcohol and vinyl 
boronates. All attempts were negative using these alkenes (Scheme 28). Previously, using alkyne 
1.33 and 1-hexene the reaction succeeded and could be conducted in tandem with the 
silylvinylation reaction (conducted by Jinbo Zhao65).  
Scheme 28: Unsuccessful Examples of Cross Metathesis Reactions 
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A few general reactions were successful but formed low yields of products. Several epoxidation 
reactions were conducted, and it is theorized that most of the reagents used for this transformation 
(m-CPBA98, DMDO99, Davis oxaziridine100, and Payne oxidation101) are not selective for the 
terminal olefin (Scheme 29). In some cases the vinyl silicon was destroyed or Tamao products 
were observed by 1H NMR, along with some epoxide formation.  
Scheme 29: Epoxidation Reagents 
 
Nevertheless, using m-CPBA in DCM provided racemic epoxide 1.159 in a 38% yield (Scheme 
30). The hydroboration/oxidation provided alcohol 1.160 with minor impurities after isolation. 
Dihydroxylation followed by cleavage of the terminal olefin would be an extremely useful 
transformation. It would generate a novel anti-“silylformylation” product that is difficult to obtain. 
The dihydroxylation reaction was discovered to work in moderate yield using acidic conditions 
developed by Plietker et al.102, 103 The oxidative cleavage of diol 1.161 requires future 
investigation. 
Scheme 30: Un-optimized Derivatization of Diene 
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 Ethylene gas was successfully utilized in the ruthenium hydride catalyzed silylvinylation of 
internal alkynes. It was demonstrated that this protocol was useful for the synthesis of highly 
substituted conjugated dienes. When the reaction was conducted at increased pressure of ethylene 
(80 psi) competing cycloisomerization of the starting enyne was inhibited and not observed. 
Additionally, it was demonstrated that alkyl substituted alkynes produced silylvinylation products 
in excellent yield. The resulting dienes were transformed into epoxy-ketones and enones using 
complementary oxidation conditions. Finally, a regio- and stereoselective Heck coupling was 
reported which further enhances the scope of this chemistry beyond simple vinyl moieties.   
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1.3.3 Silylvinylation of Terminal Alkynes 
Alkynes are key functional groups used in the preparation of many organic molecules. 
Transformations of alkynes often include the production of alkenes. Catalytic transformations of 
terminal alkynes that provide chemists with reliable functional handles appended to the resultant 
alkene are perpetually in demand. Some of the most useful transformations include 
hydrosilylation30, 104-106 and silylformylation.69, 75, 77, 107, 108 Transition metal-catalyzed 
hydrosilylation of terminal alkynes are highly predictable resulting in well defined vinylsilanes.109 
Intermolecular hydrosilylation of terminal alkynes can produce three isomers, the trans-, the cis-
 or the  adducts. This of course can be attenuated depending on factors including temperature 
and catalyst.104 Transitioning an intermolecular reaction into an intramolecular reaction using 
temporary silicon tethers helps to define a more robust system with added predictability.27 In 
addition to being highly selective, these reactions create complex silanes which offer a versatile 
functional handle for further manipulation.110 For example, intramolecular hydrosilylation of 
terminal alkynes is in most cases regio and stereo specific. Silylformylation is a remarkably 
efficient intramolecular transformation of terminal alkynes.71, 84 Included in this regime of 
chemistry are several tandem processes that produce very diversely functionalized molecules. 
Denmark has consistently improved and utilized silylation chemistry followed by palladium 
catalyzed coupling of the activated silicon species.41, 111 While in another realm, Leighton elegantly 
provided the community with silylformylation/allyl and crotylsilylation methods to produce 
polyols.108, 112   
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Figure 9: Hydrosilylation and Silylformylation of Terminal Alkynes 
Intramolecular ruthenium catalyzed transformations of terminal alkynes consist mainly of 
cycloisomerization,9, 113, 114 enyne metathesis17, 115, 116 and hydrosilylation.29, 30, 117, 118 We have 
recently developed a regiospecific ruthenium hydride catalyzed silylvinylation of internal alkynes 
for the synthesis of conjugated dienes.28, 65, 119 These methods produce oxasilacycles via trans-exo-
dig cyclizations. The catalytic trans addition to alkynes is rare but not unprecedented.29-31, 33-35 
However, the empirical data gathered in these laboratories does not favor a direct trans addition 
in the silylvinylation of alkynes.28, 65 In previous studies with increased concentration of ethylene 
gas we observed higher chemoselectivity for vinylation over cycloisomerization with the sacrifice 
of stereochemistry. Presumably a traditional syn addition to the alkyne followed by an 
isomerization affords the observed products. It is believed that the isomerization is only partially 
observered due to the rapid incorporation of exogenous ethylene. Given the utility of this 
transformation, development of a complementary route toward the selective syn silylvinylation of 
alkynes was desired. Herein the execution of this protocol using vinyl siloxy tethered terminal 
alkynes is reported.  
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Figure 10: Ruthenium Hydride Catalyzed Silylvinylation of Terminal Alkynes (This Work) 
It was initially observed that higher concentrations of ethylene gas promote a more smooth 
transition to silylvinylation products, albeit as a mixture of stereoisomers (section 1.3.2). This 
study began with a solvent and temperature screen utilizing RuHCl(CO)(SIMes)(PPh3) at 80 psi 
of ethylene gas. Complex RuHCl(CO)(SIMes)(PPh3) had previously out performed other hydride 
catalysts [RuHCl(CO)(PCy3)2, RuHCl(CO)(Pt-Bu2Me)2, RuHCl(CO)(Pt-Bu2Cy)2, and 
RuHCl(CO)(PCy2t-Bu)2]  bearing two phosphine ligands with ethylene transposition (section 
1.3.1),65 and with silylvinylation at 1 atmosphere of ethylene (section 1.3.2). Alkyne 
silylvinylation at increased pressure of ethylene had previously performed well in toluene at 80 
C. Extrapolation of these conditions with terminal alkynes for 24 hours (table 16, entry 1) 
consumed the starting material with only 40 % crude yield of product. Considering the high 
temperature and pressure it was thought that the ene-yne (i.e. 1.162) is transformed to a diene 
based on the proposed mechanism (Figure 7, section 1.3.2) followed by possible polymerization, 
isomerization or decomposition. Ruthenium hydrides are known to polymerize olefins120 and 
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isomerize 1,3-dienes at high temperature.121 The reaction time and temperature were gradually 
decreased and revealed a positive trend. At 60°C after 3 hours the reaction was complete and a 
crude yield of 68% was obtained. Seeking to further increase the yield of this reaction we set out 
to elucidate the ideal conditions to avoid the possible deleterious pathways. Previously, non-polar 
solvents such as toluene and DCE performed well (Table 16).  
Table 16: Solvent and Temperature Screen for Silylvinylation of Terminal Alkynes 
 
Entry  Solvent Temp. (°C) Time (h) Conversion (%) Yield (%)f 
1a  PhMe 80 24 100 40 
2a  DCE 80 24 100 45 
3a  Dioxane 80 24 100 54 
4a  Dioxane 60 24 52 33 
5a  PhMe 60 3 100 68 
6a  THF 60 23 100 60 
7a  CPMEe 60 18 38 21 
8a  THF 50 18 66 50 
9a  PhMe 50 24 - - 
10a  DCE 50 24 - - 
11a  MeTHF 50 23 61 48 
12b  THF 120 1 100 60 
13b  CPME 120 1 100 60 
14c  Dioxane 110 0.5 100 63 
15c  CPME 110 0.5 100 65 
16c  MeTHF 110 0.5 60 40 
17cd  CPME 100 0.5 100 73 
18cd  Dioxane 100 0.5 100 75 
19cd  CPME 90 0.5 >95 76 
20cd  Dioxane 90 0.5 >95 73 
       
a reaction conditions: Alkyne (0.3 mmol), RuH (2 mol %), solvent (0.2M). bRuH (5 mol %), solvent (0.05M). c RuH 
(5 mol %), solvent (0.1M). d Reaction conducted by Alex Dixon. e CPME = cyclopentyl methyl ether.f determined by 
1H NMR using mesitylene as an internal standard 
 
Along with toluene and DCE we chose other conventional solvents used in organometallic 
reactions. Ethereal solvents like THF and 1,4-dioxane required longer reaction times at 60°C but 
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produced 1.163 in 60% crude yield. However, using 1,4-dioxane under these conditions did not 
fully consume alkyne 1.162. At 60°C in toluene the reaction was not complete after 2h. Increased 
temperatures have the benefit of decreasing the reaction time so we conducted the reaction in high 
dilution THF (0.05M) at 120°C for 1h. To our surprise the crude yield was 60%, only 2% lower 
than the 24 h reaction at 60°C. When 1,4-dioxane was examined at increased temperature diene 
1.163 was produced in 67% crude yield with no other discernable byproducts in just 30 minutes. 
Two other ethereal solvents, 2-methyl-THF and cyclopentyl methyl ether (CPME), are green 
alternatives to the customary ethers (Et2O, THF, 1,4-dioxane and MTBE).
122, 123 At 120 °C in 
CPME the reaction afforded the desired product 1.163 in 65% crude yield. Lowering the 
temperature to 100 °C in both CPME and 1,4-dioxane gave full conversion and 73% and 75% 
crude yields, respectively. With only a two percent difference in crude yield of 1.163, CPME was 
deemed a suitable replacement for the more hazardous choices. 
Seeking to enhance the formation of product 1.163 a catalyst screen was performed. 
Previous results with bis-phosphine ruthenium hydrides indicated little improvement from 
RuHCl(CO)(SIMes)(PPh3) (section 1.3.2). However, bis-phosphine ruthenium hydrides were 
examined (Table 17, Entries 2-5) and compared to complex RuHCl(CO)(SIMes)(PPh3). 
Surprisingly, complex RuHCl(CO)(PCy3)2 reacted with alkyne 1.162 but only produced 21 % of 
the desired diene 1.163. The remainder of the catalysts performed admirably specifically 
RuHCl(CO)(PCy2t-Bu)2. The dicyclohexyl-tert-butyl phosphine ligand appears to exhibit similar 
properties as the SIMes (NHC) ligand associated with RuHCl(CO)(SIMes)(PPh3).  
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Table 17: Catalyst Screen in CPME 
 
entry catalyst time (h) conv. (%) yield 1.163 (%)a 
1 RuHCl(CO)(SIMes)(PPh3) 0.5 100 65 
2 RuHCl(CO)(PCy3)2 0.5 80 21 
3 RuHCl(CO)(Pt-Bu2Me)2 0.5 90 52 
4 RuHCl(CO)(Pt-Bu2Cy)2 0.5 100 44 
5 RuHCl(CO)(PCy2t-Bu)2 0.5 100 55 
a Crude yield determined by 1H NMR using mesitylene as an internal standard 
Unfortunately, the current equipment does not safely allow for greater than 80 psi of 
ethylene gas. However, with the results obtained four alkynes were subjected to the conditions 
previously established (Scheme 31). In toluene at 80 °C, four alkynes were reacted with 
RuHCl(CO)(SIMes)(PPh3) and dienes 1.163-1.166 were obtained in good yields. The methyl 
group appended to the propargylic position appears to be a stabilizing factor due to the increased 
yields of 1.165 and 1.166. 
Scheme 31: Silylvinylation Substrate Scope of Terminal Alkynes 
 
Further analysis of reaction conditions is being investigated. The analysis includes 
temperature, time and catalyst loading. A thorough substrate survey is underway which may 
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include terminal alkynes with a variety of vinyl silicon tethers, homopropargyl substituents and 
variation at the propargylic position.   
In conclusion, we have developed a syn-selective silylvinylation of terminal alkynes. The 
reaction provides exocyclic conjugated dienes in good yields. The reaction proceeds rapidly (0.5 
h) with 5 mol % loading of RuHCl(CO)(SIMes)PPh3 at 110 °C in several solvents, and especially 
well with cyclopentyl methyl ether. The catalyst loading can be lowered at the expense of reaction 
time. Alkyl substitution at the propargylic position appears to be beneficial to the stability of the 
diene products. Further synthetic elaboration of the diene products to deliver other useful organic 
building blocks will be presented in due course.  
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2.0  SYNTHESIS OF IMIDAZOPYRIDINES 
2.1 INTRODUCTION 
Heterocyclic structures, specifically those containing nitrogen, are prevalent in 
pharmaceutical drugs and are used to treat many diseases. Nitrogenous heterocycles are also 
frequently utilized in several other useful areas including structural modifications in medicinal 
chemistry research, natural product synthesis and pesticides manufacturing (Figure 11).  
 
Figure 11: Common Nitrogen Based Heterocycles 
 
Figure 12: Imidazopyridine Nomenclature 
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Figure 13: Molecules possessing imidazopyridine structures 
One class of heterocycle of particular interest is the imidazopyridines (Figure 12). 
Imidazopyridines are biologically relevent structures commonly utilized in pharmaceuticals. These 
molecules possess many beneficial qualities that medicinal chemists seek, including solubility and 
the capacity for hydrogen bonding.124-138 These structures appear as building blocks in many drug-
like molecules and central scaffolds in natural products (Figure 13). 129-131, 139-148 The 
imidazopyridine scaffold represents a diverse group of nitrogenous heterocycles. There are several 
classes of imidazopyridines depending on the location of the pyridine and imidazole ring fusion. 
The deazapurines or imidazo[4,5-(b/c)]pyridines are often scaffolds utilized in drug candidates 
because they are isosteric with the nucleotide purine bases, adenine and guanine. Imidazo[4,5-
b]pyridines and imidazo[4,5-c]pyridines have been thoroughly investigated and several 
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pharmacological properties have been noted. For example, Ageladine A (Figure 13), is an anti-
cancer natural product isolated from marine sponge.149 One specific natural product, pentosidine, 
was a molecule of interest for its potential use as a biochemical marker.150 Access to pentosidine 
required an efficient approach to the imidazopyridine core in a regiodefined method. A simple 
protection or N-alkylation of commercially available imidazo[4,5-b]pyridine cannot be controlled 
regiospecifically and results in a mixture of three isomers (Scheme 32). Therefore a more specific 
and straightforward approach to the imidazopyridine core was needed in order to synthesize 
pentosidine. 
Scheme 32: N-Alkylation of Imidazo[4,5-b]pyridine 
 
In general, the most current methods for the production of imidazo[4,5-b]pyridines in a 
regiospecific fashion require multiple synthetic steps.133, 151-158 For example, Senanayake 
developed a three step sequence to produce a modest selection of alkyl substituted 
imidazopyridines. The sequence began with the condensation of 1,3-dicarbonyl derivatives and 
malonamidines with subsequent Hofmann rearrangement mediated by PhI(OAc)2 to provide cyclic 
urea derivatives. Finally, the urea carbonyl was activated with magnesium and condensed with 
carboxylic acids to provide substitution at the 2-position of the imidazole core (Scheme 33). 
However, this elegant procedure suffered from the lack of N-substitution.   
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Scheme 33: Senanyake Approach to Imidazo[4,5-b]pyridines 
 
In other classical syntheses, imidazopyridines are built from ortho-diaminopyridines, often 
requiring harsh conditions (Scheme 34).159 This approach to the imidazopyridine scaffold also 
lacks regioselective N-substitution or requires tedious synthetic sequences to access them. For 
instance, a more recent and divergent approach utilizes a solid-supported synthesis of 1- and 3-
deazapurines (Scheme 35).160 This method requires five or more steps with overall yields ranging 
from 20-70% and 40-80% purity. Also, because the starting pyridine contains a 3-nitro group 
access to substitution at the 3-position was not accomplished. 
Scheme 34:  Classic example of imidazopyridine synthesis 
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Scheme 35: Soural’s retrosynthetic solid phase synthesis of 1- and 3-deazapurines 
 
A new straightforward approach to the imidazo[4,5-b]pyridine scaffold in an efficient and 
regioselective manner was in demand. Previous syntheses of imidazo[4,5-b]pyridines by the 
Buchwald161 and Ma162 groups, utilized 2-halo-3-acylaminopyridines coupled with amines to give 
N-3-substituted products (Scheme 36). However, these approaches did not permit N-1 substitution. 
In 2012 Clark et al. developed a strategy utilizing a palladium catalyzed amide coupling reaction 
with a successive dehydration to form N-1 substituted imidazo[4,5-b]pyridines regioselectively 
(Scheme 37).157 The strategy utilized readily available 2-chloro-3-aminopyridines that were 
substituted with various functionality at the 3-amino group. Since then the method was utilized to 
synthesize the core imidazopyridine of pentosidine. The total synthesis of pentosidine was 
accomplished in six steps beginning with a reductive amination to protect the 3-amino group 
followed by the formation of the imidazopyridine core. The remaining steps included 
regioselective chlorination at the 2-position followed by a nucleophilic aromatic substitution and 
pyridine-N-alkylation. The final step required a global deprotection in TFA and provided 
pentosidine in a remarkable overall yield of 30% (Scheme 37).   
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Scheme 36: Previous approaches to imidazopyridines using 2-halo-pyridines 
 
 
Scheme 37: Palladium Catalyzed Amidation-Dehydration Strategy 
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2.2 DEVELOPMENT OF NEW CONDITIONS USING XANTPHOS AND A MIXED 
SOLVENT SYSTEM 
The synthesis of pentosidine demonstrated the power and utility of an amide coupling-
dehydration strategy. This work had established that bulky biaryl phosphine ligands were 
necessary to facilitate the amide coupling. Due to the high cost of these ligands, the use of alternate 
phosphine based ligands which were more economically viable was pursued. Since the inception 
of this project it was sought to improve the generality and practicality of this process. Also, a more 
diverse substrate scope with regard to chloro-pyridines and amide coupling partners was 
envisioned. In particular, the use of electron deficient benzyl moieties was ineffective using our 
previous protocol. Substrates that had unhindered chlorides (i.e. 4-chlorobenzyl) were also not 
compatible with our previous method.  
In our previous study we observed no reaction when Xantphos was used in tert-butanol. 
However, others had previously achieved Pd-catalyzed amide couplings using xantphos in aprotic 
solvents.163-165 Xantphos was re-evaluated using aprotic solvents and the desired imidazopyridine 
was obtained along with a minor amount of dehalogenated pyridine. It was hypothesized that the 
dehalogenation reaction could be attenuated by using a protic co-solvent such as tert-butanol used 
in the previous study. After a great deal of optimization, it was found that using Xantphos as a 
ligand in a mixed solvent system (1,4-dioxane and tert-amyl alcohol) gave imidazo[4,5-
b]pyridines in excellent yield (Table 18).166  
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Table 18: Substrate scope utilizing Xantphos and a mixed solvent system 
 
Entry R Yield (%)b Product 
1 1a CH2(4-OMeC6H4) 93 2a 
2 1b CH2(2,4-OMeC6H3) 81 2b 
3 1c CH2(2,5-OMeC6H3) 85 2c 
4 1d CH2(4-Me2NC6H4) 94 2d 
5 1e CH2(3-FC6H4) 94 2e 
6 1f CH2(4-FC6H4) 96 2f 
7 1g CH2(2-ClC6H4) 79 2g 
8 1h CH2(4-ClC6H4) 94 2h 
9 c 1i CH2(4-PhC6H4) 70 2i 
10 1j CH2Ph  85 2j 
11 1k (R)-CH(CH3)Ph 96 2k 
12c,d 1l CH2(3,5-OMeC6H3) 71 2l 
13 1m CH2(4-CF3C6H4) 95 2m 
14e 1n CH2(3-NO2C6H4) 57 2n 
15c,d,f 1o CH2(4-CNC6H4) 70 2o 
16 1p Ph 94 2p 
17 1q CH2(C6H11) 77 2q 
18 c 1r Cy 63 2r 
19 1s Cyp 85 2s 
20 1t i-Pr  91 2t 
a)  Reaction Conditions: 1 (0.4 mmol), Pd2(dba)3·CHCl3 (0.004 mmol, 1 mol %), XantPhos (0.02 mmol, 5 mol %), 
formamide (0.6 mmol), K3PO4 (0.6 mmol), solvent (0.2 M), 110°C, 6.5h. b) Isolated Yields c) 90% conversion based 
on crude 1H NMR using mesitylene as an internal standard. d) 2 mol% Pd2(dba)3·CHCl3 and 10 mol% XantPhos. e) 
65% conversion based on crude 1H NMR using mesitylene as an internal standard.f reaction conducted by RJW 
 
Indeed, the new approach displayed an expanded substrate scope compared to the previous 
conditions which utilized the biaryl ligand set. Electron-donating substituents (Table 18, entries 1-
4), as well as halogenated substrates (Table 18, entries 5-8) performed well, giving 79-94% yields. 
Notably, using our previous conditions, the o-chlorobenzyl subtrate 1g provided 2g in 51% yield; 
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this new protocol provided a much improved 79% yield of 2g (Table 18, entry 7).  The  p-
chlorobenzyl substrate 1h was not amenable to our previous conditions and resulted in multiple 
coupling events followed by decomposition of 1h. Under the current conditions 2h was formed in 
94% yield (Table 18, entry 8). Benzyl and 4-biphenylbenzyl substrates were also well tolerated 
under the reaction conditions (Table 18, entries 9 and 10).  As anticipated, chiral subtrate 1k 
showed no racemization and provided 2k in excellent 96% yield (Table 18, entry 11). Additionally, 
the new reaction conditions showed superiority when electron deficient benzyl were subjected to 
the protocol. Compound 1l bearing inductively withdrawing methoxy groups provided 2l in 71% 
yield. Pyridine 1m bearing a trifluoromethyl group afforded 95% yield of 2m (entry 13). In 
addition, m-nitrobenzyl 1n and p-cyano 1o gave 2n and 2o in 57% (65% conversion by 1H NMR) 
and 70% (90% conversion by 1H NMR) yields, respectively (Table 18, entries 14 and 15). Nitro 
groups previously proved detrimental to the reaction and substantial decomposition of the starting 
material and poor yields were observed for 2n. Aryl subsituents continue to perform well, with 1p 
giving a 94% yield of 2p (Table 18, entry 16). N-Alkyl substrates were again well tolerated. 
Substrate 1q with the sterically encumbered cyclohexylmethyl and cyclohexyl 1r gave 2q and 2r 
in 77% and 63% yields, respectively (Table 18, entries 17 and 18). Pyridines 1s and 1t bearing 
cyclopentyl and isopropyl moieties afforded 2s in 85% and 2t in 91% yield (Table 18, entries 19 
and 20). 
A more diverse series of amides were also compatible (Scheme 38). Benzamide and 
acetamide previously produced yields in the low 60%, and here these amides provided yields of 
78% and 83% respectively. Previously no reaction was observered using the remaining amides. 
Under the improved protocol trans-cinnamamide (96%), cyclohexane carboxamide (79%) and 
furanamide (97%) all provided the respective substituted imidazopyridines. 
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Scheme 38: Extended amide scope using the improved protocol 
 
Reaction Conditions: pyridine (0.4 mmol), Pd2(dba)3·CHCl3 (0.004 mmol, 1 mol %), Xantphos (0.02 mmol, 5 mol 
%), Amide (0.6 mmol), K3PO4 (0.6 mmol), solvent (0.2 M), 110°C. All yields are isolated. b) Amide used as limiting 
reagent, conducted by RJW. 
 
This protocol using less expensive bidentate ligand xantphos and a mixed solvent system 
greatly enhanced the access to functionalized imidazo[4,5-b]pyridines. Further studies utilizing 
this protocol will be discussed in the subsequent chapters.  
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2.3 SYNTHESIS OF IMIDAZO[4,5-C]PYRIDINES 
The construction of imidazo[4,5-b]pyridines previously discussed showed the utility and 
control that can be achieved with these systems. It was easy to target the more rare imdazo[4,5-
c]pyridine using the protocol. Imidazo[4,5-c]pyridines are currently being investigated for the 
inhibition of hepatitis C virus replication,167, 168 cyclin-dependent kinase inhibitors (i.e. 
grossularine 1 and 2)169 and other biologically relevant targets.140, 170-178 Suffering from the same 
problems as imidazo[4,5-b]pyridines, substituted imidazo[4,5-c]pyridines are also difficult to 
obtain selectively.171 However, these recent endeavors provided a means to obtain these 
medicinally relevant targets with ease.  
To begin with the appropriately substituted 3-amino-4-chloropyridines, a short synthesis 
was required in order to explore a cross coupling route. Previously, the method used for 
substitution of the N-3 nitrogen of the analogous 3-amino-2-chloropyridine  utilized reductive 
amination,179 or Chan-Lam coupling.180, 181 Attempts to substitute the 3-amino-4-chloropyridines 
using these techniques did not lead to preparative yields. Due to these unforeseen difficulties an 
alternative route to these systems was desired. The known material, 4-chloro-3-N-Boc-pyridine 
34,182 was produced from the corresponding 3-N-Boc-pyridine via directed metallation and 
chlorination.183-188 This method provided a more stable precursor as an entry into N-substituted 
pyridines (Scheme 39). Compound 34 was easily prepared and utilized readily accessible materials 
that were air and moisture stable. Another reason to manufacture 34 was due to the instability of 
commercially available 3-amino-4-chloropyridine which decomposes readily even after 
recrystallization. Starting from 3-aminopyridine, Boc protection in aqueous isopropanol gave 
compound 33 in 87% yield.189 Treating compound 33 with n-BuLi in the presence of TMEDA at 
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-78 °C followed by chlorination gave compound 34 in 65% yield. The directed metallation is 
currently being investigated in our laboratory utilizing 1,2-dimethoxy ethane as a replacement 
solvent which does not require the addition of TMEDA to facilitate this reaction. 
Scheme 39: Production of 4-chloro-3-N-Boc-pyridine 34 
 
With ample amounts of 34 in hand, various N-3 subtituted 4-chloro-3-N-Boc-pyridines 
were produced. Base mediated alkylation of the carbamate nitrogen provided N-alkyl and N-
benzyl products from the corresponding alkyl or benzyl halides; and removal of the Boc group was 
accomplished by TFA in DCM (Scheme 40).  
Scheme 40: Alkylation and Deprotection of 34 
 
 
Substituting aryl and heteroaryl functionality by this strategy was not practical. A metal 
catalyzed coupling would suffice for these substitutions. Palladium catalysis was disregarded 
because of the activated aryl chlorine present in 34. Palladium in this case could produce 
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competitive couplings or dehalogenation that would likely limit the substrate scope. Copper was 
envisioned as an ideal catalyst for the N-C coupling of an aryl halide and the carbamate nitrogen. 
Copper catalyzed amidation chemistry dates back to the early 1900’s and recently has become a 
reliable method for nitrogen substitution.190 Basic pyridines are known to interfere with copper 
catalyzed reactions, and pyridine itself is occasionally used as a ligand.191 Nevertheless, copper 
catalyzed conditions were investigated to deliver the desired N-3 aryl substituted pyridine 
products.  
Studies commenced with copper (I) iodide and diamine ligands previously used for copper-
catalyzed amidation (Table 19).190, 192-194 None of the desired product (35h) was observed using 
N,N’-Dimethylethylenediamine (DMEDA) as a ligand in either DMF or toluene; although 79% 
conversion and 43% yield of 35h was obtained in 1,4-dioxane (entries 1-3). Ethylenediamine 
(EDA), a less encumbered ligand, gave 71% conversion and an increased 59% yield of 35h (entry 
4). The more rigid trans-1,2-diaminocyclohexane gave similar results when the reaction was 
carried out in toluene (entry 5); when 1,4-dioxane was utilized complete conversion and 96% 
isolated yield of 35h was obtained (entry 6). The more electron-rich N,N’-dimethyl analog L2 gave 
moderate conversion (72%) but only trace 35h (entry 7). These results coinicide with the 
underlying hypothesis described by Buchwald.190 The unencumbered diamine ligands aid the 
coupling of bulky secondary amides.190, 193   
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Table 19: Copper-Catalyzed Amidation Optimization 
 
Entryab Ligand Solvent Conversionc (%) Yieldc (%) 
1 DMEDA DMF 100 0 
2 DMEDA Tol 100 0 
3 DMEDA Dioxane 79 43 
4 EDA Dioxane 71 59 
5 L1 Tol 70 65 
6 L1 Dioxane 100 96d 
7 L2 Dioxane 72 trace 
a Reactions conducted by Adam Rosenberg b Reaction Conditions: 10 mol% CuI, 20 mol% Ligand, 2 Eq. Base, 0.5 
M. c Using mesitylene as an internal standard  d Isolated yield.  
 
With optimized copper-amidation conditions elucidated, the substrate scope of the C-N 
coupling reaction followed by TFA mediated carbamate deprotection was explored (Table 20). As 
shown previously, iodobenzene gave 96% yield of 35h and Boc deprotection under acidic 
conditions then provided 36h in 97% yield (entry 1). Analogous conditions using 4-iodotoluene 
gave 35i in 76% yield and 36i in 92% yield (entry 2). Aryl bromides were also effective substrates 
for the copper catalyzed amidation conditions. Electron-poor 4’-bromoacetophenone and 4-
bromo-trifluorotoluene gave 35j in 90% and 35k in 79%, respectively (entries 3 and 4). Electron-
rich arylbromides 4-bromoanisole (entry 5) and 3,5-dimethylbromobenzene (entry 6) gave partial 
conversion for the amidation and the crude reaction mixtures were deprotected for ease of isolation 
to give 36l and 36m in 47% and 66% yield respectively, over two steps. The use of halopyridines 
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as coupling partners did not adversely affect the amidation or deprotection reactions as 3-
bromopyridine gave 35n in 88% and Boc deprotection afforded 36n in 89% yield (entry 8).  
 
Table 20: Copper-Catalyzed Amidation Scope 
 
Entrya ArX yield of amidationb (%) yield of deprotectionb (%) 
 
 
  
1d         R=H            96 (35h)             97 (36h) 
2         R=Me            76 (35i)             92 (36i) 
 
 
  
3         R=Acetyl           90 (35j)             89 (36j) 
4         R=CF3           79 (35k)             89 (36k) 
5         R=OMe           -             47 (36l)c 
6 
 
          -             66 (36m)c 
    
7 
 
          88 (35n)             89 (36n) 
a reaction conditions: 1) 1 equiv. 34, 1.1 equiv. ArX, 10 mol% CuI, 20 mol% L1, 2 equiv. K3PO4, 1,4-dioxane 
(0.5 M); 2) 25% TFA in CH2Cl2. b isolated yield c yield over two steps.d reaction conducted by Adam Rosenberg 
 
With the desired N-substituted 3-amino-4-chloropyridine substrates in hand, investigations into 
the palladium catalyzed formation of the desired imidazo[4,5-c]pyridines began . Substrate 36h 
(3-amino-N-phenyl-4-chloropyridine) was chosen to evaluate conditions for the synthesis of 
imidazo[4,5-c]pyridine 37h (Figure 14, Table 21).
157 The newly developed Me3(OMe)t-
BuXPhos195 ligand was utilized in place of the Me4t-BuXPhos or t-BuBrettPhos ligands previously 
employed. This ligand performed well giving the desired product 37h in 90% yield. The 
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cBRIDP196 ligand developed by Takasago afforded 81% yield, and Singer’s BippyPhos197 gave 
87% yield of product 37h. TrippyPhos198 furnished only trace amounts of 37h.  No product was 
observed for other ligands, for example: RuPhos, tri-tert-butylphosphine, tricyclohexylphosphine, 
and Xantphos.  
 
Figure 14: Ligand Structures Used in Palladium Catalyzed Amidation 
 
Table 21: Ligand Screen for Palladium Catalyzed Amidation 
 
Entry Ligand Conversion (%)b Yield(%)b 
1d Me3(OMe)t-BuXPhos 100 90c 
2d cBRIDP 100 81 
3d BippyPhos 100 87 
4 TrippyPhos 10 trace 
5 RuPhos 15 0 
6e (t-Bu3PH)BF4 17 0 
7e (Cy3PH)BF4 18 0 
8e Xantphos 17 0 
a Reaction Conditions: 36h, Pd (1 mol %), ligand ( 5 mol %), 1.5 eq. Formamide, 0.2 M t-BuOH, 110 °C, 4 h. b 
Using mesitylene as an internal standard. c Isolated yield. d Reaction carried out by Adam Rosenberg. e Reaction 
carried out by Lauren Kaminsky. 
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With useful palladium-catalyzed amidation conditions in hand, attention turned to 
examining the reaction scope. As illustrated in Table 22, benzyl derivitives 36a-36e performed 
well in this reaction (52-85% yield); with electron-donating, electron-withdrawing, aryl and 
fluorine substitution all being tolerated (entries 1-5). Methyl (36f) and n-propyl (36g) substitution 
gave 37f in 58% and 37g 85% yields, respectively (entries 6 and 7). The aryl substituted derivatives 
provided the cyclized products 37h-37m in excellent 80–91% yields, with both electron-poor and 
electron-rich systems performing admirably (entries 8-13). Additionally, bis-pyridine moiety 36n 
was well tolerated under the reaction conditions giving 37n in 86% yield (entry 14).  
Table 22: Palladium Catalyzed Amidation/Cyclization 
 
Entrya R yield (%)b product 
1c 36a  CH2(C6H5)  84 37a 
2c 36b  CH2(2,5-OMe-C6H3)  85 37b 
3d 36c  CH2(3,5-OMe-C6H3)  52 37c 
4  36d  CH2(4-F-C6H4)  75 37d 
5 36e  CH2(4-Ph-C6H4)  75 37e 
6 36f  Me  58 37f 
7c 36g  n-Pr  85 37g 
8c 36h  Ph  90 37h 
9 36i  4-Me-Ph  89 37i 
10 36j  4-Ac-Ph  87 37j 
11 36k  4-CF3-Ph  91 37k 
12 36l  4-OMe-Ph  80 37l 
13 36m  3,5-Xylyl   90 37m 
14 36n  3-Pyridine   86 37n 
a reaction conditions: 1 equiv. 36, Pd (1 mol %), ligand (5 mol %), 1.5 equiv. formamide, 1.5 equiv. K3PO4, 0.2 M t-
BuOH, 110 °C, 4 h. b isolated yield.c reaction conducted by Adam Rosenberg. d reaction conducted by Lauren 
Kaminsky 
 
The use of substituted amides under conditions optimized for formamide only lead to the 
formation of dimer 38 (Scheme 41). Since amides are less nucleophilic than anilines,199 substrate 
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36h must out-compete the amide for binding to palladium, leading to a facile dimerization. In the 
absence of amide under otherwise identical reaction conditions the formation of 38 was also 
observed. This unwanted dimerization could be thwarted by increasing the amount of amide from 
1.5 to ≥ 5 equivalents. Using these slightly modified conditions C2-substituted imidazo[4,5-
c]pyridines 39 and 40 could be obtained in 61% and 51% yields, respectively.    
 
Scheme 41: Amide Coupling Partner Scope 
 
conditions: 1 equiv. 36h, Pd (2 mol %), ligand (10 mol %), 2 equiv. K3PO4, a 10 equiv. acetamide, b 5 equiv. 
furanamide, 0.2 M t-BuOH, 110 °C, 4 h. 
 
In order to demonstrate the utility of the imidazo[4,5-c]pyridine system further synthetic 
elaboration of the reaction products was explored (Scheme 42). Selective-deprotonation of 37h at 
C2 with LDA and quenching the resulting lithiate with hexachloroethane produced compound 41 
in 85% yield. Alternatively, mCPBA can be used to oxidize 37h to pyridine-N-oxide 42 in 89% 
yield.  Pyridine-N-oxide 42 was subsequently treated with POCl3 at 100C for 2 hours to form aryl 
chloride 43 regioselectively in 84% yield.200 Thus, we have demonstrated complementary 
regioselective chlorination protocols to obtain functionalized chloro- imidazo[4,5-c]pyridines 41 
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and 43.  Additionally, treatment of 42 with TMSCN and triethylamine in acetonitrile201 gave the 
Reissert-Henze product 44 in 89% yield as a single regioisomer.  
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Scheme 42: Functionalization of imidazo[4,5-c]pyridines 
 
 
In summary, copper-catalyzed conditions for the arylation of 3-amino-4-chloropyridine 34 with 
aryl and heteroaryl halides, providing a high-yielding and direct route to monoarylated 3-amino-
4-chloropyridines were developed. Subsequent palladium catalyzed amidation produced 
imidazo[4,5-c]pyridines in excellent yields using amide coupling partners.  Further 
functionalization of the imidazo[4,5-c]pyridines by halogenation and cyanation was demonstrated 
yielding diverse imidazo[4,5-c]pyridine scaffolds primed for further manipulation. 
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2.4 DEVELOPMENT OF A REGIOSELECTIVE AMIDE COUPLING 
It was envisioned that the xantphos improved protocol would be applicable to a 
regioselective amide coupling of polychlorinated pyridines. The process would yield 
imidazopyridines with an additional chloride for further synthetic elaboration. N-substituted 3-
aminopyridines that contain chlorine entities at the 2-position along with the 4, 5 or 6 positions 
were considered and based on previous studies the amide coupling is hypothesized to be selective 
for the 2-position (Scheme 43).  
Scheme 43: Regioselective Coupling Hypothesis 
 
Regiospecific palladium catalyzed methodologies using polychloro heterocyclic systems 
have been reported by other groups. In 2000, scientists at Amgen demonstrated a selective 
Sonogashira coupling at the 2-position of 2,4-dichlor-3-amino-6-methylpyridine (Scheme 44, eq 
1).202 Similarly, Delvare and co-workers developed an amide coupling that was also selective for 
the 2-position of 2,4-dichloropyridines (Scheme 44, eq 2).203 Altering the substrate to a 2,5-
dichloropyridine, Castanet et al. performed a carbonylative Suzuki coupling that provided a good 
yield of the desired products (Scheme 44, eq 3).204  
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Scheme 44: Regioselective coupling of 2,4 and 2,5-dichloropyridines 
 
Another example of a regiospecific coupling using Suzuki chemistry with 2,6-
dichloropyridine system was discovered. In 2003, Yang and co-workers attempted to produce 6-
amino-2-arylnicotinamides from the 2,6-dichloronicotinic acid precursor (Scheme 45, eq 1). When 
the carbonyl moiety was substituted as an ester, the reaction in methanol favored a coupling at the 
2-position in a 2.5 to 1 ratio. This result was attributed to the ester selectively chelating with the 
palladium. When the ester was exchanged with a stronger chelating amide the selectivity improved 
favoring coupling at the 2-position in a 15:1 ratio.205 More recently, Langer and co-workers 
conducted Suzuki reactions with 2,6-dichloropyridines. Langer found that by using the boronic 
acid as the limiting reagent selective coupling at the 2-position of 2,6-dichloro-3-
trifluoromethylpyridine was observed (Scheme 45, eq 2).206 
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Scheme 45: Regioselective Suzuki Couplings of 2,6-dichloropyridines 
 
From our studies it was gathered that bidentate ligands were un-cooperative in the synthesis 
of imidazo[4,5-c]pyridines leaving the activated chlorine at the 4 position intact. It was also 
discovered that regioselective amidation could be attained under the Xantphos conditions and it 
was demonstrated with 2-chloro-N-(4-chlorobenzyl)pyridin-3-amine. There were a few concerns 
for the regioselective coupling under the new Xantphos mixed solvent conditions. With multiple 
chlorides on the pyridine ring there certainly could be some reduction products or over coupling. 
Pyridine 47 was examined with the standard Xantphos conditions previously elucidated (Section 
2.2). After eleven hours a 77% conversion with a 44% crude yield was observed. Direct 
comparison with DPEPhos under identical conditions after only four hours there was a 95% 
conversion with 64% crude yield observed (Table 22). 
Scheme 46: Regioselective Amidation 
 
Table 23: Comparison of Xantphos and DPE Phos 
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Entry Lingand Time (h) Conv. (%) Yield 48 (%) 
1 Xantphos 11 77 44 
2 DPE Phos 4 95 64 
 
With excellent conversion but relative low yield a combination of conditions were 
examined. Increasing the amount of t-amyl-OH beyond a ratio of 4:1 was detrimental to the crude 
yield of product (Table 24, entries 1 and 2). Changing from potassium phosphate to cesium 
carbonate, another inorganic base commonly used in catalysis, had a dramatic increase in yield 
(Table 24, entry 3). Increasing the amount of base used to 5 equivalents reduced the reaction time 
to 4 h and provided 48 in a 70% crude yield. At this point it was noticed that further reducing the 
amount of alcohol co-solvent had no change. The co-solvent was eliminated and the reaction was 
found to be identical to entries 7 and 8 using 5 equivalents of cesium carbonate. With this much 
base the reaction needed to be stirred vigorously for good mixing.  
Table 24: Base and Solvent Screen for Regioselective Coupling Using DPE Phos 
Entry Base (equiv.) Solventa Time Conv. (%) Yield 48 (%) 
1 K3PO4 (1.5) 2:1 3.5 85 45 
2 K3PO4 (2) 1:0 6.5 87 48 
3 Cs2CO3 (2) 10:1 4 95 64 
4 Cs2CO3 (2) 4:1 4 90 75 
5 Cs2CO3 (2) 2:1 4 87 50 
6 Cs2CO3 (2) 1:1 4 84 60 
7 Cs2CO3 (5) 10:1 4 96 70 
8 Cs2CO3 (5) 20:1 2 96 70 
9 Cs2CO3 (5) 1:0 2 96 70 
aSolvent ratio represents 1,4-dioxane:t-amyl alcohol 
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Table 25: Palladium and Ligand Screen for Regioselective Coupling 
 
Entry Pd Sourcea Ligand Bite Angle (L) Time (h) Conv.(%) Yield (%) 
1 Pd2(dba)3·CHCl3 L1 108° 6 78 45 
2 Pd2(dba)3·CHCl3 L2 107° 2 96 70 
3 PdCl2 L2 107° 2 - - 
4 Pd(OAc)2 L2 107° 2 91 66 
5 Pd(TFA)2 L2 107° 2 95 63 
6 [Pd(allyl)Cl]2 L2 107° 2 95 56 
7 Pd(OAc)2 L3 111° 6 95 46 
8 Pd(OAc)2 L4 113° 6 52 44 
9 Pd(OAc)2 L5 97° 2 - - 
10 Pd(OAc)2 L6 87° 4 20 - 
aStandard conditions: 4 mol % Pd (2 mol % for dinuclear sources), 10 mol % L 
 
Figure 15: Bidentate Ligands Examined for Regioselective Palladium Catalyzed Amidation 
 
To evaluate the activity of certain combinations of catalysts and ligands the model reaction 
conditions contain 47, 1.5 equivalents of formamide and 5 equivalents of cesium carbonate in 1,4-
dioxane an 110 °C (Table 25). The combination of Pd2(dba)3·CHCl3 and DPE Phos L2 provided 
excellent conversion and good yield (entry 2). Altering the palladium source can impact the 
formation of the active catalyst species, however, this had a minimal effect over the sources that 
were screened and PdCl2 did not work (entry 3). Presumably the active catalyst was not formed in 
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this example. Palladium acetate provided a clean reaction with barely any discerable impurities in 
the crude 1H NMR and it was utilized for the ligand screen (entries 4, 7-10). Bi-dentate ligands 
with similar characteristics were examined. When Xantphos (L1) and DPE Phos (L2) are bound 
to metals they have similar bite angles of 108° and 107° respectively. Although bite angles are 
flexible in organometallic complexes, it is believed that this was playing a crucial role in the 
reaction. These two (L1 and L2) performed similarly in previous experiments; however, mono-
dentate ligands (PCy3, P(o-Tol)3 and P(2-Furyl)3) and ligands with smaller bite angles (L5, 97° and 
L6, 87°) delivered no product in this reaction. The Floriani ligand (L3),207, 208 and DPBP (L4),209-
211 were examined for the small differences to L1 and L2. The Floriani ligand L3 lacks the oxygen 
hetereo atom which may have a weak interaction with the palladium in the transition state.212 The 
reaction with L3 was much slower than with L2 and only delivered 46% crude yield of 48. It is 
theorized that the weak interaction with the heteroatom may be beneficial to the reductive 
elimination step of the elementary catalytic process. The DPBP (L4) ligand possessing a carbonyl 
functional group was analyzed. The carbonyl should have a stronger interaction with the metal 
than an ethereal moiety. The reaction using L4 was slower than previous ligands but at only 52% 
conversion of 47 we observed 44% crude yield of 48. It is speculated that a longer reaction time 
with L4 would produce the greatest quantity of 48.  
In summary, we have discovered reaction conditions for the regioselective amidation of 
2,6-dichloro-3-aminopyridine 47 to provide the chlorinated imidazopyridine 48. Further 
exploration of the reaction conditions (reaction time, temperature, catalyst/ligand ratio) and 
substrate scope will be carried out to improve this reaction. Additional work will be required for 
the production of 2,4-dichloro-3-aminopyridines and subsequent evaluation of these moieties. 
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3.0  APPENDIX I: EXPERIMENTALS 
3.1 GENERAL EXPERIMENTAL 
3.1.1 General Procedures: Unless otherwise indicated, all reactions were conducted in oven 
(140°C) or flame-dried glassware using distilled and degassed solvents under positive pressure of 
dry argon with standard Schlenk techniques. All air-sensitive reagents were stored in an MBraun 
labmaster glovebox containing dry argon gas. Dry tetrahydrofuran (THF), toluene, acetonitrile 
(CH3CN), diethyl ether (Et2O) and methylene chloride (DCM) were obtained by passing 
commercially available pre-dried, oxygen-free formulations through two activated alumina 
columns using an MBraun MB-SPS solvent purification system. Stainless steel syringes or 
cannulae that had been oven-dried (140°C) and cooled under an argon atmosphere or in a 
desiccator were used to transfer air- and moisture-sensitive liquids. Yields refer to 
chromatographically and spectroscopically (1H NMR) homogeneous materials, unless otherwise 
stated.  Reactions were monitored by thin-layer chromatography (TLC) carried out on pre-coated 
glass plates of silica gel (0.25 mm) 60 F254 from EMD Chemicals Inc. using the indicated solvent 
system. Visualization was accomplished with ultraviolet light (UV 254 nm), or by shaking the 
plate in a sealed jar containing silica gel and Iodine.  Alternatively, plates were treated with one of 
the following solutions (this was accomplished by holding the edge of the TLC plate with forceps 
or tweezers and immersing the plate into a wide-mouth jar containing the desired staining solution) 
and carefully heating with a hot-air gun (450°C) for approximately 1-2 min (NOTE: excess stain 
was removed by resting the TLC on a paper towel prior to heating): 10% phosphomolybdic acid 
in ethanol, 1% potassium permanganate/7% potassium carbonate/0.5% sodium hydroxide aqueous 
solution, and/or anisaldehyde in ethanol with 10% sulfuric acid.  Flash column chromatography 
was performed using Silia Flash® P60 silica gel (40-63 μm) from Silicycle.  All work-up and 
purification procedures were carried out with reagent grades solvents (purchased from VWR) in 
air.   
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3.1.2 Instrumentation: Infrared (IR) spectra were recorded on a Thermo Nicolet IR-100 
spectrometer, νmax in cm
-1, and were obtained from samples prepared as thin films between NaCl 
plates. 1H NMR spectra were recorded on Bruker Avance DPX-300 (300 MHz) spectrometer and 
Bruker Avance III HD (400 MHz) spectrometer with CryoProbe Prodigy.  Chemical shifts are 
reported in parts per million (ppm) and are calibrated using residual undeuterated solvent as an 
internal reference (CDCl3: δ 7.26 ppm; CD3OD: δ 3.31 ppm).  Data are reported as follows: 
chemical shift, multiplicity, coupling constants (Hz), and integration.  The following abbreviations 
or combinations thereof were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, 
q = quartet, pent = pentet, sext = sextet, sept = septet, m = multiplet, br = broad.  13C NMR spectra 
were recorded on Bruker Avance DPX-300 (75 MHz) spectrometer and Bruker Avance III HD 
(100 MHz) spectrometer with CryoProbe Prodigy with complete proton decoupling.  Chemical 
shifts are reported in ppm and are calibrated using residual undeuterated solvent as an internal 
reference (CDCl3: δ 77.16 ppm; CD3OD: δ 49.00 ppm). 
19F NMR spectra were recorded on a 
Bruker Avance DPX-300 (282.4 MHz) spectrometer.  Chemical shifts are reported in ppm and are 
calibrated using solvent as an external reference (CFCl3: δ 0.00 ppm). Melting points (m.p.) are 
uncorrected and were recorded using an Electrothermal Mel-Temp® melting point apparatus. 
Elemental Analyses were performed on a Costech ECS 4010 elemental analyzer with a thermal 
conductivity detector and 2 meter GC column maintained at 65°C. 
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3.2 SYNTHESIS OF VINYL SILICON TETHERED ALKYNES  
Reagents and Catalysts: Reagents and ligands were purchased at the highest commercial quality 
and used without further purification, unless otherwise stated. 
Alkynes not listed were prepared according to the literature procedure.28, 65 
 
 
To a solution of phenylacetylene (2.6 mL, 24 mmol) in Et2O (100 mL) at –78°C was added 
nBuLi (2.5 M in hexane, 9.6 mL, 24 mmol) over 20 min. After stirring at –78°C for an additional 
20 min, trimethylaluminum (2.0 M in hexane, 12 mL, 24 mmol) was added via addition funnel 
over 5 min. The reaction was stirred at –78°C for 30 min, –45°C for 30 min, and then cooled to –
78°C, whereupon cis-2,3-epoxybutane (20 mmol) in Et2O (11 mL) was added over 10 min. After 
stirring for 15 min, boron trifluoride diethyl etherate (2.8 mL, 22 mmol) in Et2O (11 mL) was 
added slowly over 15 min and stirred at –78°C for 1 h. Methanol (36 mL) was added dropwise via 
addition funnel over 10 min, then the reaction was allowed to warm to rt over 25 min before sat. 
NH4Cl(aq) (36 mL) was added. After stirring at rt for an additional 30 min, the reaction mixture 
was diluted with water (150 mL), extracted with Et2O (3 x 100 mL), dried over Na2SO4, filtered, 
and concentrated in vacuo. The residue was purified by flash column chromatography 
(hexane:Et2O = 5:1) on silica gel to give the alcohol (1.36 g, 39%) as an orange oil. The reaction 
of the alcohol (508 mg, 2.9 mmol), imidazole (395 mg, 5.8 mmol), DMAP (71 mg, 0.58 mmol) 
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and vinyldimethylchlorosilane (0.6 mL, 4.35 mmol) in DCM (20 mL) afforded the silyl ether 1.36 
(660 mg, 88%) as a colorless oil. 
 
TLC (hexanes:Et2O = 10:1): Rf = 0.83 
 
1H NMR (400 MHz, CDCl3): δ 7.41-7.37 (m, 2 H), 7.30-7.24 (m, 3 H), 6.18 (dd, J = 20.1, 14.7 
Hz, 1H), 6.01 (dd, J = 14.7, 3.9 Hz, 1H), 5.79 (dd, J = 20.2, 3.9 Hz, 1H), 3.96-3.90 (m, 1H), 2.75-
2.68 (m, 1H), 1.23 (d, J = 6.2 Hz, 3H), 1.21(d, J = 7.0 Hz, 3H), 0.21 (s, 6H) 
 
13C NMR (100 MHz, CDCl3): δ 138.1, 133.1, 131.7, 128.2, 127.6, 124.1, 92.6, 81.9, 71.0, 34.5, 
20.1, 15.5, -1.2, -1.3 
 
IR (film): 3082, 2977, 2879, 2233, 1573, 1252, 1155, 915 
 
Anal. calcd for C16H22OSi: C 74.36, H 8.58; found: C 74.08, H 8.67. 
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Dimethyl((2-methyl-4-phenylbut-3-yn-1-yl)oxy)(vinyl)silane (1.140a): To a flame 
dried 50 mL round bottom flask with a magnetic stir bar was added alcohol S1213 (1.08 
g, 6.75 mmol), DCM (20 mL), DMAP (165 mg, 1.35 mmol) and imidazole (919 mg, 13.5 mmol). 
Vinyldimethylchlorosilane was added dropwise (1.39 mL, 10.125 mmol) to the resulting solution 
and the reaction stirred at RT for 2 h. The reaction mixture was poured into sat. NH4Cl (aq.) (30 
mL), extracted with DCM (2 x 20 mL), dried over MgSO4, filtered and concentrated in vacuo to 
give a yellow residue. The yellow residue was purified via flash column chromatography (1% 
diethyl ether/hexanes) to yield 1.140a as a clear oil (1.37 g, 84%). 
Rf = 0.72 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.40-7.38 (m, 2H), 7.28-7.25 (m, 3H), 6.15 (dd, J = 20.0, 15.0 
Hz, 1H), 6.03 (dd, J = 14.8, 4.0 Hz, 1H), 5.81 (dd, J =20.0, 4.2 Hz, 1H), 3.76 (dd, J = 9.8, 6.0 Hz, 
1H), 3.53 (dd, J = 9.8, 7.6 Hz, 1H), 2.81 (sext., J = 6.8 Hz, 1H), 1.25 (d, J = 6.8 Hz, 3H), 0.22 (s, 
6H) 
13C NMR (100 MHz, CDCl3): δ = 137.4, 133.5, 131.7, 128.3, 127.7, 123.8, 92.1, 81.6, 67.1, 29.7, 
17.5, -1.9 
IR (film): v = 3053, 2967, 2909, 1596, 1490, 1253, 1086, 837 cm-1 
Anal. calcd. for C15H20OSi: C 73.71, H 8.25; found: C 73.83, H 8.19 
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Dimethyl((1-phenylhex-3-yn-1-yl)oxy)(vinyl)silane (1.152a): To a flame dried 250 mL 3-neck 
round bottom flask equipped with a pressure equalizing addition funnel, large magnetic stir bar 
and freshly prepared propargyl magnesium bromide (0.63M in Et2O, 145 mmol) at -40
oC was 
added benzaldehyde (9.9 mL, 97 mmol) dropwise. The reaction stirred at RT for 4 h, then poured 
into 1M HCl (200 mL). The layers were separated and the organics were dried over MgSO4, 
filtered and concentrated in vacuo to give a yellow oil (13.7 g). To a flame dried 500 mL round 
bottom flask with magnetic stir bar was added the resulting crude alcohol (13.7 g, 94 mmol), DCM 
(235 mL) and PPTS (2.36 g, 9.39 mmol). The yellow solution was cooled to 0oC (ice/H2O bath) 
and DHP (17.1 mL, 188 mmol) was added dropwise. The reaction mixture stirred at RT for 4 hours 
and then was quenched by sat. NaHCO3(aq) (100 mL). The layers were separated and the organics 
were dried over MgSO4, filtered and concentrated in vacuo to give a yellow oil (22.4 g). To a flame 
dried 500 mL 3-neck round bottom flask equipped with a pressure equalizing addition funnel and 
large magnetic stir bar was added the resulting crude alkyne (5.0 g, 21.7 mmol) and THF (130 
mL). The yellow solution was cooled to -78oC (dry ice/acetone bath) and nBuLi (10.4 mL, 2.5M, 
26.0 mmol) was added dropwise. After stirring for 1 h, bromoethane (7.3 mL, 98 mmol) was added 
dropwise then the solution was warmed to RT and stirred overnight. The reaction mixture was 
quenched by the addition of sat. NH4Cl(aq) (100 mL) at -78
oC (dry ice/acetone bath). The layers 
were separated and the aqueous was extracted with Et2O (2 x 50 mL). The combined organics were 
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dried over MgSO4, filtered and concentrated in vacuo to give a orange oil (5.36 g). To an oven 
dried 100 mL round bottom flask with magnetic stir bar was added the resulting orange oil (5.36 
g, 21 mmol), EtOH (50 mL) and PPTS (1.56 g, 6.2 mmol). The orange solution stirred at 50oC for 
4 h, then was cooled to RT and concentrated in vacuo. The residue was dissolved in DCM and 
washed with brine (2 x 50 mL). The organics were dried over MgSO4, filtered and concentrated in 
vacuo to give a brown oil. Purification via flash column chromatography (gradient elution with 5-
10% EtOAc/hexanes) gave alcohol as a yellow oil (1.48 g, 41% over 3 steps). To an oven dried 
100 mL round bottom flask with magnetic stir bar was added alcohol (1.48 g, 8.5 mmol), DCM 
(45 mL), imidazole (1.16 g, 17 mmol) and DMAP (208 mg, 1.7 mmol). The solution was cooled 
to 0oC (ice/H2O bath) and vinyldimethylchlorosilane (1.8 mL, 12.7 mmol) was added dropwise. 
The resulting yellow suspension stirred at RT overnight. The reaction was quenched with sat. 
NH4Cl(aq) (50 mL) and the organics were dried over Na2SO4, filtered and concentrated in vacuo to 
give a yellow residue. Purification via flash column chromatography (gradient elution with 1-3% 
diethyl ether/hexanes) gave alkyne 1.152a as a pale yellow oil (1.39 g, 63%). 
Rf = 0.59 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.30 (m, 5H), 6.09 (dd, J = 20.0, 14.8 Hz, 1H), 5.97 (dd, J = 4.0, 
14.8 Hz, 1H), 5.74 (dd, J = 4.0, 20.0 Hz, 1H), 4.78 (dd, J = 6.0, 7.6 Hz, 1H), 2.51 (m, 2H), 2.14 
(qt, J = 10.0, 2.4 Hz, 2H), 1.09 (t, J = 7.6 Hz, 3H), 0.17 (s, 3H), 0.12 (s, 3H)  
13C NMR (100 MHz, CDCl3): δ = 144.2, 137.9, 133.3, 128.2, 127.5, 126.2, 83.7, 76.8, 74.5, 31.2, 
14.3, 12.7, -1.3, -1.4 
IR (film): v = 3051, 2973, 2373, 1438, 1252, 1070 cm-1 
Anal. calcd. for C16H22OSi: C 74.36, H 8.58; found: C 74.31, H 8.58  
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Dimethyl((1-phenyloct-3-yn-1-yl)oxy)(vinyl)silane (1.153a): To a flame dried 250 mL 3-neck 
round bottom flask with a pressure equalizing addition funnel and magnetic stir bar was added 1-
hexyne (4.1 g, 49.9 mmol) and THF (50 mL). The solution was cooled to -78 oC (dry ice/acetone 
bath) and nBuLi (30 mL, 1.66M, 49.9 mmol) was added dropwise via addition funnel. After 
stirring at -78oC for 1 h, a solution of styrene oxide (5 g, 41.6 mmol) in HMPA (10.9 mL, 62.4 
mmol) was added dropwise via addition funnel. After 10 minutes, the reaction mixture was 
allowed to warm to RT. The reaction was poured into 100 mL water and extracted with diethyl 
ether. The organic layer was washed with 1M HCl and brine, dried over MgSO4, filtered and 
concentrated in vacuo to afford a yellow oil (1.57 g, 18%). To a flame-dried 250 mL round bottom 
flask with stir bar was added the crude alcohol (1.57 g, 7.76 mmol) and DCM (50 mL). To the 
yellow solution was sequentially added imidazole (1.06 g, 15.52 mmol, ) and DMAP (0.2 equiv.). 
The resulting mixture was cooled to 0oC (ice/H2O bath) and vinyldimethylchlorosilane was added 
dropwise. After stirring at 0oC for 10 minutes, the resulting suspension was allowed to warm to 
RT. After 4 h, the reaction was quenched with sat. NH4Cl(aq) (30 mL) and extracted with DCM (3 
x 30 mL). The combined organics were washed with brine (2 x 50 mL), dried with MgSO4(s), 
filtered and concentrated to yield a yellow oil. The oil was purified via flash column 
chromatography (2% diethyl ether/hexanes) to yield 1.153a as a clear oil (1.73 g, 78%). 
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Rf = 0.64 (10% diethyl ether/hexanes)  
 
1H NMR (400 MHz, CDCl3): δ = 7.35-7.22 (m, 5H), 6.08 (dd, 1H, J = 20.0, 14.8 Hz), 5.96 (dd, 
1H, J = 14.8, 4.2 Hz), 5.74 (dd, 1H, J =20.0, 4.2 Hz), 4.77 (t, 1H, J = 6.3 Hz), 2.61-2.44 (m, 2H), 
2.12 (tt, 2H, J = 9.2, 6.8, 2.4 Hz), 1.47-1.32 (m, 4H), 0.88 (t, 3H, J = 7.2 Hz), 0.16 (s, 3H), 0.11 
(s, 3H) 
 
13C NMR (100 MHz, CDCl3): δ = 144.1, 137.8, 133.2, 128.1, 127.4, 126.1, 82.2, 74.4, 31.1, 31.1, 
22.0, 18.6, 13.8, -1.3, -1.5 
  
IR (film): v = 3030, 2957, 2931, 2871 cm-1 
 
Anal. calcd. for C18H26OSi: C 75.46, H 9.15; found: C 75.29, H 9.05 
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Dimethyl((1-phenyldec-3-yn-1-yl)oxy)(vinyl)silane (1.154a): Prepared following the procedure 
for 20a: 1-octyne (3.5 mL, 24 mmol), nBuLi (9.6 mL, 2.5M, 24 mmol), styrene oxide (2.28 mL, 
20 mmol) in HMPA (5.2 mL, 30 mmol). The reaction was poured into 100 mL water and extracted 
with diethyl ether. The organic layer was washed with 1M HCl and brine, dried over MgSO4, 
filtered and concentrated in vacuo to afford a yellow oil (2.74g, 59%).  To a flame dried 100 mL 
round bottom flask was added the crude alcohol (1.39 g, 6.04 mmol), DCM (20 mL), DMAP (147 
mg, 1.21 mmol) and imidazole (822 mg, 12.08 mmol). Vinyldimethylchlorosilane (1.25 mL, 9.06 
mmol) was added dropwise to the yellow solution and the resulting suspension stirred overnight. 
The reaction mixture was poured into sat. NH4Cl (aq.) (30mL), extracted with DCM (2 x 20 mL), 
dried with MgSO4, filtered and concentrated in vacuo to give a yellow residue. Purification via 
column chromatography (1% diethyl ether/hexanes) to yield 1.154a as a clear oil (1.21 g, 64%). 
Rf = 0.37 (2% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.35-7.28 (m, 3H), 7.25-7.22 (m, 2H), 6.08 (dd, J = 20.0, 15.2 
Hz, 1H), 5.96 (dd, J = 14.8, 4.4 Hz, 1H), 5.81 (dd, J = 20.2, 4.2 Hz, 1H), 4.77 (t, J = 6.5 Hz, 1H), 
2.60-2.44 (m, 2H), 2.13-2.08 (m, 2H), 1.47-1.23 (m, 8H), 0.89 (t, J = 6.6 Hz, 3H), 0.16 (s, 3H), 
0.11 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 144.1, 137.7, 133.2, 128.1, 127.4, 126.1, 82.2, 74.3, 31.5, 31.1, 
29.0, 28.7, 22.7, 18.2, 14.2, -1.3, -1.5 
IR (film): v = 2932, 2859, 1594, 1454, 1252, 1090, 836 cm-1 
Anal. calcd. for C20H30OSi: C 76.37, H 9.61; found: C 76.21, H 9.56 
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 ((1-1([1,1’-biphenyl]-4-yl)but-3-yn-1-yl)oxy)dimethyl(vinyl)silane 
(1.162):To a flame-dried 100 mL round bottom flask was added imidazole (1.00 
g, 14.76 mmol) and DMAP (0.181 g, 1.48 mmol), dichloromethane (40 mL), and alcohol (1.30 g, 
7.38 mmol). The mixture was allowed to stir until complete dissolution and then cooled to 0 °C in 
an ice-water bath.  inyl dimethyl chlorosilane (0.93 mL, 6.71 mmol) was then added dropwise.  
After addition, the reaction was allowed to warm to room temperature. After 7 h, the reaction was 
complete as judged by TLC analysis and quenched with the addition of sat. 40 mL aq NH4Cl.  The 
organic layer was dried with Na2SO4 and concentrated in vacuo to yield a yellow oil.  The crude 
product was purified on a silica gel column using 250 mL of 10:1 hexanes:ether to give the product 
(1.63 g, 79%) as a yellow oil. 
 
TLC Rf (10% EtOAc / Hexanes): 0.39 
1H NMR (400 MHz, CDCl3) δ= 7.47 (m, 10 H), 6.11 (dd, J = 20 Hz, 14.8 Hz, 1H), 5.99 (dd, J = 
4.4 Hz, 14.8 Hz, 1 H), 5.77 (dd, J = 4.4 Hz, 20 Hz, 1 H), 4.88 (t, J = 6.4 Hz, 1 H), 2.62 (ddd, J = 
2.8 Hz, 6.8 Hz, 16.4 Hz, 2H), 1.99 (t, J = 2.8 Hz, 1 H), 0.20 (s, 3 H), 0.15 (s, 3 H) 
13C NMR (100 MHz, CDCl3) δ= 142.7, 141.0, 140.5, 137.6, 133.6, 128.9, 127.3, 127.2, 127.0, 
126.5, 81.6, 73.5, 70.3, 30.7, -1.32, -1.48 
FT-IR (NaCl, thin film) ν = 3305, 2121 cm-1. 
Anal. Calc. for C20H22OSi: C, 78.38; H, 7.24; Found: C, 78.36; H, 7.14 
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Dimethyl((1-1(prop-2-yn-1-yl)cyclohexyl)oxy)(vinyl)silane (1.164a): To a flame-
dried 100 mL round bottom flask was added imidazole (1.00 g, 14.76 mmol) and 
DMAP (0.181 g, 1.48 mmol), dichloromethane (40 mL), and alcohol (1.02 g, 7.38 mmol). The 
mixture was allowed to stir until complete dissolution and then cooled to 0 °C in an ice-water bath. 
Vinyl dimethyl chlorosilane (0.93 mL, 6.71 mmol) was then added neat, via syringe, dropwise. 
After addition, the reaction was allowed to warm to room temperature. After 25 h, the reaction 
was complete as judged by TLC analysis and quenched with the addition of 40 mL sat. aq NH4Cl. 
The organic layer was dried with Na2SO4 and concentrated in vacuo to yield a colorless oil. The 
crude product was purified on a silica gel column using 250 mL of 20:1 hexanes:ether to give the 
product (1.26 g, 85%) as a colorless oil. 
 
TLC Rf (5% EtOAc / Hexanes): 0.61 
1H NMR (400 MHz, CDCl3) δ= 6.22 (dd, J = 20.4 Hz, 14.8 Hz, 1H), 5.93 (dd, J = 4 Hz, 10.8 Hz, 
1H), 5.76 (dd, J = 14.4 Hz, 3.6 Hz, 1H), 2.39 (d, J = 2.8 Hz), 2.01 (t, J = 2.8 Hz), 1.44 (m, 10H), 
0.22 (s, 6H) 
13C NMR (100 MHz, CDCl3) δ= 140.2, 131.7, 81.8, 75.0, 70.8, 37.6, 33.0, 25.7, 22.4, 0.9 
FT-IR (NaCl, thin film) ν = 3313, 2121cm-1. 
Anal. Calc. for C13H22OSi: C, 70.21; H, 9.97; Found: C, 70.35; H, 10.20 
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Syn-Aldol adduct S3: To a 1 L round bottom flask (3-neck) equipped with an 
addition funnel was added oxazolidinone S2 (10.00 g, 42.9 mmol) and 
dichloromethane (430 mL). The solution was cooled to -15 °C in an ice-brine bath. 
To the solution was added TiCl4 (4.9 mL, 45 mmol), dropwise and the reaction mixture is allowed 
to stir for 20 minutes. Diisopropylethylamine (8.2 mL, 47.2 mmol) is then added dropwise over a 
period of 10 minutes, and the resulting solution is allowed to stir for 1 hour, before adding N-
methyl-2-pyrrolidone (4.1 mL, 42.9 mmol) dropwise, and stirring for an additional 15 minutes. 
Benzaldehyde (4.8 mL, 47.2 mmol) is then added dropwise. After 1.5 h, the reaction is complete 
as judged by TLC analysis. The reaction mixture is quenched with saturated aqueous NH4Cl (400 
mL) and the aqueous phase extracted with dichloromethane (3 x 100 mL). The combined organics 
were dried with MgSO4 and concentrated in vacuo to give an oily solid (13.18 g, 90%). Spectral 
data matches that in the literature. The crude product was carried on without further purification.  
 
1H NMR(400 MHz, CDCl3) δ= 7.28 (m, 10H), 5.10 (d, J = 5.2 Hz, 1H), 4.60 (m, 1H), 4.11 (m, 
4H), 3.25 (dd, J = 4.4, 17.6 Hz, 1H), 3.05 (bs, 1H), 2.78 (dd, J = 12.4, 17.6 Hz, 1H), 2.04 (s, 1H), 
1.23 (d, J = 9.2 Hz, 3H) 
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Weinreb Amide (S4):214Made by Daniel Nguyen 
To an oven-dried 3-neck 500 mL RBF equipped with magnetic stir bar and 
pressure equalizing addition funnel under Ar(g) was added Weinreb salt (10.4 g, 106 mmol, 3 equiv) 
and THF (55 mL). The suspension was cooled to 0°C (ice/H2O bath) and AlMe3 (54 mL, 107 
mmol, 3.02 equiv) was added dropwise over 30 min. (Caution: Vigorous gas evolution!) Once the 
addition was complete the cooling bath was removed and the cloudy solution stirred at rt for 30 
min. The solution was re-cooled to -15°C (salt/ice/H2O bath) and a solution of aldol adduct S3 
(12.0 g, 35.4 mmol, 1 equiv) in THF (55 mL) was added dropwise. (Caution: Vigorous gas 
evolution!) The reaction mixture stirred for 45 min then was quenched by cannula transfer into a 
2 L RBF cooled at 0°C (ice/H2O bath) containing 1:2 DCM/1N HCl(aq) (780 mL). (Caution: 
Vigorous gas evolution!) After stirring for 30 min the layers were separated and the aqueous was 
extracted with DCM (3 x 250 mL). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated in vacuo to give a yellow oil. To the oil was added DMF 
(55 mL), imidazole (4.8 g, 71 mmol, 2 equiv) and TBSCl (5.9 g, 39 mmol, 1.1 equiv). The yellow 
solution stirred at rt overnight then poured into H2O (200 mL) and extracted with EtOAc (3 x 200 
mL). The organic layers were washed with brine, dried over Na2SO4, filtered and concentrated in 
vacuo to give a yellow oil. Purification via column chromatography (silica gel 4.5 x 10 cm; 
gradient elution with 10%-30% EtOAc/hexanes) gave S4 as a clear oil (10.5g, 88% over two steps). 
Rf (30% EtOAc/hexanes) = 0.56  
[α]D24 = -2.1° (c = 1.030 in CHCl3) 
1H NMR (400 MHz, CDCl3) δ = 7.34-7.17 (m, 5H), 4.80 (d, 1H, J = 8.6 Hz), 3.26 (s, 3H), 3.16 
(bs, 1H), 2.95 (s, 3H), 1.27 (d, 3H, J = 6.8 Hz), 0.87 (s, 9H), 0.04 (s, 3H), -0.22 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ = 175.6, 144.3, 128.0, 127.4, 127.0, 76.6, 61.3, 45.5, 31.9, 26.0, 
18.4, 15.0, -4.4, -4.8 
FT-IR (NaCl, thin film) ν = 3499, 3032, 2959, 1660, 1462, 1256 cm-1 
Anal. calcd for C18H31NO3Si: C 64.05, H 9.26, N 4.15; found: C 63.99, H 9.33, N 4.07. 
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Methyl Ketone (S5): Made by Daniel Nguyen 
To a flame-dried 25 mL RBF equipped with a magnetic stir bar under Ar(g) was added 
a solution of Weinreb amide S4 (1.0 g, 3.0 mmol, 1 equiv) in THF (6 mL). The reaction mixture 
was cooled to 0°C (ice/water bath) and methylmagnesium chloride (2 mL, 6.0 mmol, 2 equiv) was 
added dropwise. The reaction stirred at 0°C for 5 min then was warmed to rt and stirred for 3 h. 
The white suspension was poured into 1M HCl (10 mL) and the layers were separated. The 
aqueous phase was extracted with ether (3 x 10 mL) then the combined organic extracts were dried 
over MgSO4, filtered and concentrated in vacuo to give a yellow oil. Purification via column 
chromatography (silica gel 2.5 x 15 cm; gradient elution with 1%-4% EtOAc/hexanes) gave S5 as 
a clear oil (718 mg, 82%). 
 
Rf (15% EtOAc/hexanes) = 0.59 
[α]D24 = -16.9° (c = 0.946 in CHCl3) 
1H NMR (300 MHz, CDCl3) δ = 7.33-7.21 (m, 5H), 4.83 (d, 1H, J = 6.8 Hz), 2.86-2.77 (m, 1H), 
1.91 (s, 3H), 1.16 (d, 3H, J = 6.9 Hz), 0.88 (s, 9H), 0.03 (s, 3H), -0.22 (s, 3H) 
13C NMR (75 MHz, CDCl3) δ = 211.2, 143.4, 128.1, 127.5, 126.3, 76.3, 56.0, 30.5, 25.9, 18.2, 
12.6, -4.5, -5.1  
FT-IR (NaCl, thin film) ν = 2959, 1715, 1454, 1360, 1256 cm-1 
Anal. calcd for C17H28O2Si: C 69.81, H 9.65; found C 69.65, H 9.52. 
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Enol Triflate (S6): Made by Daniel Nguyen 
To a oven-dried 100 mL RBF equipped with a magnetic stir bar under Ar(g) was added 
freshly prepared KHMDS (1M in THF, 7.5 mmol, 1.1 equiv). The pale yellow solution was cooled 
to -78°C (dry ice/acetone bath) and methyl ketone S5 (2.0 g, 6.8 mmol, 1 equiv) in THF (6.8 mL) 
was added dropwise. Comins' reagent215 (5.3 g, 13.6 mmol, 2 equiv) in THF (6.8 mL) was 
subsequently added in one portion. The yellow solution stirred at -78°C for 2 h. The reaction 
mixture was warmed slightly and quenched with H2O (15 mL). The layers were separated and the 
aqueous phase was extracted with DCM (3 x 10 mL). The combined organics were dried over 
MgSO4, filtered and concentrated in vacuo to give a yellow oil. The residue was purified by column 
chromatography (silica gel; gradient elution with 1%-2% EtOAc/hexanes) to give S6 as a clear oil 
(2.35 g, 81%). 
 
Rf (10% EtOAc/hexanes) = 0.68 
[α]D24 = +1.4° (c = 0.946 in CHCl3) 
1H NMR (300 MHz, CDCl3) δ = 7.34-7.21 (m, 5H), 5.17 (d, 1H, J = 3.8 Hz), 4.95-4.93 (m, 2H), 
2.67-2.59 (m, 1H), 1.05 (d, 3H, J = 6.9 Hz), 0.91 (s, 9H), 0.02 (s, 3H), -0.18 (s, 3H)  
13C NMR (75 MHz, CDCl3) δ = 158.6, 142.8, 128.2, 127.6, 126.4, 118.8 (q, JC-F = 316.4 Hz), 
105.5, 74.0, 47.7, 26.0, 18.5, 11.3, -4.5, -5.3 
Anal. calcd for C18H27F3O4SSi: C 50.92, H 6.41; found C 50.47, H 6.38. 
enol triflate S6 was treated with TBAF to produce alkyne S7 which was taken on crude to the next 
step. 
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dimethyl(((1S,2R)-2-methyl-1-phenylbut-3-yn-1-yl)oxy)(vinyl)silane (1.165a): To 
a flame-dried 100 mL round bottom flask was added imidazole (.850 g, 12.48 mmol) 
and DMAP (.153 g, 1.25 mmol), dichloromethane (40 mL), and S7 (1.00 g, 6.24 
mmol). The mixture was allowed to stir until complete dissolution and then cooled to 0 °C in an 
ice-water bath. Vinyl dimethyl chlorosilane (1.3 mL, 9.36 mmol) was then added neat, via syringe, 
dropwise. After addition the reaction mixture was allowed to warm to room temperature. After 15 
minutes, the reaction was complete as judged by TLC analysis and quenched with the addition of 
40 mL sat. aq NH4Cl. The aqueous phase was extracted with dichloromethane (3 x 20 mL), and 
the combined organics were washed with brine (40 mL), dried with MgSO4, concentrated in vacuo 
to give a slightly colored oil. The crude product was purified on a silica gel column (2.5 x 12 cm) 
using 100 mL hexanes, 300 mL 99:1 hexanes:ether, 100 mL 30:1 hexanes:ether to give the product 
(1.28 g, 84%) as a colorless oil. 
TLC Rf (10% Ether / Hexanes): 0.75 
1H NMR (400 MHz, CDCl3) δ= 7.29 (m, 5H), 6.04 (dd, J = 14.8, 19.6 Hz, 2H), 5.95 (dd, J = 4.4, 
14.8 Hz, 2H), 5.71 (dd, 4.8, 20 Hz, 2H), 4.59 (d, J = 6.8 Hz, 1H), 2.70 (pd, J = 2.8, 7.2 Hz, 1H), 
1.99 (d, J = 2.4 Hz, 1H), 1.19 (d, J = 7.2 Hz, 3H), 0.12 (s, 3H), 0.07 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ= 142.9, 137.7, 133.3, 128.0, 127.6, 127.1, 86.8, 78.0, 70.4, 35.4, 
16.9, -1.31, -1.48 
FT-IR (NaCl, thin film) ν = 3310, 2114 cm-1. 
[α]D23λ 589 nm (c 0.51, CHCl3) = -47.3° 
Anal. Calc. for C15H20OSi: C, 73.71; H, 8.25; Found: C, 73.74; H, 8.19 
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(S)-4-benzyl-3-propionyloxazolidin-2-one (S2): Prepared according to the literature procedure 
by Gage and Evans216 to give colorless needles (92%). 
MP: 44-45oC;   
1H NMR (300 MHz, CDCl3): δ = 7.20-7.37 (m, 5H), 4.72-4.62 (m, 1H), 4.24-4.15 (m, 2H), 3.31 
(dd, J = 13.5, 3.3 Hz, 1H), 3.05-2.89 (m, 2H), 2.77 (dd, J = 13.5, 9.6 Hz, 1H), 1.21 (t, J = 7.5 Hz, 
3H). 
 
Prepared from S2 and benzaldehyde according to procedure by Evans et al.217To a 
flame dried 250 mL round bottom flask equipped with a stir bar was added 
oxazolidinone S2 (7.0g, 30 mmol) and ethyl acetate (100 mL). To the stirred 
solution was added MgCl2 (570 mg, 6 mmol), triethylamine (5.7 mL, 45 mmol), and benzaldehyde 
(3.66 mL, 36 mmol). The reaction was stirred over night then the yellow solution was filtered 
through a plug of silica (5 cm x 5 cm) with diethyl ether (500 mL). The volatiles were removed in 
vacuo followed by the addition of methanol (50 mL) and 3 drops of trifluoroacetic acid. The 
solution was stirred for 1 h; a white precipitate formed, was filtered and washed with methanol (50 
mL). The white solid was dried to obtain 8.28 g (81%).  
1H NMR (300 MHz, CDCl3): δ = 7.45-7.28 (m, 8H), 7.17-7.14 (m , 2H), 4.82 (d, J = 7.8 Hz, 1H), 
4.73-4.65 (m, 1H), 4.39-4.30 (m, 1H), 4.22-4.12 (m, 2H), 3.19 (dd, J = 13.5, 3.3 Hz, 1H), 2.67 
(dd, J = 13.5, 9.5 Hz, 1H), 1.11 (d, J = 6.6 Hz, 3H). 
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(S8): To a flame dried 250 mL round bottom flask equipped with a magnetic stir 
bar and cooled under Ar(g) , was added aldol adduct (8.28 g, 24.4 mmol), DCM 
(100 mL) , and 2,6-lutidine (3.4 mL, 29.3 mmol) with stirring. Once homogenous 
the solution was cooled to -45 °C in a dry ice-acetone bath. TBSOTf (6.75 mL, 29.3 mmol) was 
added dropwise via syringe and the solution was allowed to warm to r.t. The reaction was stirred 
for 30 mins and was judged complete by TLC. Hexanes (150 mL) were added and the organic 
layer was washed with water (2 x 100 mL), and Brine (2 x 25 mL). The organic layer was dried 
with sodium sulfate, filtered, and concentrated in vacuo to afford the crude TBS protected product 
(quant. 11.07 g). 
Thioester (S9): To a flame dried 500 mL 3 neck round bottom flask equipped with 
an addition funnel and a magnetic stir bar was added THF (200 mL) and ethanethiol 
(6.0 mL, 83 mmol) and cooled to -78 °C in a dry ice-acetone bath. To the cooled 
solution was added n-BuLi (2.5 M in hexanes, 23 mL, 57.5 mmol) dropwise via addition funnel. 
After complete addition, the milky white solution was warmed to 0 °C and stirred for 1 h. The 
crude S8 (11.07 g, 24.4 mmol) was dissolved in THF (50 mL) and added slowly to the stirred 
solution. The reaction was judged complete by TLC at 2 h and 200 mL of ethylacetate:hexanes 
(1:1) was added. The organics were washed with 1M NaOH (3 x 100 mL) and brine (3 x 100 mL), 
dried with MgSO4, filtered and concentrated in vacuo. The sticky solid was dissolved in DCM (20 
mL) and hexanes (150 mL) were added to precipitate the oxazolidinone. The solid was filtered and 
washed with hexanes (100 mL). The hexanes were concentrated to afford the thioester (6.5 g, 79% 
over 2 steps) which was sufficiently pure to continue to the next step.  
TLC Rf (20% ethyl acetate/hexanes) = 0.89 
1H NMR (400 MHz, CDCl3) δ = 7.38-7.29 (m, 5H), 4.51 (d, J = 7. 1 Hz, 1H), 2.80 (m, 1H), 2.21 
(d, J = 2.5 Hz, 1H), 1.10 (d, J = 7.0 Hz, 1H) 
 13C NMR (100 MHz, CDCl3) δ = 141.3, 128.4, 128.1, 126.7, 85.5, 77.5, 71.4, 35.1, 17.4 
FT-IR (NaCl, thin film) ν = 3568, 3296, 2979, 2879, 1453, 1173, 701 cm-1 
Anal. calcd. for C11H12O: C, 82.24; H, 8.63; found C 82.13; H, 8.49  
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Aldehyde (S10): To a 50 mL round bottom flask equipped with a magnetic stir bar was 
added 5% Pd/C (692 mg, 0.325 mmol) then S9 (1.10 g, 3.25 mmol) in acetone (7 mL). 
To the stirred solution was added triethylsilane (1.56 mL, 9.75 mmol) dropwise and the mixture 
was stirred for 7 h. The reaction was filtered through a pad of celite with acetone (60 mL) and the 
volatiles were removed in vacuo to afford a light yellow oil (0.875 g, 96%). *Pd(OAc)2 can be used 
and the reaction is complete in 0.5 h. Matches the literature data218 
TLC Rf (10% ether/hexanes) = 0.54 
1H NMR (400 MHz, CDCl3) δ = 9.81 (d, J = 2.7 Hz, 1H), 7.36-7.25 (m, 5H), 4.76 (d, J = 7.6 Hz, 
1H), 2.68 (dp, J = 7.0 Hz, 2.7 Hz, 1H), 0.88 (d, J = 6.7 Hz, 3H), 0.84 (s, 9H), 0.01 (s, 3H), -0.25 
(s, 3H)  
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To a flame dried 100 mL round bottom flask equipped with a magnetic stir bar and 
cooled under Ar(g) , was added THF (5 mL) and di-isopropylamine (0.55 mL, 3.86 
mmol). The solution was cooled to -78 °C then n-BuLi (2.44M in hexanes, 1.58 mL, 3.86 mmol) 
was added dropwise. The mixture was stirred for 30 minutes followed by the addition of 
TMSCH2N2 (2.0M in hexanes, 1.93 mL, 3.86 mmol) dropwise. After 30 minutes at -78 
°C, S4 
(0.833 g, 3.0 mmol) in THF (5 mL) was added dropwise and stirred for 1h then warmed to rt and 
quenched with water (30 mL). The aqueous layer was extracted with diethyl ether (3 x 20 mL), 
dried with MgSO4, filtered and concentrated in vacuo. The crude oil was applied to a silica gel 
column (2.5 x 15 cm) and eluted with 5% ethyl ether in hexanes to afford 703 mg (86%) of clear 
oil.  
TLC Rf (10% ethyl acetate/hexanes) = 0.94 
1H NMR (300 MHz, CDCl3) δ = 7.35-7.25 (m, 5H), 4.60 (d, J = 6.0 Hz, 1H), 2.71 (dp, J = 7.0 Hz, 
2.4 Hz, 1H), 2.06 (d, J = 2.7 Hz, 1H), 1.01 (d, J = 6.7 Hz, 3H), 0.87 (s, 9H), 0.05 (s, 3H), -0.15 (s, 
3H)  
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 (1S,2S)-2-methyl-1-phenylbut-3-yn-1-ol (S11): To a 20 mL scintillation vial 
equipped with a magnetic stir bar was added the TBS protected alkyne (400 mg, 1.46 
mmol), MeCN (3.0 mL, 0.5M), and KF·2H2O (192 mg, 2.04 mmol). To the stirred suspension was 
added trimethylchlorosilane (0.28 mL, 2.19 mmol) dropwise and the yellow solution as stirred for 
3 h. The reaction was quenched by the dropwise addition of saturated aqueous NaHCO3 (4 mL), 
extracted with CH2Cl2 (2 x 30 mL) and the combined organic layers were washed with DI H2O (40 
mL) and brine (20 mL). The organics were dried with MgSO4, filtered and concentrated in vacuo. 
The crude oil was applied to a silica gel column (2.5 x 15 cm) and eluted with 25% ethyl acetate 
in hexanes to afford 161 mg (69%) of clear oil. 
TLC Rf (10% ether/hexanes) = 0.15 
1H NMR (400 MHz, CDCl3) δ = 7.38-7.29 (m, 5H), 4.51 (d, J = 7. 1 Hz, 1H), 2.80 (m, 1H), 2.21 
(d, J = 2.5 Hz, 1H), 1.10 (d, J = 7.0 Hz, 1H) 
 13C NMR (100 MHz, CDCl3) δ = 141.3, 128.4, 128.1, 126.7, 85.5, 77.5, 71.4, 35.1, 17.4 
[α]D23λ 589 nm (c 0.960, CHCl3) αD = -74.8628 
FT-IR (NaCl, thin film) ν = 3568, 3296, 2979, 2879, 1453, 1173, 701 cm-1 
Anal. calcd. for C11H12O: C, 82.24; H, 8.63; found C 82.13; H, 8.49  
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dimethyl(((1S,2S)-2-methyl-1-phenylbut-3-yn-1-yl)oxy)(vinyl)silane (1.166a): To 
a flame-dried 50 mL round bottom flask was added imidazole (150 mg, 2.2 mmol) and 
DMAP (30 mg, 0.22 mmol), dichloromethane (15 mL), and S6 (161 mg, 1.01 mmol). The mixture 
was allowed to stir until complete dissolution and then cooled to 0 °C in an ice-water bath. Vinyl 
dimethyl chlorosilane (0.21 mL, 1.51 mmol) was then added neat, via syringe, dropwise. After 
addition, the reaction mixture was allowed to warm to room temperature. After 3 h, the reaction 
was complete as judged by TLC analysis and quenched with the addition of 40 mL sat. aq NH4Cl. 
The organic layer was dried with MgSO4 and concentrated in vacuo to yield a yellow oil. The 
crude product was purified on a silica gel column eluting with 1% ethyl ether in hexanes to afford 
the product (219 mg, 89%) as a colorless oil. 
TLC Rf (10% ether/hexanes) = 0.79 
1H NMR (400 MHz, CDCl3) δ = 7.33-7.25 (m, 5H), 6.05 (dd, J = 19.6 Hz, 14.8 Hz, 1H), 5.95 (dd, 
J = 14.8 Hz, 4.4 Hz, 1H), 5.72 (dd, J = 19.6 Hz, 4.4 Hz, 1H), 4.60 (d, J = 6.4 Hz, 1H), 2.75 (dp, J 
= 7.0 Hz, 2.4 Hz, 1H), 2.07 (d, J = 2.4 Hz, 1H), 1.02 (d, J = 7.0 Hz, 3H), 0.13 (s, 3H), 0.07(s, 3H) 
 13C NMR (100 MHz, CDCl3) δ = 142.1, 137.6, 127.9, 127.6, 127.0, 86.6, 77.8, 70.0, 35.2, 16.8, -
1.3, -1.5 
FT-IR (NaCl, thin film) ν = 2979, 2879, 1453, 1173, 701 cm-1 
Anal. calcd. for C15H20OSi: C, 73.71; H, 8.25; found C 73.59; H, 8.07 
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3.3 INTERMOLECULAR COUPLING DATA 
3.3.1 Acrylamides and Acrylates 
(2E,4Z)-N-(tert-butyl)-4-phenyl-4-(2,2,5-trimethyl-1,2-oxasilolan-3-
ylidene)but-2-enamide (1.34): In a glove box, to a 25 mL Schlenk tube 
equipped with a magnetic stir bar was added ruthenium hydride complex 
RuHCl(CO)(SIMes)(PPh3) (36 mg, 0.05 mmol), tert-butyl acrylamide (63mg, 0.5 mmol),  and 
alkyne 1a (62 mg, 0.25 mmol) in 1.0 mL toluene. The tube was sealed and brought out of the glove 
box and placed under an argon atmosphere. The vessel was immersed into a preheated 110 oC oil 
bath for 2h. The reaction was judged complete by TLC and was filtered through a plug of silica 
eluting with dichloromethane. The solution was concentrated in vacuo and applied to a SiO2 
column eluting with 10% ethyl acetate in hexanes. The product was obtained as brown oil with 
unidentified impurities (62 mg, 72%*).  
1H NMR (300 MHz, CDCl3) δ = 7.73 (d, J = 15Hz, 1H), 7.36-7.31 (m, 5H), 5.37 (d, J = 
15Hz, 1H), 5.22 (bs, NH), 4.21-4.15 (m, 1H), 3.08 (dd, J = 16.5, 5.4 Hz 1H), 2.43 (dd, J = 16.5, 
8.1Hz 1H), 1.34 (s, 9H), 1.30 (d, J = 6.0 Hz, 3H), -0.09 (s, 3H), -0.20 (s, 3H); 
Impurities: 7.12-7.09 (m, 2.4H), 3.77 (s, 0.07H), 3.69 (s, 0.12 H), 3.43 (s, 0.14H), 2.29-
2.26 (m, 0.66H); 
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(2E,4Z)-tert-butyl-4-phenyl-4-(2,2,4,5-tetramethyl-1,2-oxasilolan-3-
ylidene)but-2-enoate (1.37): In a glove box, to a 25 mL Schlenk tube was added 
RuHCl(CO)(SIMes)(PPh3) (9 mg, 0.0125 mmol), and 1q (68mg, 0.25 mmol) in 
0.5 mL toluene. The vessel was sealed, removed from the glovebox and placed under an argon 
atmosphere. Tert-butyl acrylate (0.2 mL, 1.25 mmol) was added via syringe and the reaction vessel 
was immersed in a preheated 110 oC oil bath. After 45 minutes the reaction was judged complete 
by TLC and cooled to room temperature. The solution was filtered through a plug of silica gel, 
eluted with dichloromethane and concentrated in vacuo. The oil obtained was applied to a SiO2 
column and eluted with 1% diethyl ether in hexanes. The fractions obtained were concentrated at 
reduced pressure to afford clear oil (46 mg, 52%); 
Rf (10% ethyl ether/hexanes): 0.24 
1H NMR (300 MHz, CDCl3) δ = 7.73 (d, J = 15.6 Hz, 1H), 7.32-7.28 (m, 3H), 7.11-7.08 (m, 2H), 
5.46 (d, J = 15.6 Hz, 1H), 4.11 (q, J = 12.6, 6.3 Hz, 1H), 2.97 (q, J = 14.4, 7.2 Hz, 1H), 1.43 (s, 
9H), 1.22 (d, J = 7.2Hz, 3H), 1.16 (d, J = 6.3 Hz, 3H), 0.14 (s, 3H), -0.44 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ = 167.0, 157.7, 145.8, 141.0, 141.0, 129.5, 128.2, 127.7, 124.1, 
80.5, 19.9, 44.8, 28.2, 24.6, 21.9, 2.1, 0.6; 
Anal. calcd. for C21H30O3Si: C, 70.35; H, 8.43; found C, 70.12; H, 8.45; 
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3.3.2 Vinyl Boronates 
 
Vinyl Boronate (1.39a): Prepared with an adaptation to the literature 
procedure.38 Freshly prepared vinylmagnesium bromide (0.91M in THF, ~175 
mL) was added dropwise over 1 h to a stirred solution of anhydrous trimethylborate (10.2 mL, 180 
mmol) in dry THF (100 mL) at −78 °C (dry ice/acetone bath) under Ar(g). The reaction stirred at -
78 oC for 1 h then was warmed to rt, followed by addition of 20% HCl (44 mL). After 10 min, a 
solution of 2,2-dimethylpropane-1,3-diol (11.3 mL, 90 mmol) in Et2O (9 mL) was added and the 
reaction stirred for 1 h. The two phases were separated and the aqueous phase extracted with Et2O 
(100 mL). The combined organic extracts were washed with sat. NaHCO3(aq) (2 x 100 mL) and 
water (2 x 100 mL), dried over MgSO4, filtered and concentrated in vacuo to give the crude product 
as a yellow oil. Distillation under vacuum (b.p. 19-21 C at ~0.5 mmHg) gave 1.39a as a clear 
liquid (43%). 
1H NMR (300 MHz, CDCl3) δ = 6.07 (dd, 1H, J = 18.9, 4.8 Hz), 5.89-5.85 (m, 1H), 5.77 (dd, 1H, 
J =18.9, 13.5 Hz), 3.64 (s, 4H), 0.97 (s, 6H) 
13C NMR (75 MHz, CDCl3) δ = 134.5, 72.1, 31.8, 21.9 
11B NMR (96 MHz, CDCl3) δ = 27.8 
Anal. calcd for C7H13BO2: C 60.06, H 9.36; found: C 59.95, H 9.29 
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4,4,6-trimethyl-2-vinyl-1,3,2-dioxaborinane (1.39b): prepared according to 
literature procedure and matched spectroscopic data.38 Distilled under vacuum (34-
35°C at ~0.5 mmHg) to yield a clear oil (45%); 
 1H NMR (300 MHz, CDCl3) δ = 6.04 (dd, J = 18.3, 5.6 Hz, 1H), 5.89-5.86 (m, 1H), 5.76 (dd, J 
= 18.3, 13.5 Hz, 1H), 4.27-4.16 (m, 1H), 1.79 (dd, J = 14.1, 3.0 Hz, 1H), 1.50 (dd, J =13.8, 11.7 
Hz, 1H), 1.30 (s, 6H), 1.27 (d, J = 6.0 Hz, 3H); 
11B NMR (96 MHz, CDCl3) δ = 27.7; 
 
Vinyl MIDA (1.39d): prepared according to literature protocol and matched 
spectroscopic data.63  Also commercially available from Sigma-Aldrich.  
 
1H NMR (300 MHz, Acetone-D6) δ = 5.97 (dd, J = 18.6, 13.8 Hz, 1H), 5.70-5.63 (m, 2H), 4.22 
(d, J = 16.8 Hz, 2H), 4.02 (d, J = 16.8 Hz, 2H), 3.00 (s, 3H); 
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General Procedure for the Vinyl Boronate Coupling 
To an oven-dried 25 mL Schlenk tube equipped with a magnetic stir bar in an argon filled glovebox 
was added ruthenium hydride RuHCl(CO)(PCy3)2 (0.05 equiv), alkyne (1.0 equiv) in toluene 
(0.5M) and vinyl boronate 1.39b (2.0 equiv). The sealed reaction vessel was removed from the 
glovebox and placed under a positive stream of Ar(g), then stirred at 85 
oC until TLC analysis 
indicated complete consumption of the starting material. The orange/brown solution was cooled 
to rt, filtered through a plug of silica gel (eluted with ether) and concentrated in vacuo to give an 
amber-colored oil. The residue was purified by column chromatography on silica gel. 
 
Diene (1.60): Following the general procedure, ruthenium hydride 
RuHCl(CO)(PCy3)2 (9 mg, 0.0125 mmol, 0.05 equiv), alkyne 1.46 (75.0 mg, 
0.25 mmol, 1.0 equiv) in toluene (1.0 mL) and vinyl boronate 1.39b (87 µL, 
0.50 mmol, 2.0 equiv) were combined and stirred at 85 oC for 6 h. The residue was purified by 
column chromatography (silica gel 2.5 x 15 cm; eluted with 5% ether/hexanes) to give 1.60 as a 
pale brown oil (69 mg, 65%). 
Rf (10% ether/hexanes) = 0.28 
1H NMR (300 MHz, CDCl3) δ = 7.43 (d, 1H, J = 17.7 Hz), 7.28-7.22 (m, 3H), 7.08-7.05 (m, 2H), 
5.19 (d, 1H, J = 18.0 Hz), 4.30-4.17 (m, 1H), 2.73 (s, 2H), 1.79 (dd, 1H, J = 14.1, 3.0 Hz), 1.70-
1.43 (m, 11H), 1.29-1.26 (m, 9H), -0.18 (s, 3H), -0.19 (s, 3H)  
13C NMR (75 MHz, CDCl3) δ = 148.7, 146.4, 144.7, 142.1, 129.9, 127.8, 127.0, 80.0, 71.0, 64.9, 
46.1, 39.7, 34.8, 31.7, 31.3, 28.2, 25.8, 23.3, 23.1, 22.8, 1.2, 1.1 
11B NMR (96 MHz, CDCl3) δ = 27.6 
FT-IR (NaCl, thin film) ν = 2974, 2933, 1522, 1392, 1291, 1207, 1057, 1035 cm-1 
HRMS (ESI) calc. for (C25H37BO3Si)Na
+: 447.2497; found 447.2496. 
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Diene (1.62): Following the general procedure, ruthenium hydride 
RuHCl(CO)(PCy3)2 (18 mg, 0.025 mmol, 0.10 equiv), alkyne 1.48 (76.5 mg, 
0.25 mmol, 1.0 equiv) in toluene (0.5 mL) and vinyl boronate 1.39b (87 µL, 0.50 
mmol, 2.0 equiv) were combined and stirred at 85 oC for 5.5 h. The residue was 
purified by column chromatography (silica gel 2.5 x 15 cm; eluted with 10% ether/hexanes) to 
give 1.62 as a pale brown oil (58 mg, 54%). 
Rf (10% ether/hexanes) = 0.23 
1H NMR (400 MHz, CDCl3) δ = 7.47-7.27 (m, 9H), 7.13-7.10 (m, 2H), 5.25 (d, 1H, J = 18.0 Hz), 
5.05 (dd, 1H, J = 9.6, 5.2 Hz), 4.24-4.16 (m, 1H), 3.41 (ddd, 1H, J = 16.4, 5.3, 3.6 Hz), 2.65 (ddd, 
1H, J = 16.4, 9.6, 2.4 Hz), 1.77 (dd, 1H, J = 13.9, 2.9 Hz), 1.47 (dd, 1H, J = 13.4, 11.8 Hz), 1.27 
(s, 6H), 1.24 (dd, 3H, J = 6.2, 1.6 Hz), 0.08 (s, 1.5H), 0.07 (s, 1.5H), -0.19 (s, 1.5H), -0.21 (s, 1.5H) 
13C NMR (100 MHz, CDCl3) δ = 148.5, 145.1, 144.7, 144.5, 141.8, 129.8, 128.5, 127.9, 127.4, 
127.2, 125.7, 78.1, 71.0, 64.9, 46.1, 42.2, 31.3, 28.2, 23.3, 0.6, 0.5, -0.5, -0.6 
11B NMR (128 MHz, CDCl3) δ = 27.7 
FT-IR (NaCl, thin film) ν = 2972, 1582, 1491, 1390, 1302, 1207, 1161, 1030 cm-1 
HRMS (ESI) calc. for (C26H33BO3Si)Na
+: 455.2184; found 455.2183. 
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Diene (1.63): Following the general procedure, ruthenium hydride 
RuHCl(CO)(PCy3)2 (8.7 mg, 0.012 mmol, 0.05 equiv), alkyne 1.49 (74.5 mg, 
0.24 mmol, 1.0 equiv) in toluene (0.5 mL) and vinyl boronate 1.39b (83 µL, 0.48 
mmol, 2.0 equiv) were combined and stirred at 85 oC for 4 h. The residue was 
purified by column chromatography (silica gel 2.5 x 15 cm; eluted with 10% ether/hexanes) to 
give 1.63 as a pale brown oil (68 mg, 63%). 
Rf (10% ether/hexanes) = 0.23 
1H NMR (300 MHz, CDCl3) δ = 7.46-7.26 (m, 9H), 7.12-7.09 (m, 2H), 5.24 (d, 1H, J = 17.7 Hz), 
5.04 (dd, 1H, J = 9.6, 5.4 Hz), 4.24-4.14 (m, 1H), 3.40 (ddd, 1H, J = 16.5, 5.4, 2.7 Hz), 2.64 (app 
dd, 1H, J = 15.3, 9.9 Hz), 1.76 (dd, 1H, J = 13.8, 2.7 Hz), 1.47 (dd, 1H, J = 13.5, 11.7 Hz), 1.27-
1.23 (m, 9H), 0.08 (s, 1.5H), 0.06 (s, 1.5H), -0.20 (s, 1.5H), -0.21 (s, 1.5H) 
13C NMR (75 MHz, CDCl3) δ = 148.5, 145.1, 144.7, 144.5, 141.8, 129.8, 128.5, 127.9, 127.4, 
127.2, 125.7, 78.1, 71.0, 64.9, 46.0, 42.2, 31.3, 28.2, 23.2, 0.5, 0.4, -0.6, -0.7 
11B NMR (96 MHz, CDCl3) δ = 28.1 
FT-IR (NaCl, thin film) ν = 2975, 1719, 1599, 1492, 1392, 1304, 1272, 1030 cm-1 
HRMS (ESI) calc. for (C26H33BO3Si)Na
+: 455.2184; found 455.2183. 
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Diene (1.65): Following the general, ruthenium hydride 
RuHCl(CO)(PCy3)2 (9.1 mg, 0.0125 mmol, 0.05 equiv), alkyne 
1.51(72.4 mg, 0.25 mmol, 1.0 equiv) in toluene (0.5 mL) and vinyl 
boronate 1.39b (87 µL, 0.50 mmol, 2.0 equiv) were combined and stirred at 85 
oC for 4 h. The 
residue was purified by column chromatography (silica gel 2.5 x 15 cm; gradient elution with 10%-
15% ether/hexanes) to give 1.65 as a yellow oil (63.1 mg, 60%). 
Rf (10% ether/hexanes) = 0.14 
1H NMR (300 MHz, CDCl3) δ = 8.22 (d, 2H, J = 8.7 Hz), 7.58 (d, 2H, J = 8.7 Hz), 7.39 (dd, 1H, 
J = 17.7, 2.4 Hz), 7.31-7.27 (m, 3H), 7.11-7.08 (m, 2H), 5.26 (d, 1H, J = 17.7 Hz), 5.14 (dd, 1H,  
J = 9.6, 5.4 Hz), 4.23-4.17 (m, 1H), 3.46 (ddd, 1H, J = 16.2, 5.1, 3.9 Hz), 2.56 (ddd, 1H, J = 16.2, 
9.6, 3.0 Hz), 1.77 (dd, 1H, J = 14.1, 3.0 Hz), 1.49 (app t, 1H, J = 11.7 Hz), 1.30-1.23 (m, 9H), 0.09 
(s, 1.5H), 0.07 (s, 1.5H), -0.19 (s, 1.5H), -0.20 (s, 1.5H) 
13C NMR (75 MHz, CDCl3) δ = 152.4, 149.2, 147.2, 144.1, 143.4, 141.6, 129.7, 128.0, 127.4, 
126.3, 123.8, 77.1, 71.1, 65.0, 46.0, 41.7, 31.3, 28.2, 23.3, 0.5, 0.4, -0.6, -0.7 
11B NMR (96 MHz, CDCl3) δ = 27.8 
FT-IR (NaCl, thin film) ν = 3024, 2973, 2933, 2858, 1585, 1390, 1293, 1249 cm-1 
HRMS (ESI) calc. for (C26H32BNO5Si)Na
+: 500.2035; found 500.2033. 
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Diene (1.68): Following the general, ruthenium hydride 
RuHCl(CO)(PCy3)2 (18 mg, 0.025 mmol, 0.10 equiv), alkyne 1.54 (69.1 
mg, 0.25 mmol, 1.0 equiv) in toluene (1.0 mL) and vinyl boronate 1.39b (87 
µL, 0.50 mmol, 2.0 equiv) were combined and stirred at 85 oC for 3 h. The residue was purified 
by column chromatography (silica gel 2.5 x 15 cm; eluted with 10% ether/hexanes) to give 1.68 
as a pale brown oil (68 mg, 68%). 
Rf (10% ether/hexanes) = 0.38 
1H NMR (300 MHz, CDCl3) δ = 7.41 (dd, 1H, J = 18.0, 1.8 Hz), 6.98 (d, 2H, J = 8.7 Hz), 6.81 (d, 
2H, J = 8.7 Hz), 5.21 (d, 1H, J = 17.7 Hz), 4.23-4.16 (m, 2H), 3.79 (s, 3H), 3.06 (ddd, 1H, J = 
16.5, 5.4, 4.2 Hz), 2.38 (ddd, 1H, J = 16.2, 8.1, 4.2 Hz), 1.77 (dd, 1H, J = 14.1, 3.0 Hz), 1.47 (dd, 
1H, J = 13.8, 11.4 Hz), 1.32 (d, 3H, J = 6.3 Hz), 1.29-1.24 (m, 9H), -0.07 (s, 1.5H), -0.09 (s, 1.5H), 
-0.21 (s, 1.5H), -0.22 (s, 1.5H)  
13C NMR (75 MHz, CDCl3) δ = 158.7, 148.0, 145.7, 144.9, 134.3, 130.9, 113.2, 72.7, 70.9, 64.9, 
55.3, 46.1, 40.7, 31.3, 28.2, 24.1, 23.2, 0.8, 0.7, -0.2, -0.3   
11B NMR (96 MHz, CDCl3) δ = 27.9 
FT-IR (NaCl, thin film) ν = 2972, 2932, 1607, 1510, 1391, 1303, 1272, 1035 cm-1 
HRMS (ESI) calc. for (C22H33BO4Si)Na
+: 423.2133; found 423.2132. 
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Diene (1.69): Following the general, ruthenium hydride RuHCl(CO)(PCy3)2 
(9 mg, 0.0125 mmol, 0.05 equiv), alkyne 1.55 (65 mg, 0.25 mmol, 1.0 equiv) in 
toluene (0.5 mL) and vinyl boronate 1.39b (87 µL, 0.50 mmol, 2.0 equiv) were 
combined and stirred at 85 oC for 3 h. The residue was purified by column chromatography (silica 
gel 2.5 x 15 cm; eluted with 5% ether/hexanes) to give 1.69 as a pale brown oil (57.1 mg, 59%). 
Rf (10% ether/hexanes) = 0.41 
1H NMR (300 MHz, CDCl3) δ = 7.41 (dd, 1H, J = 18.0, 1.5 Hz), 7.06-6.94 (m, 4H), 5.15 (d, 1H, 
J = 17.7 Hz), 4.23-4.17 (m, 2H), 3.06 (dd, 1H, J = 16.2, 5.4, 4.2 Hz), 2.39 (ddd, 1H, J = 16.2, 8.1, 
3.9), 1.78 (dd, 1H, J = 13.8, 3.0 Hz), 1.50 (app t, 1H, J = 13.8), 1.33 (d, 3H, J = 6.3 Hz), 1.28-1.25 
(m, 9H), -0.08 (s, 1.5H), -0.09 (s, 1.5H), -0.21 (s, 1.5H), -0.22 (s, 1.5H)  
13C NMR (75 MHz, CDCl3) δ = 163.7, 160.5, 147.3, 146.5 (d, JC-F = 1.4 Hz), 144.7, 137.8 (d, JC-
F = 3.4 Hz), 131.4 (d, JC-F = 8.0 Hz), 114.8 (d, JC-F = 21.1 Hz), 72.7, 71.1, 65.0, 40.8, 31.3, 28.2, 
24.1, 23.3, 0.7, 0.6, -0.3, -0.4 
11B NMR (96 MHz, CDCl3) δ = 27.9     
19F NMR (282.3 MHz, CDCl3) δ = ((-115.9) – (-116.1)) m 
FT-IR (NaCl, thin film) ν = 2976, 1719, 1602, 1508, 1384, 1304, 1259, 1091 cm-1 
Anal. calcd for C21H30BFO3Si: C 64.95, H 7.79; found C 65.04, H 7.72. 
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Diene (1.70): Following the general, ruthenium hydride RuHCl(CO)(PCy3)2 
(17.4 mg, 0.024 mmol, 0.10 equiv), alkyne 1.56 (69 mg, 0.24 mmol, 1.0 equiv) 
in toluene (1.0 mL) and vinyl boronate 1.39b (83 µL, 0.48 mmol, 2.0 equiv) 
were combined and stirred at 85 oC for 4.5 h. The residue was purified by 
column chromatography (silica gel 2.5 x 12 cm; eluted with 15% ethyl acetate/hexanes) to give 
1.70 as a pale brown oil (45.0 mg, 45%). 
Rf (20% ether/hexanes) = 0.14 
1H NMR (300 MHz, CDCl3) δ = 7.90 (m, 2H), 7.41 (dd, 1H, J = 18.0, 1.5 Hz), 7.20-7.17 (m, 2H), 
5.11 (d, 1H, J = 18.0 Hz), 4.24-4.16 (m, 2H), 3.10 (ddd, 1H, J = 16.2, 5.4, 3.9 Hz), 2.61 (s, 3H), 
2.42 (ddd, 1H, J = 16.5, 8.1, 3.6 Hz), 1.78 (dd, 1H, J = 14.1, 3.0 Hz), 1.49 (dd, 1H, J = 14.1, 11.7 
Hz), 1.34 (d, 3H, J = 6.0 Hz), 1.29-1.25 (m, 9H), -0.08 (s, 1.5H), -0.09 (s, 1.5H), 0.21 (s, 1.5H), -
0.23 (s, 1.5H)  
13C NMR (75 MHz, CDCl3) δ = 198.0, 147.3, 147.2, 146.5, 144.1, 136.0, 130.1, 128.1, 72.6, 71.1, 
65.0, 46.1, 40.9, 31.3, 28.2, 26.8, 24.1, 23.2, 0.7, 0.6, -0.2, -0.3 
11B NMR (96 MHz, CDCl3) δ = 28.8 
FT-IR (NaCl, thin film) ν = 2923, 1685, 1601, 1560, 1094 cm-1 
Anal. calcd for C23H33BO4Si: C 66.98, H 8.07; found C 66.69, H 8.35. 
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 Diene (1.71): To an oven-dried 25 mL Schlenk tube equipped with a magnetic 
stir bar in an argon filled glovebox was added ruthenium hydride 
RuHCl(CO)(PCy3)2 (20 mg, 0.025 mmol, 0.05 equiv) and a solution of alkyne 
1.33 (122 mg, 0.5 mmol, 1.0 equiv) and vinyl boronate 1.39c (155 mg, 1.0 mmol, 
2.0 equiv) in toluene (1.0 mL). The sealed reaction vessel was removed from the glovebox and 
placed under a positive stream of Ar(g), then the reaction mixture stirred at 85 
oC for 4 h. TLC 
analysis indicated complete consumption of the starting material. The brown solution was cooled 
to rt, filtered through a plug of silica gel (eluted with DCM) and concentrated in vacuo to give a 
brown oil. The residue was purified by column chromatography (silica gel 2.5 x 15 cm; eluted 
with 10% ether/hexanes) to give 1.71 as a light brown oil (102 mg, 55%). 
Rf (10% ether/hexanes) = 0.12 
1H NMR (400 MHz, CDCl3) δ = 7.50 (d, 1H, J = 17.8 Hz), 7.28-7.24 (m, 3H), 7.08-7.05 (m, 2H), 
5.26 (d, 1H, J= 18.2 Hz), 4.22-4.16 (m, 1H), 3.09 (dd, 1H, J = 16.0, 5.3 Hz), 2.41 (dd, 1H, J = 
16.0, 8.0 Hz), 1.32 (d, 3H, J = 6.3 Hz), 1.23 (s, 12H), -0.08 (s, 3H), -0.22 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ = 148.0, 147.5, 147.3, 141.3, 129.8, 127.9, 127.2, 83.3, 72.6, 40.8, 
24.9, 24.8, 24.0, 0.5, -0.4 
11B NMR (128 MHz, CDCl3) δ = 30.0 
FT-IR (NaCl, thin film) ν = 2975, 2928, 1597, 1492, 1344, 1251, 1144, 1060 cm-1 
Anal. calcd for C21H31BO3Si: C 68.10, H 8.44; found C 67.95, H 8.24. 
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Diene (1.72): Following the general, ruthenium hydride RuHCl(CO)(PCy3)2 
(11 mg, 0.015 mmol, 0.05 equiv), alkyne 1.46 (89 mg, 0.3 mmol, 1.0 equiv) in 
DCE (0.5 mL) and vinyl boronate 1.39c (93 mg, 0.50 mmol, 2.0 equiv) were 
combined and stirred at 85 oC for 2.5 h. The residue was purified by column 
chromatography (silica gel 2.5 x 15 cm; eluted with 5% ether/hexanes) to give 1.72 as a pale brown 
oil (91 mg, 72%). 
Rf (10% ether/hexanes) = 0.25 
1H NMR (400 MHz, CDCl3) δ = 7.66 (d, 1H, J = 17.9 Hz), 7.46-7.40 (m, 3H), 7.24-7.22 (m, 2H), 
5.42 (d, 1H, J= 17.9 Hz), 2.91 (s, 2H), 1.85-1.51 (m, 10H), 1.43 (s, 12H), 0.00 (s, 6H) 
13C NMR (100 MHz, CDCl3) δ = 147.3, 147.0, 146.2, 140.4, 128.8, 126.8, 126.1, 82.3, 78.9, 43.0, 
38.6, 24.6, 23.8, 21.9, 0.0 
11B NMR (128 MHz, CDCl3) δ = 30.8 
FT-IR (NaCl, thin film) ν = 2978, 2931, 2857, 1597, 1444, 1379, 1249, 970, 828 cm-1 
Anal. calcd for C25H37BO3Si: C 70.74, H 8.79; found C 71.08, H 8.64. 
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Diene (1.73): Following the general procedure, ruthenium hydride 
RuHCl(CO)(PCy3)2 (11 mg, 0.015 mmol, 0.05 equiv), alkyne 1.47 (96 mg, 0.3 
mmol, 1.0 equiv), vinyl boronate 1.39c (93 mg, 0.50 mmol, 2.0 equiv) and DCE 
(0.5 mL) were combined and stirred at 85 oC for 2.5 h. The residue was purified 
by column chromatography (silica gel 2.5 x 15 cm; gradient elution with 5%-10% ether/hexanes) 
to give 1.73 as a pale brown oil (89 mg, 67%). 
Rf (10% ether/hexanes) = 0.28 
1H NMR (400 MHz, CDCl3) δ = 7.60-7.54 (m, 3H), 7.42-7.27 (m, 7H), 7.14-7.12 (m, 2H), 5.34 
(d, 1H, J = 17.9 Hz), 3.33 (d, 1H, J = 16.6 Hz), 3.10 (d, 1H, J = 16.6 Hz), 1.61 (s, 3H), 1.32 (s, 
12H), 0.00 (s, 3H), -0.09 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ = 149.4, 148.6, 147.1, 147.1, 141.5, 129.8, 128.2, 128.0, 127.3, 
126.6, 124.8, 83.5, 81.7, 46.6, 32.1, 25.0, 24.9, 0.8, 0.8 
11B NMR (128 MHz, CDCl3) δ = 30.9 
FT-IR (NaCl, thin film) ν = 3058, 2978, 2929, 1598, 1444, 1379, 1250, 1205, 1144, 1031, 830 
cm-1 
Anal. calcd for C26H33BO3Si: C 72.64, H 7.90; found C 72.70, H 8.14. 
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Diene (1.74): Following the general procedure, ruthenium hydride 
RuHCl(CO)(PCy3)2 (11 mg, 0.015 mmol, 0.05 equiv), alkyne 1.48 (96 mg, 
0.31 mmol, 1.0 equiv), vinyl boronate 1.39c (96 mg, 0.62 mmol, 2.0 equiv) and 
DCE (0.6 mL) were combined and stirred at 85 oC for 5 h. The residue was 
purified by column chromatography (silica gel 2.5 x 15 cm; eluted with 10% ether/hexanes) to 
give 1.74 as a pale brown oil (90 mg, 67%). 
Rf (10% ether/hexanes) = 0.16 
1H NMR (400 MHz, CDCl3) δ = 7.50 (d, 1H, J = 18.1 Hz), 7.41-7.27 (m, 8H), 7.12-7.09 (m, 2H), 
5.29 (d, 1H, J = 18.1 Hz), 5.05 (dd, 1H, J = 9.5, 5.4 Hz), 3.43 (dd, 1H, J = 16.4, 9.5 Hz), 2.65 (dd, 
1H, J = 16.4, 5.4 Hz), 1.23 (s, 12H), 0.07 (s, 3H), -0.18 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ = 148.2, 147.2, 146.8, 144.6, 141.3, 129.8, 128.5, 128.0, 127.4, 
127.4, 125.6, 83.4, 78.0, 42.3, 24.9, 0.4, -0.5 
11B NMR (128 MHz, CDCl3) δ = 30.3 
FT-IR (NaCl, thin film) ν = 2978, 1598, 1492, 1384, 1306, 1251, 1144, 847 cm-1 
Anal. calcd for C26H33BO3Si: C 72.21, H 7.69; found C 72.29, H 7.39. 
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Diene  (1.75): To an oven-dried 25 mL Schlenk tube equipped with a magnetic stir 
bar was added silyl boronate 1.74 (50 mg, 0.12 mmol, 1.0 equiv), Pd(OAc)2 (1.3 
mg, 0.006 mmol, 0.05 equiv), S-Phos (5.0 mg, 0.012 mmol, 0.10 equiv) and K3PO4 
(76.4 mg, 0.36 mmol, 3.0 equiv). The vessel was evacuated then placed under Ar(g). To the solids 
was added degassed H2O (6.5 µL, 0.36 mmol, 3.0 equiv), degassed THF (1.2 mL) and iodobenzene 
(20 µL, 0.18 mmol, 1.5 equiv). The resulting orange suspension stirred at 50 oC overnight. TLC 
analysis indicated complete consumption of the starting material. The orange suspension was 
cooled to rt, filtered through a plug of silica gel (eluted with ether) and concentrated in vacuo to 
give an orange oil. The residue was purified by column chromatography (silica gel 1.5 x 15 cm; 
gradient elution with 2%-4% ether/hexanes) to give 1.75 as a yellow solid (33.3 mg, 73%). 
Rf (10% ether/hexanes) = 0.35 
M.P. = 117-118 oC 
1H NMR (400 MHz, CDCl3) δ = 7.37-7.09 (m, 16H), 6.13 (d, 1H, J = 16.0 Hz), 5.02 (m, 1H), 3.30 
(dd, 1H, J = 16.0, 6.0 Hz), 2.61 (dd, 1H, J = 16.0, 9.3 Hz), 0.00 (s, 3H), -0.22 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ = 147.3, 144.9, 143.6, 142.1, 137.5, 133.5, 129.9, 128.8, 128.6, 
128.2, 128.1, 128.0, 127.6, 127.5, 126.9, 125.6, 78.0, 42.4, 0.6, -0.3 
FT-IR (NaCl, thin film) ν = 3059, 3030, 2927, 1599, 1492, 1447, 1249, 1031 cm-1  
Anal. calcd for C26H26OSi: C 81.63, H 6.85; found C 81.57, H 6.66. 
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Vinyl Iodide (1.76): To an oven-dried 50 mL Schlenk tube equipped with a 
magnetic stir bar under under Ar(g) was added silyl boronate 1.74 (46 mg, 0.11 
mmol, 1.0 equiv) and THF (0.24 mL). To the pale yellow solution was added 
NaOH (5M in H2O, 66 µL, 0.33 mmol, 3.0 equiv) dropwise via syringe. After stirring for 20 min, 
a solution of I2 (56 mg, 0.22 mmol, 1.5 equiv) in THF (0.3 mL) was added dropwise. The dark red 
solution stirred at rt for 20 min. TLC analysis indicated complete consumption of the starting 
material. The reaction was quenched by addition of sat. Na2S2O3(aq) (1 mL). The aqueous layer was 
extracted with DCM (3 x 1 mL) and the combined organic layers were dried over Na2SO4, filtered 
and concentrated in vacuo to give an orange oil. The residue was filtered through a plug of silica 
gel (eluted with chloroform) to give 1.76 as a yellow oil (31.3 mg, 66%). 
Rf (5% ether/hexanes) = 0.33 
1H NMR (400 MHz, CDCl3) δ = 7.55 (d, 1H, J = 14.5 Hz), 7.40-7.27 (m, 8H), 7.15-7.13 (m, 2H), 
6.07 (d, 1H, J = 14.5 Hz), 5.07 (dd, 1H, J = 9.6, 5.6 Hz), 3.23 (dd, 1H, J = 16.4, 5.3 Hz), 2.54 (dd, 
1H, J = 16.4, 9.5 Hz),  0.06 (s, 3H), -0.16 (s, 3H) 
13C NMR (100 MHz, CDCl3) δ = 146.7, 144.5, 144.4, 143.8, 140.5, 129.6, 128.6, 128.4, 127.9, 
127.5, 125.5, 84.2, 77.7, 42.3, 0.3, -0.5 
FT-IR (NaCl, thin film) ν = 3059, 2958, 1491, 1249, 1030, 703 cm-1 
Anal. calcd for C20H21IOSi: C 55.56, H 4.90; found C 55.38, H 4.75. 
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Alkyne  (1.77): To an oven dried 50 mL Schlenk tube equipped with magnetic stir 
bar was added PdCl2(PPh3)2 (10 mg, 0.014 mmol, 0.05 equiv), CuI (5 mg, 0.028 
mmol, 0.10 equiv),  phenylacetylene (33 µL, 0.30 mmol, 1.1 equiv) and vinyl 
iodide 1.76 (120 mg, 0.28 mmol, 1 equiv) in 1:1 NEt3/THF (2.0 mL). The Schlenk 
tube was capped with a rubber septum and two cycles of freeze/pump/thaw were conducted. The 
reaction was warmed to rt then heated to 60 °C. After 15 min TLC indicated the reaction was 
complete. The mixture was filtered through a plug of Celite® (eluted with ether), washed with sat. 
NH4Cl(aq) and brine then dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (silica gel 2.5 x 15 cm; eluted with 5% EtOAc/hexanes) to 
give 1.77 as a yellow oil (100 mg, 88%). 
Rf (20% EtOAc/hexanes) = 0.74 
1H NMR (400 MHz, CDCl3) δ = 7.45-7.34 (m, 9H), 7.33-7.28 (m, 4H), 7.22 (d, 1H, J = 15.8 Hz), 
7.21-7.19 (m, 2H), 5.54 (d, 1H, J = 15.8 Hz), 5.13 (dd, 1H, J = 9.3, 5.5 Hz), 3.35 (dd, 1H, J = 16.7, 
5.7 Hz), 2.68 (dd, 1H, J = 16.5, 9.3 Hz), 0.10 (s, 3H), -0.11 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ = 146.5, 145.9, 144.6, 140.8, 140.0, 131.6, 129.7, 128.5, 128.5, 
128.4, 127.8, 127.4, 125.5, 123.5, 112.9, 94.3, 89.3, 77.8, 42.3, 0.4, -0.4 
FT-IR (NaCl, thin film) ν = 3059, 3030, 2959, 2246, 1600, 1489, 1249, 1054, 860 cm-1 
Anal. calcd for C28H26OSi: C 82.71, H 6.45; found C 82.47, H 6.40. 
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 Diene  (1.78): ruthenium hydride RuHCl(CO)(PCy3)2 (20 mg, 0.025 mmol, 0.05 
equiv), alkyne 1.33 (122 mg, 0.5 mmol, 1.0 equiv) in THF (1.0 mL) and vinyl 
boronate 1.39c (155 mg, 1 mmol, 2 equiv) were combined and stirred at 70 oC 
overnight. In a separate oven-dried 50 mL Schlenk tube equipped with a magnetic 
stir bar was added added Pd(OAc)2 (6.0 mg, 0.025 mmol, 0.05 equiv), S-Phos (20 mg, 0.05 mmol, 
0.10 equiv), 4-iodotoluene (218 mg, 1.0 mmol, 2.0 equiv), K3PO4 (2M, freshly prepared and 
degassed prior, 1.5 mmol, 0.75 mL, 3 equiv) and THF (3 mL, degassed). To the resulting solution 
was added the crude diene reaction mixture then the mixture stirred at 50 oC overnight. TLC 
analysis indicated complete consumption of the starting material. The solution was cooled to rt, 
filtered through a plug of silica gel (eluted with DCM) and concentrated in vacuo. The residue was 
purified by column chromatography (silica gel 2.5 x 12 cm; eluted with 2% ether/hexanes) to give 
1.78 (92 mg, 55% over two steps). 
Rf (10% ether/hexanes) = 0.18  
1H NMR (400 MHz, CDCl3) δ = 7.39-7.08 (m, 10H), 6.16 (d, 1H, J = 15.9 Hz), 4.30-4.20 (m, 
1H), 3.07 (dd, 1H, J = 16.2, 5.1 Hz), 2.43 (dd, 1H, J = 16.2, 8.4 Hz), 2.32 (s, 3H), 1.36 (d, 3H, J = 
6.0 Hz), -0.07 (s, 3H), -0.19 (s, 3H) 
13C NMR (75 MHz, CDCl3) δ = 147.1, 143.4, 142.0, 137.7, 134.6, 132.9, 129.7, 129.3, 127.9, 
127.2, 127.1, 126.6, 72.4, 40.8, 24.0, 21.2, 0.5, -0.4 
FT-IR (NaCl, thin film) ν = 3078, 3026, 2966, 2866, 2241, 1603, 1584, 1510, 1491, 1376, 1249, 
1124, 1095 cm-1 
Anal. calcd for C22H26OSi: C 78.99, H 7.83; found C 78.77, H 7.44. 
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3.4 ETHYLENE TRANSFER DATA 
 
3.4.1 Intramolecular Ethylene Transfer: MVK 
General Experimental for Ethylene Transposition: 
In an argon-filled glovebox, a 15 mL sealed tube equipped with a stir bar was charged with 
RuHCl(CO)(SIMes)(PPh3) (0.05 equiv.), the silyl ether (1.0 equiv.), MVK (0.10 equiv.) and dry 
DCE (0.5 M). The reaction mixture was sealed with a teflon cap, removed from the glovebox and 
immersed in a preheated 85oC oil bath. After being stirred at 85oC for the allotted time, the reaction 
mixture was concentrated in vacuo and purified by flash chromatography on silica gel. 
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According to the general experimental, the reaction of the silyl ether 1.83 (124 mg, 0.5 mmol), 
MVK (4 μL, 4 mg, 0.05 mmol) and RuHCl(CO)(SIMes)(PPh3) (18 mg, 0.025 mmol) in DCE (1 
mL, 0.5 M) afforded the product Z-1.102 (81 mg, 65%) as a colorless oil. 
TLC (hexanes:Et2O = 10:1): Rf = 0.21 
Flash chromatography (2.5 cmφ× 15 cm): hexanes:Et2O = 45:1 
1H NMR (300 MHz, CDCl3): δ= 7.33-7.27 (m, 3H), 7.13-7.10 (m, 2H), 6.88 (dd, J= 17.4, 10.8 
Hz, 1H), 5.23 (dd, J = 10.8, 1.8 Hz, 1H), 4.86 (dd, J = 17.4, 1.8 Hz, 1H),4.12-4.08 (m, 1H), 2.98-
2.93 (m, 1H), 1.27 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 7.2 Hz, 3H), 0.13 (s, 3H), -0.41 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ 150.5, 146.6, 141.5, 135.3, 129.8, 127.9, 127.2, 118.6, 74.5, 42.0, 
19.1, 14.3, 1.7. -1.2 
IR (film): 3082, 2967, 2869, 1598, 1491, 1141, 743 
Anal. calcd for C16H22OSi: C 74.36, H 8.58; found: C 74.44, H, 8.98 
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According to the general experimental, the reaction of the silyl ether 1.84 (258 mg, 1.0 mmol), 
MVK (8 μL, 0.10 mmol) and RuHCl(CO)(SIMes)(PPh3) (34 mg, 0.05 mmol) in DCE (1.5 mL, 
0.67 M) afforded the product Z-1.38 (157 mg, 61%) as a colorless oil.  
TLC (hexanes:Et2O = 10:1): Rf = 0.38 
Flash chromatography (2.5 cmφ× 15 cm): hexanes:Et2O = 45:1 
1H NMR (300 MHz, CDCl3): δ= 7.33-7.27 (m, 3H), 7.15-7.12 (m, 2H), 6.88 (dd, J = 17.1, 10.5 
Hz, 1H), 5.24 (dd, J = 10.5, 1.5 Hz, 1H), 4.88 (dd, J = 17.4, 1.8 Hz, 1H), 4.11-4.06 (m, 1H), 2.86-
2.83 (m, 1H), 1.21 (d, J = 7.2 Hz, 3H), 1.17 (d, J = 6.6 Hz, 3H), 0.15 (s, 3H), -0.43 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ 148.1, 148.1, 141.8, 135.4, 129.8, 127.9, 127.3, 118.7, 80.0, 44.3, 
24.6, 21.3, 2.3, 0.7 
IR (film): 3025, 2960, 2867, 1581, 1490, 1250, 842 
Anal. calcd for C16H22OSi: C 74.36, H 8.58; found: C 74.34, H 8.89 
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3.4.2 Silylvinylation Using Ethylene Gas 
General procedure for Silylvinylation at 1 atmosphere ethylene: 
 
 
An oven dried 50 mL Schlenk tube equipped with a magnetic stir bar was brought into an 
argon filled glove box. To the Schlenk tube was added RuHCl(CO)(SIMes)(PPh3) (1-5 mol%) 
followed by the alkyne substrate (1.0 equivalent) in 1,2-dichloroethane or toluene (0.25M). The 
Schlenk tube was sealed and removed from the glovebox. The solution was purged with ethylene 
gas for 1-5 minutes via balloon and steel needle. The needle was removed from the solution and 
placed 3-4 cm above the solvent, then the apparatus was immersed in an 80C oil bath. The reaction 
was stirred until complete consumption of the starting material was visualized by thin layer 
chromatography. Upon completion, the reaction was filtered through a short plug of silica gel 
(eluted with dichloromethane) and concentrated in vacuo. A crude yield was obtained by 1H NMR 
with mesitylene (0.33 equivalents) as an internal standard. The crude product was purified via flash 
chromatography on silica gel. 
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(Z)-2,2,5-trimethyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.135) 
Following the general procedure, RuH (35 mg, 0.046 mmol) and alkyne 
1.33 (1.12 g, 4.6 mmol) in toluene (4.6 mL) stirred under ethylene (1 atm) at 80C for 1 h. 
Purification via flash column chromatography (2-3% diethyl ether/hexanes) gave diene 1.135 as a 
clear oil (80% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 10:1:1 
Rf = 0.40 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.34-7.28 (m, 3H), 7.13-7.10 (m, 2H), 6.86 (dd, J = 17.4, 10.8 
Hz, 1H), 5.23 (dd, J = 10.8, 1.5 Hz, 1H), 4.87 (dd, 17.4, 1.5 Hz, 1H), 4.24-4.16 (m, 1H), 2.96 (dd, 
J = 15.9, 5.1 Hz, 1H), 2.32 (dd, J = 15.9, 8.4 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), -0.07 (s, 3H), -0.20 
(s, 3H). Minor isomer diagnostic peaks: δ = 6.52 (dd, J = 16.8, 10.8 Hz, 1H), 5.08 (d, J = 10.5 
Hz, 1H), 4.75 (d, J = 16.8 Hz, 1H), 1.20 (d, J = 6.0 Hz, 3H), 0.42 (s, 3H), 0.39 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 148.2, 147.2, 144.4, 143.5, 141.6, 139.8, 139.8, 135.9, 129.7,  
128.9, 128.3, 127.9, 127.3, 126.9, 118.3, 116.4, 72.7, 72.5, 42.8, 40.7, 24.1, 23.8, 0.7, 0.6, 0.3, -
0.3 
IR (film): ν = 3056, 2964, 2873, 1581, 1249, 1035, 832 cm-1 
Anal. calcd. for C15H20OSi: C 73.71, H 8.25; found: C 73.71, H 8.34 
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(Z)-5-cyclohexyl-2,2-dimethyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.136) 
Following the general procedure, RuH (4 mg, 0.006 mmol) and alkyne 1.44 (78 
mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification via 
preparative TLC (1% diethyl ether/hexanes) gave diene 1.136 as a clear oil (70% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 16:2:1 
Rf  = 0.80 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.34-7.27 (m, 3H), 7.14-7.11 (m, 2H), 6.89 (dd, J = 17.4, 10.5 
Hz, 1H), 5.23 (dd, J = 10.5, 1.5 Hz, 1H), 4.87 (dd, J = 17.4, 1.5 Hz, 1H), 3.80-3.75 (m, 1H), 2.87 
(dd, J = 16.2, 5.5 Hz, 1H), 2.45 (dd, J = 16.2, 8.7 Hz, 1H), 1.96-1.92 (m, 1H), 1.78-1.66 (m, 4H), 
1.31-0.98 (m, 6H), -0.08 (s, 3H), -0.22 (s, 3H); minor isomer diagnostic peaks: δ =  6.52 (dd, J 
= 17.1, 10.8 Hz, 1H), 5.08 (d, J = 10.5 Hz, 1H), 4.75 ( d, J = 16.8 Hz, 1H),  0.40 (s, 3H), 0.39 (s, 
3H) 
13C NMR (100 MHz, CDCl3): δ 147.0, 143.7, 141.8, 135.9, 129.8, 127.9, 127.2, 118.2, 80.7, 44.8, 
36.0, 29.3, 28.7, 26.3, 26.3, 0.4, -0.2 
IR (film): ν = 2925, 2852, 1581, 1449, 1248, 1032 cm-1 
Anal. calcd. for C20H28OSi: C 76.86, H 9.03; found: C 76.52, H 8.82 
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 (Z)-2,2-dimethyl-5-phenyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.137) 
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.48 
(77mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification 
via preparative TLC (1:200 diethyl ether/hexanes) gave diene 1.137 as a clear oil (65% as a Z/E 
mixture).  
Crude ratio Z:cyclo:E = 10:1:1 
Rf = 0.20 (5% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.44-7.28 (m, 8H), 7.19-7.16 (m, 2H), 6.87 (dd, J = 17.1, 10.5 
Hz, 1H), 5.26 (d, J = 10.5 Hz, 1H), 5.08 (dd, J = 9.5, 5.5 Hz, 1H), 4.92 (d, J = 17.1 Hz, 1H), 3.29 
(dd, J = 16.3, 5.5 Hz, 1H), 2.61 (dd, J = 16.3, 9.5 Hz, 1H), -0.09 (s, 3H), -0.15 (s, 3H); minor 
isomer diagnostic peaks: δ = 6.58 (dd, J = 17.1, 10.5 Hz, 1H), 5.14 (d, J = 10.5 Hz, 1H), 4.81 (d, 
J = 17.1 Hz, 1H),  0.52 (s, 3H), 0.51 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ 147.4, 144.4, 142.9, 141.6, 135.8, 129.8, 128.5, 128.0, 127.4, 
127.4, 125.6, 118.8, 77.9, 42.0, 0.5, -0.4 
IR (film): ν = 3060, 2961, 2880, 1582, 1420, 1250, 781 cm-1 
Anal. calcd. for C20H22OSi: C 78.38, H 7.24; found: C 78.43, H 7.02 
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(Z)-2,2,5-trimethyl-5-phenyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.138) 
Following the general procedure RuH (2 mg, 0.0025 mmol) and alkyne 1.47 (80.1 
mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification via 
preparative TLC (2% diethyl ether/hexanes) gave diene 1.138 as a clear oil (70% as a Z/E mixture).  
Crude ratio Z:cyclo:E = 16:2:1 
Rf  = 0.62 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): δ = 7.52-7.49 (m, 2H), 7.38-7.30 (m, 5H), 7.27-7.22 (m, 1H), 7.16-
7.12 (m, 2H), 6.92 (dd, J = 17.4, 10.8 Hz, 1H), 5.27 (dd, J = 10.8, 1.2 Hz, 1H), 4.91 (dd, J = 17.4, 
1.2 Hz, 1H), 3.14 (d, J = 16.2 Hz, 1H), 3.03 (d, J = 16.2 Hz, 1H), 1.58 (s, 3H), -0.07 (s, 3H), -0.10 
(s, 3H); minor isomer diagnostic peaks: δ = 6.55 (dd, J = 16.8, 10.8 Hz, 1H), 5.10 (dd, J = 10.8, 
0.9 Hz, 1H), 4.75 (d, J = 17.1 Hz, 1H), 2.72 (d, J = 16.5 Hz, 1H), 2.60 (d, J = 16.5 Hz, 1H), 1.48 
(s, 3H), 0.54 (s, 3H), 0.38 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 149.5, 147.6, 143.1, 141.7, 135.8, 129.8, 128.2, 128.0, 127.4, 
126.5, 124.8, 118.6, 81.5, 46.5, 32.2, 1.0, 0.8 
IR (film): ν = 3057, 2965, 2887, 1599, 1582, 1492, 1250, 962 cm-1 
Anal. calcd. for C21H24OSi: C 78.70, H 7.55; found: C 79.07, H 7.75 
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(Z)-2,2-dimethyl-3-(1-phenylallylidene)-1-oxa-2-silaspiro[4.5]decane (1.139)  
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.46 (74 
mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 3 h. Purification via 
flash column chromatography (1% diethyl ether/hexanes) gave diene 1.139 as a clear oil (76% as 
a Z/E mixture). 
Crude ratio Z:cyclo:E = 16:2:1 
Rf  = 0.42 (5% diethyl ether/hexanes)  
1H NMR (300 MHz, CDCl3): δ = 7.34-7.25 (m, 3H), 7.15-7.12 (m, 2H), 6.89 (dd, J = 17.1, 10.8 
Hz, 1H), 5.24 (dd, J = 10.8, 1.5 Hz, 1H), 4.87 (dd, J = 17.1, 1.5 Hz, 1H), 2.65 (s, 2H), 1.70-1.41 
(m, 10H), -0.16 (s, 6H); minor isomer diagnostic peaks: δ = 6.54 (dd, J = 16.8, 10.2 Hz, 1H), 
5.06 (d, J = 10.8 Hz, 1H), 4.71 (d, J = 16.8 Hz, 1H), 2.22 (s, 3H), 0.40 (s, 6H) 
13C NMR (100 MHz, CDCl3): δ = 146.5, 143.0, 140.8, 134.9, 128.8, 126.9, 126.2, 117.0, 78.8, 
42.7, 38.7, 24.7, 22.2, 0.1 
IR (film): ν = 3055, 2931, 2857, 1582, 1443, 1249, 891 cm-1 
Anal. calcd. for C19H26OSi: C 76.45, H 8.78; found: C 76.29, H 8.47 
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(Z)-2,2,4-trimethyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.140)  
Following the general procedure, RuH (9.0 mg, 0.0125 mmol) and alkyne 1.140a 
(74.6 mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 1.5 h. 
Purification via flash column chromatography (1% diethyl ether/hexanes) gave diene 1.140 as a 
clear oil (67% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 13:1:2 
Rf = 0.36 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3):  δ = 7.33-7.25 (m, 3H), 7.14-7.10 (m, 2H), 6.90 (dd, J = 17.1, 10.5 
Hz, 1H), 5.25 (dd, J = 10.5, 1.5 Hz, 1H), 4.87 (dd, J = 17.1, 1.5 Hz, 1H), 4.00 (dd, J = 9.3, 5.1 Hz, 
1H), 3.85 (d, J = 9.6 Hz, 1H), 3.18-3.09 (m, 1H), 1.21 (d, J = 7.2 Hz, 3H), 0.14 (s, 3H), -0.41 (s, 
3H); minor isomer diagnostic peaks: δ = 6.49 (dd, J = 17.1, 10.5 Hz, 1H), 5.09 (dd, J = 10.5 , 
0.9 Hz, 1H), 4.69 (dd, J = 17.1, 1.2 Hz, 1H), 2.60-2.52 (m, 1H), 0.85 (d, J = 7.2 Hz, 3H), 0.46 (s, 
3H), 0.39 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 148.3, 147.0, 141.5, 135.3, 129.7, 127.9, 127.3, 118.7, 72.5, 38.2, 
21.1, 1.6, -1.2 
IR (film): ν = 3025, 2960, 2867, 1581, 1490, 1250, 842 cm-1 
Anal. calcd. for C15H20OSi: C 73.71, H 8.25; found: C 73.97, H 8.35 
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(Z)-2,2,4,5-tetramethyl-3-(1-phenylallylidene)-1,2-oxasilolane (1.142) 
Following the general procedure, RuH (2 mg, 0.005 mmol) and alkyne 1.36 (64.5 
mg, 0.25 mmol) in DCE (1.0 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification via 
flash column chromatography (1% diethyl ether/hexanes) gave diene 1.142 as a clear oil (70% as 
a Z/E mixture). 
Crude ratio Z:cyclo:E = 18:2:1 
Rf = 0.38 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): δ = 7.33-7.27 (m, 3H), 7.15-7.12 (m, 2H), 6.88 (dd, J = 17.1, 10.5 
Hz, 1H), 5.24 (dd, J = 10.5, 1.5 Hz, 1H), 4.88 (dd, J = 17.4, 1.8 Hz, 1H), 4.11-4.06 (m, 1H), 2.86-
2.83 (m, 1H), 1.21 (d, J = 7.2 Hz, 3H), 1.17 (d, J = 6.6 Hz, 3H), 0.15 (s, 3H), -0.43 (s, 3H); minor 
isomer diagnostic peaks: δ = 6.52 (dd, J = 17.1, 10.5 Hz, 1H), 5.08 (dd, J = 10.2, 1.2 Hz, 1H), 
4.67 (dd, J = 17.1, 1.2 Hz, 1H), 0.44 (s, 3H), 0.42 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 148.1, 148.1, 141.8, 135.4, 129.8, 127.9, 127.3, 118.7, 80.0, 44.3, 
24.6, 21.3, 2.3, 0.7 
IR (film): ν = 3025, 2960, 2867, 1581, 1490, 1250, 842 cm-1 
Anal. calcd. for C16H22OSi: C 74.36, H 8.58; found: C 74.34, H 8.89. 
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(Z)-3-(1-(4-fluorophenyl)allylidene)-2,2,5-trimethyl-1,2-oxasilolane 
(1.143) 
Following the general procedure, RuH (4 mg, 0.006 mmol) and alkyne 1.55 (79 mg, 0.3 mmol) in 
toluene (1.2 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification via preparative TLC 
(1% diethyl ether/hexanes) gave diene 1.143 as a clear oil (69% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 23:3:1 
Rf = 0.27 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): δ = 7.11-7.07 (m, 2H), 7.04-6.99 (m, 2H), 6.84 (dd, J = 17.1, 10.5 
Hz, 1H), 5.23 (d, J = 10.5 Hz, 1H), 4.82 (dd, J = 17.4, 1.8 Hz, 1H), 4.24-4.16 (m, 1H), 2.94 (dd, 
J = 16.1, 5.0 Hz, 1H), 2.31 (dd, J= 16.1, 8.2 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), -0.06 (s, 3H), -
0.18 (s, 3H); minor isomer diagnostic peaks: δ = 6.50 (dd, J = 16.8, 10.5 Hz, 1H), 5.08 (d, J = 
10.8 Hz, 1H), 4.73 (d, J = 17.1 Hz, 1H), 0.41 (s, 3H), 0.38 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 162.0 (d, JC-F = 249.7 Hz), 146.2, 144.3, 137.7 (d, JC-F = 3.4 
Hz), 136.0, 131.5 (d, JC-F = 8.5 Hz), 118.4, 115.1 (d, JC-F = 22.1 Hz), 72.6, 40.8, 24.2, 0.7, -0.1  
19F NMR (376.4 MHz, CDCl3): δ = (-115.2)-(-115.2)(m); (-115.6)-(-115.7)(m) 
IR (film): ν = 3044, 2928, 1507, 1452, 1256, 910 cm-1 
Anal. calcd. for C15H19FOSi: C 68.66, H 7.30; found: C 68.82, H 7.26 
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(Z)-3-(1-(2-chlorophenyl)allylidene)-2,2,5-trimethyl-1,2-oxasilolane (1.144) 
Following the general procedure, RuH (11.0 mg, 0.015 mmol) and alkyne 1.81 
(84.0 mg, 0.30 mmol) in 1,4-dioxane (1.2 mL) stirred under ethylene (1 atm) at 100°C for 30 
minutes. Purification via preparative TLC (1% diethyl ether/hexanes) gave diene 1.144 as a clear 
oil (70% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 12:1:3 
Rf = 0.46 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3, mixture of rotamers): δ = 7.40-7.37 (m, 1H), 7.28-7.23 (m, 2H), 7.13-
7.11 (m, 1H), 6.81 (ddd, J = 17.2, 10.5, 2.7 Hz, 1H), 5.20 (d, J = 7.9 Hz, 1H), 4.69 (d, J = 12.9 Hz, 
1H) 4.33-4.25 (m, 0.5H), 4.25-4.17 (m, 0.5H), 3.05 (dd, J = 16.2, 5.2 Hz, 0.5H), 2.94 (dd, J = 16.2, 
5.7 Hz, 0.5H), 2.47 (dd, J = 16.2, 7.1 Hz, 0.5H), 2.30 (dd, J = 16.1, 8.9 Hz, 0.5H), 1.35 (d, J = 6.1 
Hz, 1.5H), 1.32 (d, J = 6.1 Hz, 1.5H), 0.00 (s, 1.5H), -0.08 (s, 1.5H), -0.16 (s, 1.5H), -0.25 (s, 
1.5H); minor isomer diagnostic peaks: δ = 6.49 (dd, J = 16.8, 10.4 Hz, 1H), 5.07 (d, J = 10.5 Hz, 
1H), 4.60 (d, J = 17.0 Hz, 1H), 4.15-4.12 (m, 1H), 0.44 (s, 3H), 0.41 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 144.8, 144.6, 144.2, 140.0, 140.0, 134.7, 134.6, 134.2, 134.1, 
132.2, 129.8, 129.6, 129.5, 129.0, 128.6, 126.6, 126.5, 117.6, 117.6, 116.0, 72.8, 72.7, 40.8, 40.3, 
24.2, 24.1, 23.9, 1.1, 0.4, -1.1, -1.9 
IR (film): ν = 2966, 2926, 2876, 1584, 1471, 1436, 1250, 835 cm-1 
Anal. calcd. for C15H19ClOSi: C 64.61, H 6.87; found: C 64.56, H 6.76 
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(Z)-3-(1-(4-methoxyphenyl)allylidene)-2,2,5-trimethyl-1,2-oxasilolane 
(1.147): Following the general procedure, RuH (4 mg, 0.005 mmol) and 
alkyne 1.54 (82 mg, 0.3 mmol) in DCE (1.2 mL) stirred under ethylene (1 atm) at 80°C for 1 h. 
Purification via preparative TLC (3% diethyl ether/hexanes) gave diene 1.147 as a clear oil 
(73%). 
Crude ratio Z:cyclo:E = 44:3:1 
Rf = 0.26 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ= 7.05-7.01 (m, 2H), 6.89-6.80 (m, 3H), 5.22 (dd, J = 10.5, 1.5 Hz, 
1H), 4.88 (dd, J = 17.1, 1.5 Hz, 1H), 4.25-4.14 (m, 1H), 3.82 (s, 3H), 2.93 (dd, J = 16.5, 5.4 Hz, 
1H), 2.30 (dd, J = 16.5, 8.4 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), -0.05 (s, 3H), -0.18 (s, 3H)   
13C NMR (100 MHz, CDCl3): δ = 158.9, 146.8, 143.4, 136.1, 134.1, 130.8, 118.1, 113.2, 72.5, 
55.3, 40.7, 24.1, 0.7, -0.1 
IR (film): ν = 3087, 2968, 2835, 1608, 1508, 1458, 1246, 1036 cm-1 
Anal. calcd. for C16H22O2Si: C 70.03, H 8.08; found: C 70.03, H 7.81 
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(Z)-1-(4-(1-(2,2,5-trimethyl-1,2-oxasilolan-3-ylidene) allyl) phenyl) 
ethanone (1.148): Following the general procedure, RuH (2 mg, 0.0025 
mmol) and alkyne 1.56 (72 mg, 0.25 mmol) in DCE (1.0 mL) was stirred under ethylene (1 atm) 
at 80°C for 3 h. Purification via flash column chromatography (1% diethyl ether/hexanes) gave 
diene 1.148 as a clear oil (64% as a Z/E mixture). 
Crude ratio Z:cyclo:E = 7:1:1 
Rf = 0.20 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ= 7.92 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 6.85 (dd, J = 
17.1, 10.5 Hz, 1H), 5.24 (d, J = 10.5 Hz, 1H), 4.79 (d, J =18.0 Hz, 1H), 4.24-4.17 (m, 1H), 2.96 
(dd, J = 16.2, 5.4 Hz, 1H), 2.62 (s, 3H), 2.34 (dd, J = 16.2, 8.2 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), 
-0.07 (s, 3H), -0.19 (s, 3H); minor isomer diagnostic peaks: δ = 7.97 (d, J = 8.4 Hz, 2H), 7.22 
(d, J = 8.4 Hz, 2H), 6.51 (dd, J = 16.8, 10.5 Hz, 1H), 5.11 (d, J = 10.5 Hz, 1H), 4.70 (d, J =17.4 
Hz, 1H), 4.11-4.04 (m, 1H), 1.20 (d, J = 6.0 Hz, 3H), 0.42 (s, 3H), 0.39 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ 198.0, 198.0, 146.9, 146.9, 146.2, 145.5, 145.2, 144.5, 139.2, 
136.2, 135.9, 135.6, 130.1, 129.3, 128.6, 128.2, 118.6, 116.8, 72.8, 72.5, 42.8, 41.0, 26.8, 26.8, 
24.1, 23.8, 0.7, 0.3, -0.0 
IR (film): ν = 3087, 2964, 2871, 1684, 1601, 1264, 944 cm-1 
Anal. calcd. for C17H22O2Si: C 71.28, H 7.74; found: C 70.99, H 7.75 
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(Z)-2,2,6-trimethyl-3-(1-phenylallylidene)-1,2-oxasilinane (1.149) 
Following the general procedure, RuH (4 mg, 0.006 mmol) and alkyne 1.86 (77 
mg, 0.3 mmol) in DCE (1.2 mL) stirred under ethylene (1 atm) at 80°C for 1 h. Purification via 
flash column chromatography (1% diethyl ether/hexanes) gave diene 1.149 as a clear oil (82%). 
Crude ratio Z:cyclo:E = 14:1:1 
Rf = 0.74 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.30-7.26 (m, 3H), 7.09-7.02 (m, 3H), 5.21 (dd, J = 10.8, 1.8 
Hz, 1H), 4.73 (dd, J = 17.1, 1.8 Hz, 1 H), 4.10-4.03 (m, 1H), 3.08 (ddd, J = 15.9, 5.4, 3.3 Hz, 1H), 
2.47 (ddd, J = 15.9, 12.6, 3.3 Hz, 1H), 1.90-1.83 (m, 1H), 1.61-1.51 (m, 1H), 1.21 (d, J = 6.3 Hz, 
3H), -0.14 (s, 3H), -0.37 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 147.2, 141.6, 140.3, 134.3, 130.6, 127.9, 127.3, 118.7, 70.5, 
36.1, 29.1, 24.7, 1.6, 0.2 
IR (film): ν = 3080, 2965, 2846, 1558, 1490, 1248, 829 cm-1 
Anal. calcd. for C16H22OSi: C 74.36, H 8.58; found: C 74.39, H 8.69 
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General Procedure for high pressure reactions: 
 
 
 
An oven dried Fischer Porter bottle equipped with a magnetic stir bar was brought into an 
argon filled glove box. To the Fischer Porter bottle was added RuHCl(CO)(SIMes)PPh3 and the 
alkyne  in toluene. The bottle was plugged with a septum and removed from the glove box. The 
septum was replaced with a Swagelok regulator and the system was purged with ethylene (80 psi) 
and vented three times, then refilled to 80 psi and heated to 80C for the allotted time. Upon 
completion by TLC, the reaction was filtered through a short plug of silica gel (eluted with 
dichloromethane), concentrated in vacuo and a crude yield was obtained by 1H NMR with 
mesitylene (0.33 equivalents) as an internal standard. The crude product was purified by flash 
chromatography on silica gel. 
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3-(1-(4-methoxyphenyl)allylidene)-2,2,5-trimethyl-1,2-oxasilolane 
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 
1.54 (72 mg, 0.25 mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) at 80oC for 4 h. 
Purification via flash column chromatography (10% diethyl ether/hexanes) gave the diene as a 
clear oil (91% as a Z/E mixture). 
Crude ratio Z:E = 3:1 
Rf = 0.26 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): isomer Z: δ = 7.06-7.03 (m, 2H), 6.92-6.80 (m, 3H), 5.21 (d, J = 
10.5 Hz, 1H), 4.87 (dd, J = 17.1, 1.5 Hz, 1H), 4.24-4.14 (m, 1H), 3.81 (s, 3H), 2.93 (dd, J = 16.2, 
5.4 Hz, 1H), 2.29 (dd, J = 16.2, 8.4 Hz, 1H), 1.31 (d, J = 6.0 Hz, 3H), -0.05 (s, 3H), -0.17 (s, 3H); 
isomer E: δ = 7.06-7.03 (m, 2H), 6.92- 6.80 (m, 2H), 6.51 (dd, J = 16.8, 10.5 Hz, 1H), 5.07 (d, J 
= 10.5 Hz, 1H), 4.79 (d, J = 17.1 Hz, 1H), 4.10-4.03 (m, 1H), 3.82 (s, 3H) 2.43 (dd, J = 16.8, 5.1 
Hz, 1H), 2.06 (dd, J = 16.5, 8.4 Hz, 1H), 1.20 (d, J = 6.0 Hz, 3H), 0.41 (s, 3H), 0.38 (s, 3H) 
 13C NMR (75 MHz, CDCl3): δ = 158.7, 158.3, 147.4, 146.7, 143.3, 139.9, 136.0, 133.9, 130.7, 
129.9, 118.0, 116.1, 113.5, 113.1, 72.6, 72.4, 55.2, 55.2, 42.8, 40.6, 24.0, 23.7, 0.7, 0.6, 0.2, -0.3; 
IR (film): ν = 2963, 2929, 1608, 1509, 1248 cm-1 
Anal. calcd. for C16H22O2Si: C 70.03, H 8.08; found: C 70.41, H 7.80 
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3-(1-(4-fluorophenyl)allylidene)-2,2,5-trimethyl-1,2-oxasilolane: Following 
the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.55 (65.5 mg, 
0.25 mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) at 80oC for 4 h. Purification via 
flash column chromatography (10% diethyl ether/hexanes) gave the diene as a clear oil (85% as 
a Z/E mixture). 
Crude ratio Z:E = 1:1.3 
Rf = 0.27 (10% diethyl ether/hexanes)  
1H NMR (300 MHz, CDCl3): isomer Z: δ = 7.12-6.99 (m, 4H), 6.85 (dd, J = 17.4, 10.8 Hz, 1H), 
5.24 (dd, J = 10.8, 1.5 Hz, 1H), 4.82 (dd, J = 17.4, 1.2 Hz, 1H), 4.24-4.17 (m, 1H), 2.95 (dd, J = 
16.2, 5.4 Hz, 1H), 2.31 (dd, J = 16.2, 8.4 Hz, 1H), 1.32 (d, J = 6.0 Hz, 3H), -0.05 (s, 3H), -0.17 (s, 
3H); isomer E: δ = 7.12-6.99 (m, 4H), 6.51 (dd, J = 17.1, 10.5 Hz, 1H), 5.09 (dd, J = 10.8, 0.6 
Hz, 1H), 4.74 (dd, J = 17.1, 0.6 Hz, 1H), 4.11-4.02 (m, 1H), 2.38 (dd, J = 17.4, 5.1 Hz, 1H), 2.02 
(dd, J = 16.8, 8.4 Hz, 1H), 1.21 (d, J = 6.0 Hz, 3H), 0.42 (s, 3H), 0.39 (s, 3H); 
13C NMR (75 MHz, CDCl3): δ = 163.7, 163.4, 160.1, 146.9, 146.1, 145.0, 144.1, 139.7, 137.5, 
137.5, 135.9, 135.6, 135.5, 131.3, 131.2, 130.5, 130.4, 118.3, 116.4, 115.4, 115.1, 115.0, 114.7, 
72.7, 72.5, 42.8, 40.7, 24.0, 23.7, 0.7, 0.6, 0.3, -0.2 
19F NMR (282.3 MHz, CDCl3): δ = (-115.6)-(-115.7)(m); δ = (-116.1)-(-116.2)(m) 
IR (film): ν = 2966, 2927, 1601, 1506, 1252 cm-1 
Anal. calcd. for C15H19FOSi: C 68.66, H 7.30; found: C 68.52, H 7.12 
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1-(4-(1-(2,2,5-trimethyl-1,2-oxasilolan-3-ylidene)allyl)phenyl)ethanone 
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.56 
(72 mg, 0.25 mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) at 80oC for 24 h. 
Purification via flash column chromatography (10% diethyl ether/hexanes) gave the diene as a 
clear oil (86% as a Z/E mixture). 
Crude ratio Z:E = 1:7 
Rf = 0.20 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): isomer Z: δ = 7.92 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H), 
6.85 (dd, J = 17.1, 10.5 Hz, 1H), 5.24 (d, J = 10.5 Hz, 1H), 4.79 (d, J =18.0 Hz, 1H), 4.24-4.17 
(m, 1H), 2.96 (dd, J = 16.2, 5.4 Hz, 1H), 2.62 (s, 3H), 1.32 (d, J = 6.0 Hz, 3H), -0.07 (s, 3H), -0.19 
(s, 3H); isomer E: δ = 7.97 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.51 (dd, J = 16.8, 10.5 
Hz, 1H), 5.11 (d, J = 10.5 Hz, 1H), 4.70 (d, J = 17.4 Hz, 1H), 4.12-4.02 (m, 1H), 2.62 (s, 3H), 2.34 
(dd, J = 16.8, 5.1 Hz, 1H), 2.00 (dd, J = 16.8, 5.4 Hz, 1H),  1.19 (d, J = 6.0 Hz, 3H), 0.42 (s, 3H), 
0.39 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 197.8, 145.8, 145.0, 139.0, 135.7, 129.1, 128.4, 116.6, 72.6, 42.7, 
26.6, 23.6, 0.6, 0.1 
IR (film): ν = 2964, 2925, 1684, 1264 cm -1 
Anal. calcd. for C17H22O2Si: C 71.28, H 7.74; found: C 71.03, H 7.40 
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(Z)-2,2,6-trimethyl-3-(1-phenylallylidene)-1,2-oxasilinane: Following the 
general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.86 (57 mg, 0.22 
mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) for 24 h. (25:1). Purification via flash 
column chromatography (10% diethyl ether/hexanes) gave the diene as a clear oil (72%). 
Crude ratio Z:E = 25:1 
1H NMR (300 MHz, CDCl3): δ = 7.28-7.27 (m, 3H), 7.09-7.00 (m, 3H),  5.20 (dd, J = 10.5, 1.5 
Hz, 1H), 4.72 (dd, J = 17.1, 1.5 Hz, 1H), 4.11-4.00 (m, 1H), 3.06 (ddd, J = 16.2, 5.1, 3.3 Hz, 1H), 
2.45 (ddd, J = 15.9, 12.6, 3.3 Hz, 1H), 1.90-1.81 (m, 1H), 1.62-1.48 (m, 1H), 1.20 (d, J = 6.0 Hz, 
3H), -0.15 (s, 3H), -0.38 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 147.1, 141.5, 140.2, 134.1, 130.4, 127.8, 127.2, 118.7, 70.4, 36.0, 
29.0, 24.6, 1.5, 0.1 
149 
 
 
3-(but-3-en-2-ylidene)-2,2-dimethyl-5-phenethyl-1,2-oxasilolane (1.150): 
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 
1.150a (68 mg, 0.25 mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) at 80oC for 24 h. 
Purification via flash column chromatography (2% diethyl ether/hexanes) gave diene 1.150 as a 
clear oil (84%). 
Crude ratio Z:E = 1:3 
Rf = 0.64 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): major isomer E: δ = 7.32-7.16 (m, 5H), 6.35 (dd, J = 16.8, 10.2 
Hz, 1H), 5.23 (d, J = 17.3 Hz, 1H), 5.06 (d, J = 10.7 Hz, 1H), 4.12-4.02 (m, 1H), 2.88-2.67 (m, 
4H), 2.27 (dd, J = 16.2, 7.6 Hz, 1H), 1.86 (s, 3H), 0.37 (s, 3H), 0.32 (s, 3H); minor isomer Z: δ = 
6.70 (dd, J = 17.3, 10.7 Hz, 1H), 5.28 (d, J = 16.8 Hz, 1H), 5.17 (d, J = 10.8 Hz, 1H), 1.91 (s, 3H), 
0.36 (s, 3H), 0.32 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ= 142.8, 142.4, 141.7, 140.4, 140.1, 139.4, 136.1, 128.6, 128.4, 
125.8, 114.4, 112.5, 76.0, 75.7, 40.2, 40.1, 39.9, 38.4, 32.3, 20.0, 15.3, 0.9, 0.5, 0.4, 0.0 
IR (film): ν = 2957, 2931, 1585, 1453, 1250, 866 cm-1 
Anal. calcd. for C17H24OSi: C 74.94, H 8.88; found C 74.88, H 8.99 
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3-(but-3-en-2-ylidene)-2,2-dimethyl-5-phenyl-1,2-oxasilolane (1.151): 
Following the general procedure, RuH (4 mg, 0.005 mmol) and alkyne 1.151a (80 
mg, 0.32 mmol) in toluene (1.3 mL) stirred under ethylene (80 psi) at 80oC for 24 h. Purification 
via flash column chromatography (1% diethyl ether/hexanes) gave diene 1.151 as a clear oil 
(84%). 
Crude ratio Z:E = 1:2 
Rf = 0.52 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): major isomer E: δ = 7.39-7.32 (m, 4H), 7.27-7.23 (m, 1H), 6.36 
(dd, J = 17.1, 10.8 Hz, 1H), 5.23 (d, J = 16.9 Hz, 1H), 5.06 (d, J = 11.0 Hz, 1H), 5.05-5.00 (m, 
1H), 3.02 (dd, J = 16.8, 5.7 Hz, 1H), 2.50-2.44 (m, 1H), 1.86 (dd, J = 1.6, 0.7 Hz, 3H), 0.41 (s, 
3H), 0.39 (s, 3H); minor isomer Z: δ = 6.68 (dd, J = 17.3, 10.6 Hz, 1H), 5.28 (d, J = 17.3 Hz, 
1H), 5.15 (d, J = 10.6 Hz, 1H) 3.13 (ddd, J = 16.2, 5.5, 1.0 Hz, 1H), 1.92 (dd, J = 2.2, 1.0 Hz, 3H), 
0.40 (s, 3H), 0.38 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ = 144.3, 144.2, 142.2, 141.3, 139.8, 139.6, 139.1, 135.5, 128.0, 
126.9, 125.1, 114.3, 112.5, 77.7, 77.3, 42.5, 41.1, 19.6, 14.9, 0.0, 0.0, -0.3, -0.4; 
IR (film): ν = 3088, 3029, 2956, 2877, 1588, 1251, 1036, 868 cm -1 
Anal. calcd. for C15H20OSi: C 73.71, H 8.21; found C 73.43, H 8.20 
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2,2-dimethyl-3-(pent-1-en-3-ylidene)-5-phenyl-1,2-oxasilolane (1.152): 
Following the general procedure, RuH (4 mg, 0.005 mmol) and alkyne 1.152a (77 
mg, 0.3 mmol) in toluene (1.2 mL) stirred under ethylene (80 psi) at 80oC for 1 h. Purification 
via flash column chromatography (1% diethyl ether/hexanes) gave diene 1.152 as a clear oil 
(79%). 
Crude ratio Z:E = 5:1 
Rf = 0.63 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): isomer Z: δ = 7.38-7.31 (m, 4H), 7.25-7.23 (m, 1H), 6.52 (dd, J = 
17.7, 11.0 Hz, 1H), 5.29 (d, J = 17.7 Hz, 1H), 5.17 (d, J = 11.0 Hz, 1H), 5.00 (dd, J = 9.0, 5.5 Hz, 
1H), 3.10 (dd, J = 16.1, 5.5 Hz, 1H), 2.49-2.41 (m, 1H), 2.38-2.24 (m, 2H), 1.10 (t, J = 7.8 Hz, 
3H), 0.39 (s, 3H), 0.37 (s, 3H); isomer E: δ = 6.25 (dd, J = 17.3, 10.6 Hz, 1H), 5.25 (d, J = 17.3 
Hz, 1H), 5.06 (d, J = 11.0 Hz, 1H), 3.01 (dd, J = 16.5, 5.5 Hz, 1H), 1.01 (t, J = 7.8 Hz, 3H) 
13C NMR (100 MHz, CDCl3): δ = 148.2, 146.2, 144.7, 144.7, 141.4, 139.2, 138.8, 134.2, 128.4, 
127.3, 125.5, 125.4, 114.9, 112.6, 78.0, 77.8, 42.2, 41.7, 28.2, 22.7, 14.9, 13.0, 0.4, 0.1 
IR (film): ν = 3088, 2966, 2876, 1586, 1251, 1061, 907 cm -1 
Anal. calcd. for C16H22OSi: C 74.36, H 8.58; found: C 74.55, H 8.74 
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3-(hept-1-en-3-ylidene)-2,2-dimethyl-5-phenyl-1,2-oxasilolane (1.153): 
Following the general procedure, RuH (4 mg, 0.005 mmol) and alkyne 1.153a 
(86 mg, 0.3 mmol) in toluene (1.2 mL) stirred under ethylene (80 psi) at 80oC for 1 h. 
Purification via flash column chromatography (1% diethyl ether/hexanes) gave diene 1.153 as a 
clear oil (69%). 
Crude ratio Z:E = 8:1 
Rf = 0.36 (10% diethyl ether/hexanes) 
1H NMR (400 MHz, CDCl3): isomer Z: δ = 7.31-7.24 (m, 4H), 7.19-7.15 (m, 1H), 6.46 (dd, J = 
17.6, 10.8 Hz, 1H), 5.21 (d, J = 17.6 Hz, 1H), 5.09 (d, J = 10.8 Hz, 1H), 4.93 (dd, J = 9.5, 5.4 Hz, 
1H), 3.02 (dd, J = 16.2, 5.4 Hz, 1H), 2.37 (dd, J = 16.2, 5.4 Hz, 1H), 2.25-2.13 (m, 2H), 1.43-1.35 
(m, 2H), 1.33-1.24 (m, 2H), 0.86 (t, J = 7.5 Hz, 3H), 0.32 (s, 3H), 0.30 (s, 3H); isomer E: δ = 6.19 
(dd, J = 17.2, 10.4 Hz, 1H), 4.99 (d, J = 10.8 Hz, 1H), 2.93 (dd, J = 16.7, 5.4 Hz, 1H), 0.82 (t, J = 
7.1 Hz, 3H), 0.33 (s, 3H), 0.31 (s, 3H) 
13C NMR (100 MHz, CDCl3): δ= 146.8, 145.1, 144.7, 142.0, 139.4, 139.2, 134.7, 128.4, 127.3, 
127.3, 125.5, 114.8, 112.7, 78.0, 77.8, 42.5, 41.8, 35.3, 32.6, 30.8, 29.5, 23.3, 23.2, 14.1, 14.1, 0.4, 
0.3 
IR (film): ν = 3087, 2957, 2873, 1585, 1250, 1036, 867 cm -1 
Anal. calcd. for C18H26OSi: C 75.46, H 9.15; found: C 75.65, H 9.26 
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2,2-dimethyl-3-(non-1-en-3-ylidene)-5-phenyl-1,2-oxasilolane (1.154): 
Following the general procedure, RuH (2 mg, 0.0025 mmol) and alkyne 1.154a 
(78.2 mg, 0.25 mmol) in toluene (1.0 mL) stirred under ethylene (80 psi) at 80oC for 24 h. 
Purification via flash column chromatography (1% diethyl ether/hexanes) gave diene 1.154 as a 
clear oil (83%). 
Crude ratio Z:E = 7:1 
Rf = 0.78 (10% diethyl ether/hexanes) 
1H NMR (300 MHz, CDCl3): isomer Z: δ = 7.40-7.31 (m, 5H), 6.54 (dd, J = 17.4, 10.9 Hz, 1H), 
5.30 (d, J = 17.4 Hz, 1H), 5.17 (d, J = 10.9 Hz, 1H), 5.01 (dd, J = 9.6, 5.6 Hz, 1H), 3.11 (dd, J = 
16.2, 5.3 Hz, 1H), 2.46 (dd, J = 16.2, 9.6 Hz, 1H), 2.32-2.23 (m, 2H), 1.53-1.43 (m, 2H), 1.40-
1.26 (m, 7H), 0.93-0.87 (m, 3H), 0.40 (s, 3H), 0.38 (s, 3H); isomer E: δ = 6.27 (dd, J = 17.4, 10.9 
Hz, 1H), 5.07 (d, J = 10.9 Hz, 1H), 3.00 (dd, J = 16.8, 5.6 Hz, 1H), 0.41 (s, 3H), 0.39 (s, 3H) 
13C NMR (75 MHz, CDCl3): δ = 145.2, 144.7, 139.4, 134.8, 128.5, 127.3, 125.5, 114.9, 78.0, 41.8, 
35.7, 31.9, 30.5, 30.0, 22.8, 14.2, 0.3, 0.3 
IR (film) ν = 2957, 2931, 1585, 1453, 1250, 866 cm -1 
Anal. calcd. for C20H30OSi: C 76.37, H 9.61; found C 76.24, H 9.79 
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Synthetic Elaboration  
3-hydroxy-1-(3-methyl-2-phenyloxiran-2-yl)-3-phenylpropan-1-one (1.155) 
To an oven dried 25 mL round bottom flask equipped with a magnetic stir bar was 
added diene 1.137 (92 mg, 0.3 mmol) in THF (1.3 mL). To the stirred solution was added 
sequentially MeOH (2.7 mL), KF dihydrate (282 mg, 3.0 mmol), KHCO3 (300 mg, 3.0 mmol), and 
H2O2 (2.5 mL, ~23 mmol) dropwise with vigorous stirring. After stirring the cloudy white 
suspension for 4 h TLC indicated consumption of the starting diene. Na2S2O3(s) (~1.0 g) was 
carefully added in small portions to consume remaining peroxides. The reaction was diluted with 
EtOAc (20 mL) and washed with brine. The organics were dried over MgSO4, filtered and 
concentrated  in vacuo. The crude oil was purified via flash column chromatography (silica gel 2.5 
x 15 cm, eluted with 10% EtOAc/hexanes) to give ketone 1.155 as a clear oil (59 mg, 70% as a 
mixture of diastereoisomers). 
Rf = 0.25 (20% EtOAc/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.45-7.32 (m, 10H), 5.15 (t, J = 3.7 Hz, 0.5H), 5.12 (t, J = 3.7 
Hz, 1H), 3.50 (q, J = 5.2 Hz, 0.5H), 3.43 (q, J = 5.2 Hz, 0.5H), 3.08-2.82 (m, 3H), 1.06 (d, J = 5.3 
Hz, 3H) 
13C NMR (100 MHz, CDCl3): δ = 207.8, 207.8, 142.7, 142.6, 131.8, 128.6, 128.6, 128.5, 128.3, 
128.1, 128.1, 127.8, 127.8, 125.8, 125.7, 69.9, 69.7, 68.1, 59.1, 58.8, 46.3, 45.9, 14.5, 14.4 
IR (film): ν = 3511, 3060, 2967, 2926, 1708, 1494, 1022 cm -1 
Anal. calcd. for C18H18O3: C 76.57, H 6.43; found: C 76.44, H 6.41 
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(E)-1-hydroxy-1,4-diphenylhex-4-en-3-one (1.156) 
To a flame dried 50 mL round bottom flask equipped with a magnetic stir bar was 
added diene 1.137 (92 mg, 0.3 mmol, 10:1, Z:E), DMF (15 mL), KHF2 (71 mg, 0.9 mmol), 
propionic anhydride (0.96 mL, 7.5 mmol), and H2O2 (0.85 mL, 7.5 mmol) sequentially. The 
reaction was stirred at RT for 14 h then poured into water (15 mL), extracted with Et2O (3 x 15 
mL) washed with saturated NaHCO3(aq) (20 mL), dried over MgSO4, filtered and concentrated in 
vacuo. The crude oil was purified via flash column chromatography (silica gel 1.5 x 12 cm, 
gradient elution with 10-20% EtOAc/hexanes) to afford ketone 1.156 as a clear oil (68 mg, 85%, 
13:1 mixture of double bond isomers). 
Rf = 0.22 (20% EtOAc/hexanes) 
1H NMR (400 MHz, CDCl3): δ = 7.41-7.28 (m, 8H), 7.09-7.07 (m, 2H), 7.04 (q, J = 7.2 Hz, 1H), 
5.18 (dd, J = 7.4, 4.8 Hz, 1H)  3.65 (s, 1H), 2.98 (s, 1H), 2.96 (d, J = 3.3 Hz, 1H), 1.73 (d, J = 7.0 
Hz, 3H); minor isomer diagnostic peaks δ =  5.53 (q, J = 7.4 Hz, 1H), 1.82 (d, J = 7.2 Hz, 3H) 
13C NMR (100 MHz, CDCl3): δ = 200.7, 143.7, 142.9, 140.2, 135.1, 129.6, 128.4, 128.4, 127.7, 
127.5, 125.7, 70.2, 47.8, 15.7 
IR (film): ν = 3412, 3058, 2912, 1773, 1670, 1597, 1137, 700 cm-1 
Anal. calcd. for C18H18O2: C 81.17, H 6.81; found: C 81.34, H 6.83 
156 
 
 
(Z)-2,2-dimethyl-5-phenyl-3-((E)-1-phenyl-3-(p-tolyl)allylidene)-1,2-
oxasilolane (1.157) 
To an oven dried 50 mL Schlenk tube equipped with magnetic stir bar was added 
4-iodotoluene (164 mg, 0.75 mmol), K2CO3 (138 mg, 1.0 mmol), Pd(OAc)2 (6.0 
mg, 0.025 mmol and diene 1.137 (180 mg, 0.58 mmol) in DMF (5.0 mL). The reaction mixture 
was evacuated and purged with argon(g) three times, then stirred at 80°C for 8 h. Once cooled to 
RT, the solution was diluted with EtOAc (20 mL), washed with water (2 x 30 mL), dried over 
MgSO4, filtered and concentrated in vacuo. The crude oil was purified via flash column 
chromatography (silica gel 2.5 x 12 cm; 3% EtOAc/hexanes) to afford diene 1.157 as a yellow oil 
(64%, 126 mg). 
Rf = 0.51 (10% EtOAc/hexanes) 
1H NMR (400 MHz, C6D6): δ = 7.44 (d, J = 8.2 Hz, 2H), 7.40-7.35 (m, 5H), 7.30-7.28 (m, 
1H),7.25-7.21 (m, 5H), 7.08 (d, J = 7.8 Hz, 2H), 6.19 (d, J = 16.0 Hz, 1H), 5.11 (dd, J = 9.3, 5.3 
Hz, 1H), 3.38 (dd, J = 16.3, 5.5 Hz, 1H), 2.69 (dd, J = 16.3, 9.5 Hz, 1H), 2.31 (s, 3H), 0.08 (s, 3H), 
-0.13 (s, 3H) 
13C NMR (100 MHz, C6D6): δ = 147.3, 144.8, 142.8, 142.0, 137.9, 134.6, 133.4, 129.8, 129.4, 
128.5, 128.1, 127.4, 127.4, 127.0, 126.7, 125.5, 77.9, 42.3, 21.3, 0.5, 0.3 
IR (film): ν = 3027, 2958, 1583, 1249, 1031, 862 cm-1 
Anal. calcd. for C27H28O2: C 81.77, H 7.12; found: C 81.52, H 7.18 
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(E)-2,2,5-trimethyl-3-(oxiran-2-yl(phenyl)methylene)-1,2-oxasilolane (1.159): 
To a 25 mL Schlenk tube equipped with a magnetic stirbar was added mCPBA 
(85%, 120 mg, 0.58 mmol) and 0.5 mL DCM. The reaction vessel was cooled to 0°C then diene 
1.135 (94 mg, 0.38 mmol) in 0.8 ml of DCM was added dropwise via syringe. The reaction was 
warmed to room temperature and after 1.5 h was complete by TLC. The mixture was diluted 
with 5 mL of DCM and washed with sat. NaHCO3(aq.) (3 x 15 mL). The organic layer was dried 
with MgSO4, filtered and concentrated in vacuo. The crude oil was purified on a silica gel 
column, eluted with 5% ethylacetate/hexanes to afford 37 mg (38%) of a clear oil. 
Rf = 0.59 (20% EtOAc/hexanes) 
1H NMR (400 MHz, CDCl3) δ = 7.38-7.31 (m, 4H), 7.29-7.25 (m, 1H), 6.16 (dd,  J = 17.0, 10.8 
Hz, 1H), 5.37-5.30 (m, 2H), 4.32-4.24 (m, 1H), 1.92-1,82 (m, 2H), 1.31 (d, J = 6.0 Hz, 3H), 0.00 
(s, 3H), -0.37 (s, 3H)  
13C NMR (100 MHz, CDCl3) δ = 139.6, 135.8, 128.2, 127.6, 126.6, 119.2, 72.0, 71.6, 66.2, 41.9, 
23.8, -1.7, -2.2 
FT-IR (NaCl, thin film) ν = 3030, 2968, 1494, 1251, 1117, 944, 703 cm-1 
Anal. calcd. for C15H20O2Si; C, 69.19; H, 7.74; found C, 69.44; H, 7.37 
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(Z)-3-(2,2-dimethyl-5-phenyl-1,2-oxasilolan-3-ylidene)-3-phenylpropan-1-
ol (1.160): To a 25 mL schlenk tube equipped with a stir bar was added diene 
1.137 (100 mg, 0.33 mmol) in 2.0 mL Et2O. The mixture was cooled to 0 °C and BH3·THF (1.0M 
in THF, 0.36 mL) was added dropwise and stirred for 2h. NaOH(aq) (3M, 2.0 mL) was added 
followed by H2O2 (30%, 2.0 mL) and stirred for an additional 3h. The reaction was poured into 5 
mL Na2S2O3(aq) and extracted with Et2O (3 x 10 mL). The organic layer was dried with MgSO4, 
filtered and concentrated in vacuo to a yellow oil. The oil was applied to a silica gel column (2.5 
x 15 cm) eluted with 10% EtOAc in hexanes to afford 68 mg of 1.160. 
Rf = 0.11 (20% EtOAc/hexanes) 
1H NMR (400 MHz, CDCl3) δ = 7.40-7.17 (m, 10H), 5.03 (dd, J = 9.4, 5.5 Hz, 1H), 3.63-3.57 (m, 
2H), 3.13 (dd, J = 15.6, 5.1 Hz, 1H), 2.88-2.72 (m, 2H), 2.53 (dd, J = 16.3, 10.0 Hz, 1H), 0.13 (s, 
3H), -0.15 (s, 3H)  
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(E)-3-(2,2-dimethyl-5-phenyl-1,2-oxasilolan-3-ylidene)-3-phenylpropane-
1,2-diol (1.161): To a 25 mL RBF equipped with a stir bar was added NaIO4 (96 
mg, 0.45 mmol) and 0.25 mL water followed by H2SO4 (1M, 60 uL) and the mixture was cooled 
to 0 °C. RuCl3 (0.1M in H2O, 30 uL) was added and stirred until the solution turned bright yellow. 
EtOAc (1.0 mL) was added and stirred for 5 min followed by MeCN (1.0 mL) and stirred for 5 
minutes. Diene 1.137 (92 mg, 0.3 mmol) in 0.2 mL EtOAc was added then stirred for 1.5h. The 
solution was poured into a 1:1 mixture of aqueous NaHCO3:Na2S2O3 (10 mL) and extracted with 
EtOAc (3 x 10 mL). The organic layer was dried with MgSO4, filtered and concentrated in vacuo 
to a yellow oil. Crude 1H NMR indicated 25% 1.137 remained. The crude oil was applied to a 
silica gel column (2.5 x 15 cm) and eluted with 30% EtOAc in hexanes to afford 1.161 (43 mg, 
56% brsm) as a mixture of diastereomers.  
Rf = 0.06 (20% EtOAc/hexanes) 
1H NMR (400 MHz, CDCl3) δ = 7.39-7.14 (m, 10H), 5.08 (dd, J = 8.8, 5.7 Hz, 0.5H), 5.02 (dd, J 
= 9.8, 5.2 Hz, 0.5H), 4.78 (dd, J = 8.8, 3.8 Hz, 0.5H), 4.71 (dd, J = 8.8, 3.8 Hz, 0.5H), 3.70-3.45 
(m, 2H), 3.24 (dd, J = 13.4, 5.7 Hz, 0.5H), 3.20 (dd, J = 12.9, 5.3 Hz, 0.5H), 2.60 (dd, J = 15.7, 
8.5 Hz, 0.5H), 2.48 (dd, J = 15.9, 9.8 Hz, 0.5H), 0.12 (s, 1.5H), 0.00 (s, 1.5H), -0.10 (s, 1.5H), -
0.22 (s, 1.5H) ; 
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3.4.3 Silylvinylation of Terminal Alkynes 
 
General procedure for high pressure reactions with terminal alkynes: 
 
 
 
An oven dried Fischer Porter bottle equipped with a magnetic stir bar was brought into an argon 
filled glove box. To the Fischer Porter bottle was added RuHCl(CO)(SIMes)PPh3 and the alkyne  
in toluene. The bottle was plugged with a septum and removed from the glove box. The septum 
was replaced with a Swagelok regulator and the system was purged with ethylene (80 psi) and 
vented three times, then refilled to 80 psi and heated to 80 C for the allotted time. Upon 
completion by TLC, the reaction was filtered through a short plug of silica gel (eluted with 
dichloromethane, ethyl acetate, or diethyl ether), concentrated in vacuo and a crude yield was 
obtained by 1H NMR with mesitylene (0.33 equivalents) as an internal standard. The crude product 
was purified by flash chromatography on silica gel. 
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(Z)-5-([1,1'-biphenyl]-4-yl)-3-allylidene-2,2-dimethyl-1,2-oxasilolane 
(1.163): prepared according to the general procedure; 
RuHCl(CO)(SIMes)(PPh3) (2 mg, 0.0025 mmol), alkyne (78 mg, 0.25 mmol) in 1.0 mL toluene, 
24h. Flash column chromatography (5% diethylether:hexanes) 58% (45 mg) as a clear oil.  
TLC Rf = 0.57 (10% diethylether/hexanes); 
1H NMR (400 MHz, CDCl3): δ= 7.60-7.56 (m, 4H), 7.45-7.42 (m, 4H), 7.36-7.32 (m, 1H), 6.74 
(d, J = 10.8 Hz, 1H), 6.31 (dt, J = 16.6, 10.4 Hz, 1H), 5.23 (d, J = 16.6 Hz, 1H), 5.17 (d, J = 10.0 
Hz, 1H), 5.06 (dd, J =  9.5, 5.3 Hz, 1H), 2.96 (dd, J =  15.5, 5.1 Hz, 1H), 2.70-2.63 (m, 1H), 0.43 
(s, 3H), 0.42 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ= 145.2, 143.0, 140.8, 140.0, 137.7, 137.0, 128.5, 126.9, 126.9, 
126.9, 125.7, 117.5, 77.4, 45.6, -0.0, -0.1; 
FT-IR (NaCl, thin film) ν = 3028, 2956, 2926, 1592, 1486, 1252, 903 cm -1 
Anal. calc. for C20H22OSi, C, 78.38; H, 7.24; found C, 78.30; H, 6.98; 
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(Z)-3-allylidene-2,2-dimethyl-1-oxa-2-silaspiro[4.5]decane (1.164): prepared 
according to the general procedure; RuHCl(CO)(SIMes)(PPh3) (2 mg, 0.003 
mmol), alkyne (66 mg, 0.3 mmol) in 1.5 mL toluene, 22h. Flash column chromatography (2% 
diethylether:hexanes, 1.5 x 12 cm) 45% (30 mg) as a clear oil.  
TLC Rf = 0.57 (10% diethylether/hexanes); 
1H NMR (400 MHz, CDCl3): δ= 6.65 (d, J = 10.6 Hz, 1H), 6.26 (dt, J = 16.7, 10.6 Hz, 1H), 5.16 
(d, J = 16.7 Hz, 1H), 5.09 (d, J = 10.1 Hz, 1H), 2.47 (s, 2H), 1.67-1.35 (m, 11H), 0. 30 (s, 6H); 
13C NMR (100 MHz, CDCl3): δ= 146.8, 138.0, 137.5, 116.8, 80.1, 48.0, 39.3, 25.7, 23.2, 1.2; 
FT-IR (NaCl, thin film) ν = 2932, 2857, 1251, 974, 825 cm -1 
Anal. calc. for C13H22OSi, C, 70.71; H, 9.97; found C, 70.30; H, 9.70; 
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(4S,5S,Z)-3-allylidene-2,2,4-trimethyl-5-phenyl-1,2-oxasilolane (1.165): 
prepared according to the general procedure; RuHCl(CO)(SIMes)(PPh3) (4 mg, 
0.006 mmol), alkyne (73 mg, 0.3 mmol) in 1.5 mL toluene, 24h. Flash column chromatography 
(2% diethylether:hexanes) 82% (60 mg) as a clear oil.  
TLC Rf = 0.74 (10% diethylether/hexanes); 
1H NMR (400 MHz, CDCl3): δ= 7.32-7.20 (m, 5H), 6.68 (d, J = 10.8 Hz, 1H), 6.32 (dt, J = 16.6, 
10.1 Hz, 1H), 5.24 (d, J = 16.6 Hz, 1H), 5.17 (d, J = 10.1 Hz, 1H), 5.14 (d, J =  5.0 Hz, 1H), 2.88 
(m, 1H), 0.64 (d, J =  7.1 Hz, 3H), 0.47 (s, 3H), 0.39 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ= 152.0, 141.6, 137.7, 137.4, 128.1, 126.9, 126.0, 117.8, 86.7, 
47.3, 16.7, 0.8, 0.2; 
FT-IR (NaCl, thin film) ν = 3026, 2951, 1590, 1450, 1251, 988 cm -1 
[α]D23λ 589 nm (c 0.600, CHCl3) = -56.01° 
Anal. calc. for C15H20OSi, C, 73.71; H, 8.25; found C, 73.71; H, 8.37; 
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(4R,5S,Z)-3-allylidene-2,2,4-trimethyl-5-phenyl-1,2-oxasilolane (1.166): 
prepared according to the general procedure; RuHCl(CO)(SIMes)(PPh3) (4 
mg, 0.006 mmol), alkyne (73 mg, 0.3 mmol) in 1.5 mL toluene, 21h. Flash 
column chromatography (1-2% gradient elution, diethylether:hexanes, 1.5 x 12 cm) 75% (55 mg) 
as a clear oil.  
TLC Rf = 0.48 (10% diethylether/hexanes); 
1H NMR (400 MHz, CDCl3): δ= 7.37-7.26 (m, 5H), 6.57 (dd, J = 10.6, 2.6 Hz, 1H), 6.37 (dt, J = 
16.7, 10.6 Hz, 1H), 5.26 (d, J = 16.7 Hz, 1H), 5.18 (d, J = 10.2 Hz, 1H), 4.37 (d, J =  8.9 Hz, 1H), 
2.55 (m, 1H), 1.03 (d, J = 6.6 Hz, 3H), 0.43 (s, 3H), 0.40 (s, 3H); 
13C NMR (100 MHz, CDCl3): δ= 149.9, 142.7, 136.9, 136.1, 128.0, 127.4, 126.3, 117.6, 84.9, 
48.4, 13.8, 0.0, -0.0; 
FT-IR (NaCl, thin film) ν = 3028, 2956, 2926, 1592, 1486, 1252, 903 cm -1 
[α]D23λ 589 nm (c 0.640, CHCl3) = -139.70° 
Anal. calc. for C15H20OSi, C, 73.71; H, 8.25; found C, 73.96; H, 7.99; 
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3.5 IMIDAZOPYRIDINE DATA 
General Experimental A: Copper Coupling 
To an oven-dried Schlenk tube equipped with a stir bar was added copper (I) iodide (10 
mol %), potassium phosphate (2 eq.), tert-butyl-4-chloropyridin-3-yl carbamate 34 (1 eq), and the 
haloarene (1.1 eq) [if a solid]. The reaction tube was evacuated and refilled with Ar(g). (+/-)-trans-
1,2-diaminocyclohexane (L1) (20 mol %) was added, followed by 1,4-dioxane (0.5 M) and the 
haloarene (1.1 eq) [if a liquid]. The reaction was degassed with three vacuum / Ar(g) purge cycles, 
equipped with a cold-finger and placed in a pre-heated 110°C oil-bath. The reaction mixture was 
stirred for the time indicated, cooled to room temperature, and was diluted with EtOAc. The 
reaction mixture was then filtered through a Celite® plug, concentrated in vacuo and applied to a 
silica gel column eluted with the indicated solvent mixture(s) to give the N-aryl product. 
 
General Experimental B: Boc Deprotection 
To an oven-dried round-bottom flask equipped with a stir bar was added Boc-pyridine 35h-
35n (1 eq.) and DCM (0.5 M). The reaction was cooled to 0 °C (ice-water bath) and trifluoroacetic 
acid (TFA) (0.17 M) was added. The reaction was allowed to warm to room temperature and stirred 
until TLC analysis indicated consumption of the starting material (35h-35n). The reaction was 
then poured into sat. NaHCO3(aq), diluted with DCM and the layers were separated. The aqueous 
layer was extracted with DCM. The combined organic layers were dried over sodium sulfate, 
decanted and concentrated in vacuo to give the desired deprotected product. 
 
General Experimental C: Alkylation/Deprotection  
To an oven-dried round-bottom flask equipped with a stir bar was added pyridine 34 (1 
eq.) and DMF (0.5 M). The reaction mixture was cooled to 0°C (ice-water bath) and sodium 
hydride (60 wt% in mineral oil) (1.5 eq.) was added in small portions over a period of ~2 min. The 
reaction mixture was stirred for 1 hour at 0°C, at which time the appropriate benzyl or alkyl halide 
(1.5 eq.) was added drop-wise as a solution in DMF. The reaction was allowed to warm to room 
temperature and stirred until TLC analysis indicated consumption of the starting material. The 
reaction was quenched by the addition of H2O and diluted with EtOAc. The layers were separated 
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and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with 
H2O and brine, dried over Na2SO4, filtered, and concentrated in vacuo to give the crude alkylated 
product which was used without further purification. 
The crude alkylated substrate was dissolved in DCM (0.5M) and added to an oven-dried 
round-bottom flask equipped with a stir bar. TFA (0.17-0.25 M) was added drop-wise and the 
reaction stirred at room temperature until TLC analysis indicated consumption of the starting 
material. The reaction was quenched with sat. NaHCO3(aq,) and the layers were separated. The 
organic layer was dried over Na2SO4, concentrated in vacuo and applied to a silica gel column to 
give the desired product. 
 
General Experimental D: Palladium Amidation of 3-Amino-4-chloropyridines 
To an oven-dried 25 mL Schlenk tube equipped with a stirbar was added Pd2(dba)3·CHCl3 
(1 mol %), Me3(OMe)t-BuXPhos (5 mol %), K3PO4 (1.5 Eq.) and pyridine 36 (1 eq.). The reaction 
vessel was evacuated under vacuum and refilled with Ar(g). t-BuOH (0.2 M) and formamide (1.5 
eq.) were then added via syringe and the reaction mixture was degassed by three vacuum/Ar(g) 
purge cycles. The reaction vessel was then equipped with a cold-finger condenser, placed in a pre-
heated 110 °C oil-bath and stirred for the specified time. Upon consumption of pyridine 36 (as 
judged by TLC analysis) the reaction mixture was allowed to cool to room temperature.  The 
reaction mixture was diluted with methanol and passed through a Celite® plug. The crude mixture 
was concentrated in vacuo and applied to a silica gel column eluted with the indicated solvent 
mixture(s) to give the desired product. 
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tert-butyl 4-chloropyridin-3-yl(p-tolyl)carbamate (35i) 
Following general experimental A: Copper (I) Iodide (43 mg, 0.22 mmol), 
potassium phosphate (955 mg, 4.50 mmol), pyridine 34 (500 mg, 2.18 mmol), 
diamine L1 (0.06 mL, 0.44 mmol), 4-iodotoluene (539 mg, 2.48 mmol) and 1,4-
dioxane (0.5 M) were combined and stirred for 22 h. Purification via flash column 
chromatography, eluted with 20% EtOAc/Hexanes, gave 540 mg of pyridine 35i (76%) as an off-
white solid.  
 
Rf = 0.64 (30% EtOAc/Hexanes) 
1H NMR (300 MHz, CDCl3) δ = 8.50 (s, 1H), 8.40 (d, J = 5.1 Hz, 1H), 7.40 (d, J = 5.4 Hz, 1H), 
7.16-7.09 (m, 4H), 2.31 (s, 3H), 1.42 (s, 9H) 
13C NMR (75.4 MHz, CDCl3) δ = 153.0, 151.6, 148.8, 142.9, 138.8, 137.5, 129.5, 125.7, 125.0, 
82.0, 28.1, 21.0 
FT-IR: (NaCl, thin film) ν = 3036, 2979, 1715, 1554 cm-1 
EA: Calculated: C17H19ClN2O2; C, 64.05; H, 6.01; N, 8.79; found C, 64.12; H, 6.04; N, 8.99 
MP: 98-100°C 
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tert-butyl 4-chloropyridin-3-yl(4-(trifluoromethyl)phenyl)carbamate (35k) 
Following general experimental A: Copper (I) Iodide (43 mg, 0.22 mmol), 
potassium phosphate (955 mg, 4.5 mmol), pyridine 34 (500 mg, 2.18 mmol), 
diamine L1 (0.06 mL, 0.45 mmol), 4-trifluoromethylbromobenzene (0.35 mL, 
2.48 mmol) and 1,4-dioxane (0.5 M) were combined and stirred for 22 h. 
Purification via flash column chromatography, eluted with 20% EtOAc/Hexanes, gave 640 mg of 
pyridine 35k (79%) as a yellow oil.  
 
Rf = 0.69 (30% EtOAc/Hexanes) 
 
1H NMR (600 MHz, CDCl3) δ = 8.50 (s, 1H), 8.48 (d, J = 5.4 Hz, 1H), 7.55 (d, J = 8.4 Hz, 2H), 
7.46 (d, J = 5.1 Hz, 1H), 7.36 (d, J = 8.7 Hz, 2H), 1.43 (s, 9H) 
 
13C NMR (150 MHz, CDCl3) δ = 152.3, 151.6, 149.5, 144.3, 143.2, 136.5, 127.4 (q, JC-F = 32.7 
Hz), 126.0 (q, JC-F = 3.6 Hz), 125.1, 124.6, 124.0 (q, JC-F = 272.8 Hz), 83.0, 28.0 
 
19F NMR (282.3 MHz, CDCl3) δ = -62.8 
 
FT-IR: (NaCl, thin film) ν = 2982, 1722, 1615, 1161 cm-1 
 
EA: Calculated: C17H16ClF3N2O2; C, 54.77; H, 4.33; N, 7.51; found C, 54.69; H, 4.10; N, 7.27 
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tert-butyl 4-acetylphenyl(4-chloropyridin-3-yl)carbamate (35j) 
Following general experimental A: Copper (I) Iodide (42 mg, 0.22 mmol), 
potassium phosphate (929 mg, 4.38 mmol), pyridine 34 (500 mg, 2.18 mmol), 
diamine L1 (0.06 mL, 0.44 mmol), 4’-bromoacetophenone (480 mg, 2.41 mmol) 
and 1,4-dioxane (0.5 M) were combined and stirred for 24 h. Purification via flash 
column chromatography, eluted with 30% EtOAc/Hexanes, gave 686 mg of 
pyridine 35j (90%) as a yellow oil.  
 
Rf = 0.27 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.45 (s, 1H), 8.43 (d, J = 5.4 Hz, 1H), 7.85 (d, J = 8.4 Hz, 2H), 
7.41 (d, J = 5.4 Hz, 1H), 7.26 (d, J = 8.7 Hz, 2H), 2.50 (s, 3H), 1.43 (s, 9H) 
 
13C NMR (75 MHz, CDCl3) δ = 196.9, 152.1, 151.6, 149.5, 145.4, 143.1, 136.5, 133.7, 129.1, 
125.1, 123.9, 82.9, 28.0, 26.5 
 
FT-IR: (NaCl, thin film) ν = 2982, 1722, 1615, 1161 cm-1 
 
EA: Calculated: C18H19ClN2O3; C, 62.34; H, 5.52; N, 8.08; found C, 61.95; H, 5.28; N, 7.71 
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tert-butyl (4-chloropyridin-3-yl)(pyridin-3-yl)carbamate (35n) 
Following general experimental A: Copper (I) Iodide (42 mg, 0.22 mmol), 
potassium phosphate (929 mg, 4.38 mmol), pyridine 34 (500 mg, 2.18 mmol), 
diamine L1 (0.06 mL, 0.44 mmol), 3-bromopyridine (0.24 mL, 2.41 mmol) and 
1,4-dioxane (0.5 M) were combined and stirred for 24 h. Purification via flash column 
chromatography, eluted with 35% EtOAc/Hexanes, gave 590 mg of pyridine 35n (88%) as a 
yellow solid.  
 
Rf = 0.14 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.53 (s, 1H), 8.47 (d, J = 5.4 Hz, 1H), 8.47 (s, 1H), 8.40 (dd, J = 
4.7, 1.4 Hz, 1H), 7.66 (d, J = 7.5 Hz, 1H), 7.45 (d, J = 5.4 Hz, 1H), 7.27 (dd, J = 8.3, 4.8 Hz, 1H), 
1.44 (s, 9H) 
 
13C NMR (100 MHz, CDCl3) δ = 152.4, 151.5, 149.5, 146.6, 143.0, 137.9, 136.2, 132.3, 125.0, 
123.3, 82.9, 29.9 
 
FT-IR: (NaCl, thin film) ν = 2980, 1716 cm-1 
 
EA: Calculated: C15H16ClN3O2; C, 58.92; H, 5.27; N, 13.74; found C, 58.94; H, 4.98; N, 14.01 
 
MP: 55-57°C 
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4-chloro-N-(4-fluorobenzyl)pyridin-3-amine (36d):  
Following general experimental C: Pyridine 34 (457 mg, 2 mmol), DMF 
(4 mL) and sodium hydride (60% wt in mineral oil) (120 mg, 3 mmol) were 
combined and stirred for 1 h, then 1-(chloromethyl)-4-fluorobenzene 2 (432 
mg, 3 mmol) was added and the reaction mixture was stirred for an additional 2 h. Subsequent 
workup gave the crude alkylated product which was dissolved in DCM (5 mL) and TFA (1 mL) 
and stirred for 4 h. Purification via flash column chromatography, eluted with 25% EtOAc/Hexane, 
gave 236 mg of pyridine 36d (50% over two steps) as a pale yellow solid.  
 
Rf = 0.71 (50% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 7.98 (s, 1H), 7.90 (d, J = 5.1 Hz, 1H), 7.35-7.31 (m, 2H), 7.20 
(d, J = 5.1 Hz, 1H), 7.08-7-02 (m, 2H), 4.61 (bs, NH), 4.43 (d, J = 5.4 Hz, 2H) 
 
13C NMR (75 MHz, CDCl3) δ = 162.3 (d, JC-F = 244.5 Hz), 140.1, 139.0, 133.7 (d, JC-F = 9 Hz), 
133.5, 128.9 (d, JC-F = 8.25 Hz), 127.6, 123.8, 115.7 (d, JC-F = 21.75 Hz), 46.9 
 
19F NMR (282.3 MHz, CDCl3) δ = [(-115.1)-(-115.2)](m)  
 
FT-IR: (NaCl, thin film) ν = 3424, 1603 cm-1 
 
EA: Calculated C12H10ClFN2; C, 60.90; H, 4.26; N, 11.84; found C, 61.23; H, 4.19; N, 12.02 
 
MP: 78-79C 
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N-([1,1'-biphenyl]-4-ylmethyl)-4-chloropyridin-3-amine (36e) 
Following general experimental C: Pyridine 34 (457 mg, 2 mmol), DMF 
(4 mL) and sodium hydride (60% wt in mineral oil) (120 mg, 3 mmol) were 
combined and stirred for 1 h, then 4-(chloromethyl)-1,1'-biphenyl 4 (606 
mg, 3 mmol) was added and the reaction mixture was stirred for an 
additional 2 h. Subsequent workup gave the crude alkylated product that was dissolved in DCM 
(7 mL) and TFA (1 mL) and stirred for 4 h. Purification via flash column chromatography, eluted 
with 25% EtOAc/Hexanes, gave 240 mg of pyridine 36e (45% over two steps) as a pale yellow 
solid.  
 
Rf = 0.5 (50% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.06 (s, 1H), 7.91 (d, J = 5.1 Hz, 1H), 7.61-7.56 (m, 4H), 7.47-
7.41 (m, 4H), 7.38-7.32 (m, 1H), 7.21 (d, J = 4.8 Hz, 1H), 4.67 (t, J = 5.1 Hz, NH), 4.51 (d, J = 
5.4 Hz, 2H) 
 
13C NMR (75 MHz, CDCl3) δ = 140.7, 140.7, 140.3, 139.0, 137.0, 133.9, 128.9, 127.8, 127.7, 
127.5, 127.1, 123.8, 47.4 
 
FT-IR: (NaCl, thin film) ν = 3417, 1579 cm-1 
 
EA: Calculated C18H15ClN2; C, 73.34; H, 5.13; N, 9.50; found C, 73.27; H, 4.88; N, 9.18 
 
MP: 99-101C  
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4-chloro-N-methylpyridin-3-amine (36f) 
Following general experimental C: Pyridine 34 (708 mg, 3.09 mmol), DMF (7 mL) 
and sodium hydride (60% wt in mineral oil) (223 mg, 5.57 mmol) were combined 
and stirred for 1 h, then iodomethane (0.58 mL, 9.28 mmol) was added and the reaction mixture 
was stirred for an additional 2 h. Subsequent workup gave the crude alkylated product that was 
dissolved in DCM (15 mL) and TFA (5 mL) were combined and stirred for 4 h. Purification via 
flash column chromatography, eluted with 20% EtOAc/Hexanes, gave 174 mg of pyridine 36f 
(40% over two steps) as a light brown solid.  
 
Rf = 0.42 (5% MeOH/DCM) 
 
1H NMR (300 MHz, CDCl3) δ = 8.02 (s, 1H), 7.89 (d, J = 4.8 Hz, 1H), 7.17 (d, J = 5.1 Hz, 1H), 
4.25 (bs, NH), 2.97 (d, J = 5.4 Hz, 3H) 
 
13C NMR (75 MHz, CDCl3) δ = 141.3, 138.5, 132.9, 127.4, 123.6, 30.2 
 
FT-IR: (NaCl, thin film) ν = 3293, 2914, 1582 cm-1 
 
EA: Calculated C6H7ClN2; C, 50.54; H, 4.95; N, 19.65; found C, 50.57; H, 5.18; N, 19.45 
 
MP: 54-55C 
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4-chloro-N-(p-tolyl)pyridin-3-amine (36i) 
Following general experimental B: Pyridine 35i (436 mg, 1.4 mmol), DCM (3 mL) 
and TFA (1.5 mL) were combined and stirred for 24 h to give 280 mg of pyridine 36i 
as a yellow solid. (92%) 
 
Rf = 0.39 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.45 (s, 1H), 7.98 (d, J = 5.1 Hz, 1H), 7.25 (d, J = 5.1 Hz, 1H), 
7.16 (d, J = 8.4 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 5.90 (br s, 1H), 2.34 (s, 3H) 
 
13C NMR (75.4 MHz, CDCl3) δ = 140.5, 138.2, 137.6, 137.2, 133.7, 130.3, 129.3, 124.3, 121.5, 
20.9 
 
FT-IR: (NaCl, thin film) ν = 3401, 3233, 3030, 2920, 1571, 1517, 809 cm-1 
 
EA: Calculated: C12H11ClN2; C, 65.91; H, 5.07; N, 12.81; found C, 65.76; H, 4.71; N, 12.55 
 
MP: 59-60°C 
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4-chloro-N-(4-(trifluoromethyl)phenyl)pyridin-3-amine (36k) 
Following general experimental B: Pyridine 35k (520 mg, 1.4 mmol), DCM (3 mL) 
and TFA (1.5 mL) were combined and stirred for 24 h to give 340 mg of pyridine 
36k as a yellow solid. (89%) 
 
Rf = 0.21 (30% EtOAc/Hexanes) 
 
1H NMR (600 MHz, CDCl3) δ = 8.67 (s, 1H), 8.15 (d, J = 4.8 Hz, 1H), 7.55 (d, J = 8.4 Hz, 2H), 
7.34 (d, J = 5.1 Hz, 1H), 7.14 (d, J = 8.7 Hz, 2H), 6.10 (s, 1H) 
 
13C NMR (150 MHz, CDCl3) δ = 144.5, 143.3, 140.5, 135.9, 132.7, 127 (q, JC-F = 3.8 Hz), 124.7, 
124.3 (q, JC-F = 271.0 Hz), 124.2 (q, JC-F = 32.6 Hz), 117.6 
 
19F NMR (282.3 MHz, CDCl3) δ= -62.2 
 
FT-IR: (NaCl, thin film) ν = 3249, 2988, 1616, 1111 cm-1 
 
EA: Calculated: C12H8ClF3N2; C, 52.86; H, 2.96; N, 10.27; found C, 52.88; H, 2.98; N, 10.07 
 
MP: 138-140°C 
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1-(4-((4-chloropyridin-3-yl)amino)phenyl)ethanone (36j) 
Following general experimental B: Pyridine 35j (440 mg, 1.27 mmol), DCM (3 
mL) and TFA (1.5 mL) were combined and stirred for 24 h to give 280 mg of 
pyridine 36j as a yellow solid. (89%) 
 
 
Rf = 0.12 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.72 (s, 1H), 8.17 (d, J = 5.1 Hz, 1H), 7.93 (d, J = 8.7 Hz, 2H), 
7.36 (d, J = 5.1 Hz, 1H), 7.11 (d, J = 8.7 Hz, 2H), 6.22 (br s, 1H), 2.56 (s, 3H) 
 
13C NMR (75.4 MHz, CDCl3) δ = 196.6, 146.0, 143.8, 141.3, 135.5, 133.3, 131.2, 130.7, 124.9, 
116.6, 26.5 
 
FT-IR: (NaCl, thin film) ν = 3247, 3172, 3049, 1667, 1604, 1565, 813 cm-1 
 
EA: Calculated: C13H11ClN2O; C, 63.29; H, 4.49; N, 11.36; found C, 63.31; H, 4.14; N, 11.71 
 
MP: 115-116°C 
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4-chloro-N-(4-methoxyphenyl)pyridin-3-amine (36l) 
Following general experimental A: Copper (I) Iodide (20 mg, 0.11 mmol), K3PO4 
(465 mg, 2.18 mmol), pyridine 34 (250 mg, 1.09 mmol), diamine L1 (27 µL, 0.22 
mmol), 4-bromoanisole (0.15 mL, 1.2 mmol) and 1,4-dioxane (0.5 M) were 
combined and stirred for 29 h, cooled to room temperature, diluted with EtOAc, 
filtered through a Celite® plug and concentrated in vacuo. The crude mixture was dissolved in 
DCM (3 mL) and TFA (1.5 mL) and stirred for 24 h. The reaction was poured into sat. NaHCO3(aq), 
diluted with DCM, and the layers were separated. The aqueous layer was extracted with DCM and 
the combined organic layers were dried over Na2SO4, decanted and concentrated in vacuo to give 
brown oil. Purification via flash column chromatography, eluted with 20% EtOAc/Hexanes, gave 
120 mg of pyridine 36l (47% over two steps) as a brown solid.  
 
Rf = 0.24 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.26 (s, 1H), 7.94 (d, J = 5.1 Hz, 1H), 7.24 (d, J = 5.1 Hz, 1H), 
7.16 (d, J = 8.7 Hz, 2H), 6.92 (d, J = 9.0 Hz, 2H), 5.82 (br s, 1H), 3.82 (s, 3H) 
 
13C NMR (75.4 MHz, CDCl3) δ = 157.1, 140.0, 139.3, 136.3, 132.7, 128.4, 124.9, 124.2, 115.1, 
55.7 
 
FT-IR: (NaCl, thin film) ν = 3234, 3041, 2933, 2835, 1513, 1244 cm-1 
 
EA: Calculated: C12H11ClN2O; C, 61.41; H, 4.72; N, 11.94; found C, 61.48; H, 4.97; N, 11.67 
 
MP: 59-60°C 
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4-chloro-N-(3,5-dimethylphenyl)pyridin-3-amine (36m) 
Following general experimental A: Copper (I) Iodide (20 mg, 0.11 mmol), 
K3PO4 (465 mg, 2.18 mmol), pyridine 34 (250 mg, 1.09 mmol), diamine L1 (27 
µL, 0.22 mmol), 5-bromo-m-xylene (0.17 mL, 1.2 mmol) and 1,4-dioxane (0.5 M) 
were combined and stirred for 29 h, cooled to room temperature, diluted with EtOAc, filtered 
through a Celite® plug and concentrated in vacuo. The crude mixture was dissolved in DCM (3 
mL) and TFA (1.5 mL) and stirred for 24 h. The reaction was poured into sat. NaHCO3(aq), diluted 
with DCM, the layers were separated and the aqueous layer was extracted with DCM. The 
combined organic layers were dried over Na2SO4, decanted and concentrated in vacuo to give 
brown oil. Purification via flash column chromatography, eluted with 20% EtOAc/Hexanes, gave 
168 mg of pyridine 36m (66% over two steps) as an off-white solid.  
 
Rf = 0.42 (30% EtOAc/Hexanes) 
 
1H NMR (400 MHz, CDCl3) δ = 8.58 (s, 1H), 8.01 (s, 1H), 7.27 (d, J = 3.9 Hz, 1H), 6.81 (s, 2H), 
6.74 (s, 1H), 5.88 (s, 1H), 2.30 (s, 6H) 
 
13C NMR (100 MHz, CDCl3) δ = 140.9, 140.3, 139.6, 138.2, 137.7, 129.8, 125.5, 124.4, 118.3, 
21.4 
 
FT-IR: (NaCl, thin film) ν = 3402, 1606, 1571, 1075 cm-1 
 
EA: Calculated: C13H13ClN2; C, 67.10; H, 5.63; N, 12.04; found C, 67.17; H, 5.88; N, 11.93 
 
MP: 127-128°C 
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4-chloro-N-(pyridin-3-yl)pyridin-3-amine (36n) 
Following general experimental B: Pyridine 35n (168 mg, 0.55 mmol), DCM (2 
mL) and TFA (1 mL) were combined and stirred for 6 h to give 100 mg of pyridine 
36n as a yellow solid. (89%) 
 
Rf = 0.06 (30% EtOAc/Hexanes) 
 
1H NMR (300 MHz, CDCl3) δ = 8.49 (s, 1H), 8.46 (d, J = 2.1 Hz, 1H), 8.29 (d, J = 4.5 Hz, 1H), 
8.07 (d, J = 5.1 Hz, 1H), 7.48 (d, J = 5.1 Hz, 1H), 7.30 (d, J = 5.1 Hz, 1H), 7.24 (dd, J = 8.1, 4.8 
Hz, 1H), 6.28 (br s, 1H) 
 
13C NMR (75.4 MHz, CDCl3) δ = 144.3, 142.4, 142.3, 138.5, 137.5, 136.7, 131.4, 126.4, 124.6, 
124.0 
 
FT-IR: (NaCl, thin film) ν = 3172, 3042, 1588, 1326 cm-1 
 
EA: Calculated: C10H8ClN3; C, 58.41; H, 3.92; N, 20.43; found C, 58.36; H, 4.14; N, 20.39 
 
MP: 117-118°C 
180 
 
 
3-(4-fluorobenzyl)-3H-imidazo[4,5-c]pyridine (37d) 
Following general procedure D: Pyridine 36d (95 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 
mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 
mmol) were combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 4 h TLC analysis 
indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered through 
Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 3% MeOH/DCM, 
to give 68 mg of pyridine 37d (75%) as a pale yellow solid.  
 
Rf = 0.31 (5% MeOH/DCM) 
 
1H NMR (300 MHz, CDCl3) δ = 8.65 (d, J = 0.6 Hz, 1H), 8.39 (d, J = 5.4 Hz, 1H), 8.00 (s, 1H), 
7.66 (dd, J = 5.7, 0.9 Hz, 1H), 7.18-7.13 (m, 2H), 7.09-6.96 (m, 2H), 5.34 (s, 2H)  
 
13C NMR (75 MHz, CDCl3) δ= 162.7 (d, JC-F = 246.75 Hz), 149.1, 145.7, 142.2, 133.7, 131.5, 
130.4 (d, JC-F = 3.45 Hz), 129.2 (d, JC-F = 7.95 Hz), 116.3 (d, JC-F = 21.75 Hz), 115.1, 48.8 
 
19F NMR (282.3 MHz, CDCl3) δ= -113.0 (m) 
 
FT-IR (NaCl, thin film) ν = 1608 cm-1 
 
EA: Calculated: C13H10FN3; C, 68.71; H, 4.44; N, 18.49; found C, 68.54; H, 4.36; N, 18.32  
 
MP: 107-110C  
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3-([1,1'-biphenyl]-4-ylmethyl)-3H-imidazo[4,5-c]pyridine (37e) 
Following general procedure D: Pyridine 36e (95 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 
mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 
mmol) were combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 4.5 h TLC analysis 
indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered through 
Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 4% MeOH/DCM, 
to give 86 mg of pyridine 37e (75%) as an off-white solid.  
 
Rf = 0.34 (5% MeOH/DCM)  
 
1H NMR (300 MHz, CDCl3) δ = 8.76 (s, 1H), 8.46 (d, J = 5.7 Hz, 1H), 8.07 (s, 1H), 7.73 (dd, J = 
5.7, 1.2 Hz, 1H), 7.58-7.51 (m, 4H), 7.45-7.26 (m, 5H), 5.44 (s, 2H) 
 
13C NMR (75 MHz, CDCl3) δ = 149.1, 145.8, 142.2, 141.8, 140.1, 133.9, 133.4, 131.6, 128.9, 
127.9, 127.8, 127.7, 127.1, 115.1, 49.2 
 
EA: Calculate: C19H15N3; C, 79.98; H, 5.30; N, 14.73; found C, 79.96; H, 5.56; N, 14.39 
 
FT-IR (NaCl, thin film) ν = 1602 cm-1 
 
MP: 189-191C 
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3-methyl-3H-imidazo [4,5-c]pyridine (37f)219 
Following general procedure D: Pyridine 36f (57 mg, 0.4 mmol), Pd2(dba)3·CHCl3 
(4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 0.02 mmol), K3PO4 (128 
mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were combined with 2 mL tert-butanol in a 25 
mL Schlenk tube. After 5 h TLC analysis indicated the reaction was complete.  The reaction 
mixture was cooled to RT, filtered through Celite®, concentrated in vacuo and purified on a silica 
gel column, eluted with 4% MeOH/DCM, to give 31 mg of pyridine 37f (58%) as a pale yellow 
solid.  
 
Rf = 0.17 (5% MeOH/DCM) 
 
1H NMR (300 MHz, CDCl3): δ = 8.80 (d, J = 0.6 Hz, 1H), 8.42 (d, J = 5.4 Hz, 1H), 7.91 (s, 1H), 
7.65 (dd, J = 5.7 Hz, 0.9 Hz, 1H), 3.89 (s, 3H) 
 
13C NMR (75 MHz, CDCl3) δ= 148.7, 146.2, 142.0, 133.2, 132.3, 114.9, 31.5 
 
MP: 95-97C 
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3-(p-tolyl)-3H-imidazo[4,5-c]pyridine (37i): 
Following general procedure D: Pyridine 36i (87 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 0.02 
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were 
combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 6 h TLC analysis 
indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered through 
Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 4% MeOH/DCM, 
to give 72 mg of pyridine 37i (86%) as a light brown solid.  
 
Rf = 0.33(5% MeOH/DCM) 
 
1H NMR (600 MHz, CDCl3) δ = 8.90 (s, 1H), 8.48 (d, J = 5.7 Hz, 1H), 8.17 (s, 1H), 7.74 (dd, J = 
5.7 Hz, 0.6 Hz, 1H), 7.40-7.36 (m, 4H), 2.43 (s, 3H) 
 
13C NMR (150 MHz, CDCl3) δ= 149.1, 145.0, 142.6, 139.1, 134.3, 133.0, 131.7, 131.0, 123.9, 
115.3, 21.2 
 
FT-IR (NaCl, thin film) ν = 3051, 2924, 1518, 1480, 821 cm-1 
 
EA: Calculated: C13H11N3; C, 74.62; H, 5.30; N, 20.08; found C, 74.66; H, 5.54; N, 19.97 
 
MP: 108-109°C 
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3-(4-(trifluoromethyl)phenyl)-3H-imidazo[4,5-c]pyridine (37k): 
Following general procedure D: Pyridine 36k (108 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 0.02 
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were 
combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 6 h TLC 
analysis indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered 
through Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 4% 
MeOH/DCM, to give 96 mg of pyridine 37k (91%) as a pale yellow solid.  
 
Rf = 0.30 (5% MeOH/DCM) 
 
1H NMR (600 MHz, CDCl3) δ = 8.97 (s, 1H), 8.52 (d, J = 5.7 Hz, 1H), 8.25 (s, 1H), 7.88 (d, J = 
8.4 Hz, 2H), 7.76 (d, J = 5.7 Hz, 1H), 7.69 (d, J = 8.4 Hz, 2H) 
 
13C NMR (150 MHz, CDCl3) δ = 149.4, 144.4, 143.1, 138.5, 133.9, 131.0, 130.8 (q, JC-F = 33.3 
Hz), 127.8 (q, JC-F = 3.7 Hz), 123.9, 123.5 (q, JC-F = 272.9 Hz), 115.5 
 
19F NMR (282.3 MHz, CDCl3): δ = -63.0  
 
FT-IR (NaCl, thin film) ν = 3056, 1606, 1334, 1106 cm-1 
 
EA: Calculated: C13H8F3N3; C, 59.32; H, 3.06; N, 15.96; found C, 59.04; H, 2.77; N, 15.67 
 
MP: 166-167 °C 
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1-(4-(3H-imidazo[4,5-c]pyridin-3-yl)phenyl)ethanone (37j) 
Following general procedure D: Pyridine 36j (98 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 0.02 
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were 
combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 4 h TLC 
analysis indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered 
through Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 4% 
MeOH/DCM, to give 83 mg of pyridine 37j (87%) as a pale yellow solid.  
 
Rf = 0.33 (5% MeOH/DCM) 
 
1H NMR (600 MHz, CDCl3) δ= 8.99 (s, 1H), 8.51 (d, J = 5.7 Hz, 1H), 8.26 (s, 1H), 8.18 (d, J = 
8.7 Hz, 2H), 7.76 (dd, J = 5.7 Hz, 0.9 Hz, 1H), 7.65 (d, J = 8.7 Hz, 2H), 2.65 (s, 3H) 
 
13C NMR (150 MHz, CDCl3) δ = 196.3, 149.3, 144.3, 143.0, 139.1, 136.8, 134.0, 130.9, 130.5, 
123.3, 115.4, 26.6 
 
FT-IR (NaCl, thin film) ν =1677, 1601, 1353, 816 cm-1 
 
EA: Calculated: C14H11N3O; C, 70.87; H, 4.67; N, 17.71; found C, 70.50; H, 4.76; N, 17.43 
 
MP: 199-201°C 
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3-(4-methoxyphenyl)-3H-imidazo[4,5-c]pyridine (37l) 
Following general procedure D: Pyridine 36l (93 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 
0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) 
were combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 6.5 h 
TLC analysis indicated the reaction was complete.  The reaction mixture was cooled to RT, filtered 
through Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 3% 
MeOH/DCM, to give 69 mg of pyridine 37l (77%) as a pale yellow solid.  
 
Rf = 0.30 (5% MeOH/DCM) 
 
1H NMR (300 MHz, CDCl3) δ = 8.86 (s, 1H), 8.49 (d, J = 5.7 Hz, 1H), 8.14 (s, 1H), 7.75 (d, J = 
5.4 Hz, 1H), 7.42 (d, J = 8.7 Hz, 2H), 7.08 (d, J = 9.0 Hz, 2H), 3.88 (s, 3H) 
 
13C NMR (75.4 MHz, CDCl3) δ = 159.9, 149.0, 145.2, 142.5, 134.3, 132.1, 128.3, 125.7, 115.5, 
115.2, 55.8 
 
FT-IR (NaCl, thin film) ν = 2839, 1517, 1253 cm-1  
 
EA: Calculated: C13H11N3O; C, 69.32; H, 4.92; N, 18.66; found C, 69.44; H, 5.05; N, 18.75 
 
MP: 105-106°C 
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3-(3,5-dimethylphenyl)-3H-imidazo[4,5-c]pyridine (37m): 
Following general procedure D: Pyridine 36m (93 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 
0.02 mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) 
were combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 4 h TLC analysis indicated 
the reaction was complete.  The reaction mixture was cooled to RT, filtered through Celite®, 
concentrated in vacuo and purified on a silica gel column, eluted with 4% MeOH/DCM, to give 
80 mg of pyridine 37m (90%) as a pale yellow solid.  
 
Rf = 0.33 (5% MeOH/DCM) 
 
1H NMR (400 MHz, CDCl3) δ = 8.96 (s, 1H), 8.51 (d, J = 5.4 Hz, 1H), 8.19 (s, 1H), 7.77 (d, J = 
5.6 Hz, 1H), 7.14 (s, 3H), 2.43 (s, 6H)  
 
13C NMR (100 MHz, CDCl3) δ = 149.2, 144.9, 142.6, 140.5, 135.4, 134.6, 131.6, 130.5, 121.7, 
115.3, 21.5 
 
FT-IR (NaCl, thin film) ν = 3060, 2919, 1602, 1494, 1231 cm-1 
 
EA: Calculated: C14H13N3; C, 75.31; H, 5.87; N, 18.82; found C, 75.64; H, 5.59; N, 18.66 
 
MP: 144-146°C 
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3-(pyridin-3-yl)-3H-imidazo[4,5-c]pyridine (37n) 
Following general procedure D: Pyridine 36n (95 mg, 0.4 mmol), 
Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-butyl-XPhos
195 (10 mg, 0.02 
mmol), K3PO4 (128 mg, 0.6 mmol), formamide (0.024 mL, 0.6 mmol) were 
combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 5 h TLC analysis indicated the 
reaction was complete.  The reaction mixture was cooled to RT, filtered through Celite®, 
concentrated in vacuo and purified on a silica gel column, eluted with 4% MeOH/DCM, to give 
67 mg of pyridine 37n (86%) as a yellow solid.  
 
Rf = 0.57 (4% MeOH/DCM) 
 
1H NMR (600 MHz, CDCl3) δ = 8.94 (s, 1H), 8.88 (d, J = 2.4 Hz, 1H), 8.78 (dd, J = 4.8 Hz, 1.2 
Hz, 1H), 8.55 (d, J = 5.4 Hz, 1H), 8.23 (s, 1H), 7.91 (ddd, J = 8.0 Hz, 2.4 Hz, 1.2 Hz, 1H), 7.80 
(d, J = 5.4 Hz, 1H), 7.58 (dd, J = 8.0 Hz, 4.8 Hz, 1H) 
 
13C NMR (150 MHz, CDCl3) δ= 150.2, 149.4, 145.3, 144.5, 143.3, 133.8, 132.5, 131.4, 131.4, 
124.8, 115.6  
 
FT-IR (NaCl, thin film) ν = 3351, 3058, 2928, 1496, 1249 cm-1 
 
EA: Calculated: C11H8N4; C, 67.34; H, 4.11; N, 28.55; found C, 67.40; H, 4.15; N, 28.21 
 
MP: 138-140°C 
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2-methyl-3-phenyl-3H-imidazo[4,5-c]pyridine (39): To an oven dried 50 mL 
Schlenk tube was added pyridine 36h (82 mg, 0.4 mmol), Pd2(dba)3CHCl3 (8 
mg, 0.008 mmol), Me3(OMe)tBuXPhos
6 (20 mg, 0.04 mmol), K3PO4 (170 mg, 
0.8 mmol), and acetamide (236 mg, 4.0 mmol); the reaction vessel was sealed, evacuated under 
vacuum and  purged with Ar(g). tBuOH (2.0 mL) was added and the reaction mixture was degassed 
with three vacuum / Ar(g) purge cycles, equipped with a cold-finger condenser and placed in a pre-
heated 110°C oil-bath. After 4 h TLC analysis indicated the complete consumption of pyridine 
36h. The reaction mixture was cooled to RT, filtered through Celite®, concentrated in vacuo and 
purified on a silica gel column, eluted with 2% MeOH/DCM, to give 51 mg of pyridine 39 (61%) 
as a yellow solid.  
 
Rf = 0.26 (5% MeOH/DCM) 
 
1H NMR (400 MHz, CDCl3) δ = 8.50 (s, 1H), 8.42 (d, J = 5.6 Hz, 1H), 7.63-7.53 (m, 4H), 7.39-
7.36 (m, 2H), 2.53 (s, 3H)  
 
13C NMR (100 MHz, CDCl3) δ = 155.0, 147.9, 142.6, 135.2, 134.3, 133.3, 130.3, 129.5, 126.8, 
113.9, 14.5 
 
FT-IR (NaCl, thin film) ν = 3407, 3048, 2926, 1596, 1501, 1392, 822 cm-1 
 
EA: Calculated: C13H11N3; C, 74.62; H, 5.30; N, 20.08; found C, 74.77; H, 5.32; N, 19.85 
 
MP: 104-107°C 
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2-(furan-2-yl)-3-phenyl-3H-imidazo[4,5-c]pyridine (40): To an oven dried 
50 mL Schlenk tube was added pyridine 36h (82 mg, 0.4 mmol), 
Pd2(dba)3CHCl3 (8 mg, 0.008 mmol), Me3(OMe)tBuXPhos
6 (20 mg, 0.04 
mmol), K3PO4 (170 mg, 0.8 mmol), and furanamide (222 mg, 2.0 mmol); the reaction vessel was 
sealed, evacuated under vacuum and purged with Ar(g). tBuOH (2.0 mL) was added and the 
reaction mixture was degassed with three vacuum / Ar(g) purge cycles, equipped with a cold-finger 
condenser and placed in a pre-heated 110°C oil-bath. After 5 h TLC analysis indicated the 
complete consumption of pyridine 36h. The reaction mixture was cooled to RT, filtered through 
Celite®, concentrated in vacuo and purified on a silica gel column, eluted with 2% MeOH/DCM, 
to give 53 mg of pyridine 40 (51%) as a yellow solid.  
 
Rf = 0.21 (5% MeOH/DCM) 
 
1H NMR (400 MHz, CDCl3) δ = 8.47 (s, 1H), 8.47 (d, J= 5.6 Hz, 1H), 7.72 (dd, J= 5.6, 1.2 Hz, 
1H), 7.63-7.59 (m, 3H), 7.50 (dd, J=1.2, 0.8 Hz, 1H), 7.45-7.41 (m, 2H), 6.37 (dd, J = 3.6, 1.6 Hz, 
1H), 6.29 (dd, J= 3.6, 0.4 Hz, 1H) 
 
13C NMR (100 MHz, CDCl3) δ = 147.9, 146.6, 145.2, 144.3, 143.7, 142.9, 135.4, 134.7, 133.6, 
130.2, 130.0, 127.6, 114.2, 111.8 
 
FT-IR (NaCl, thin film) ν = 3049, 2924, 2222, 1591, 1502, 1416, 1267, 905, 819 cm-1 
 
EA: Calculated: C16H11N3O; C, 73.55; H, 4.24; N, 16.08; found C, 73.48; H, 4.28; N, 15.94 
 
MP: 153-155°C 
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5,10-diphenyl-5,10-dihydrodipyrido[3,4-b:3',4'-e]pyrazine (38): Pyridine 
36h (82 mg, 0.4 mmol), Pd2(dba)3·CHCl3 (4 mg, 0.004 mmol), Me3(OMe)t-
butyl-XPhos195 (10 mg, 0.02 mmol), K3PO4 (128 mg, 0.6 mmol), were 
combined with 2 mL tert-butanol in a 25 mL Schlenk tube. After 16.5 h the 
reaction mixture was cooled to RT, filtered through Celite®, concentrated in vacuo and purified 
on a silica gel column, eluted with 5% MeOH/DCM, to give 26 mg of pyrazine 38 (39%) as a 
yellow solid.  
 
Rf = 0.05 (10% iPrOH/DCM) 
 
1H NMR (400 MHz, CD3OD) δ = 7.68 (d, J= 1.5 Hz, 1H), 7.48 (dd, J= 6.8, 1.5 Hz, 1H), 7.21-
7.17 (m, 2H), 7.05-7.02 (m, 2H), 6.86-6.83 (m, 1H), 6.38 (d, J= 6.8 Hz, 1H) 
 
13C NMR (100 MHz, CD3OD) δ = 173.0, 143.4, 136.4, 134.9, 130.7, 122.9, 119.8, 119.3, 113.1 
 
FT-IR (NaCl, thin film) ν = 2928, 2858, 1625, 1590, 1458, 1173, 824 cm-1 
 
EA: Calculated: C22H16N4; C , 78.55; H, 4.79; N, 16.66; found C, 78.28; H, 4.84; N, 16.75 
 
MP: 168-170°C 
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2-chloro-3-phenyl-3H-imidazo[4,5-c]pyridine (41): Chloride 41 was prepared 
following a literature procedure.220 To an oven dried 25 mL Schlenk tube was 
added pyridine 37h (49 mg, 0.25 mmol) and 1.0 mL THF.  The reaction mixture 
was cooled to -78C (CO2/acetone bath) and lithium diisopropylamide (2.0M in THF, 0.19 mL) 
was added drop-wise and the reaction mixture was allowed to stir for 1 h.  Hexachloroethane (89 
mg, 0.375 mmol) was added as a solution in THF (0.25 mL) and the reaction mixture was warmed 
to RT over 45 min. The reaction was quenched by the addition of a saturated aqueous solution of 
ammonium chloride (4 mL) diluted with 5 mL of water and poured into 10 mL of EtOAc. The 
layers were separated and the aqueous layer was extracted with EtOAc (3 x 5 mL). The combined 
organic layers were dried over magnesium sulfate, filtered, concentrated in vacuo and purified on 
a silica gel column, eluted with 5% MeOH/ DCM to afford 48 mg of chloride 41 (84%) as a yellow 
solid.  
 
Rf = 0.40 (5% MeOH/DCM) 
 
1H NMR (400 MHz, CDCl3) δ = 8.58 (s, 1H), 8.52 (d, J= 5.7 Hz, 1H), 7.68 (dd, J = 6.9, 0.9 Hz, 
1H), 7.66-7.60 (m, 3H), 7.49-7.45 (m, 2H)  
 
13C NMR (100 MHz, CDCl3) δ = 146.8, 144.4, 143.0, 134.1, 133.6, 133.2, 130.1, 130.0, 126.9, 
114.0 
 
FT-IR (NaCl, thin film) ν = 1638, 1498, 1437, 1366, 1285 cm-1 
 
EA: Calculated: C12H8ClN3; C, 62.76; H, 3.51; N, 18.30; found C, 62.94; H, 3.67; N, 18.66 
 
MP: 110°C (decomposition) 
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 3-phenyl-3H-imidazo[4,5-c]pyridine 5-oxide (42): To a flame dried 25 mL 
round bottom flask containing a stir bar was added pyridine 37h (150 mg, 0.77 
mmol) and chloroform (16 mL).  After complete dissolution,  mCPBA (85%, 390 
mg, 1.93 mmol) was added as a single portion and the reaction mixture was warmed to 45C for 2 
h. The reaction mixture was cooled to room temp., concentrated in vacuo then purified on a silica 
gel column, eluted with 10% MeOH/ DCM to afford 145 mg of N-oxide 42 (89%) as a white 
powder. 
  
Rf = 0.02 (EtOAc) 
 
1H NMR (400 MHz, CDCl3) δ = 8.56 (d, J = 1.0 Hz, 1H), 8.17 (s, 1H), 8.14 (dd, J = 6.9, 1.6 Hz, 
1H), 7.65 (d, J = 6.9 Hz, 1H), 7.57-7.52 (m, 2H), 7.50-7.46 (m, 1H) 7.41-7.39 (m, 2H)  
 
13C NMR (100 MHz, CDCl3) δ = 146.2, 141.9, 135.7, 134.4, 132.1, 130.6, 129.5, 124.6, 123.7, 
117.0 
 
FT-IR (NaCl, thin film) ν = 3379, 1506, 1463, 1446, 1204 cm-1 
 
EA: Calculated: C12H9N3O; C, 68.24; H, 4.29; N, 19.89; found C, 67.93; H, 4.50; N, 19.56 
 
MP: 174-175°C 
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4-chloro-3-phenyl-3H-imidazo[4,5-c]pyridine (43): To a 25 mL Schlenk tube 
containing a  stir bar was added N-oxide 42 (42mg, 0.2 mmol) and 0.2 mL of  POCl3. 
The reaction mixture was heated in a 120C oil bath for 2 h then cooled to RT.  The 
reaction mixture was diluted with 5 mL of H2O and made basic with 1.5 mL of ammonium 
hydroxide. The aqueous layer was extracted with DCM (3 x 10 mL) and the combined organic 
layers were dried over MgSO4, filtered, concentrated in vacuo then purified on a silica gel column, 
eluted with 10% MeOH/ DCM to afford 38 mg of chloride 43 (84%) as an off-white solid. 
 
Rf = 0.50 (5% MeOH/DCM) 
 
1H NMR (300 MHz, CDCl3) δ = 8.27 (d, J = 5.5 Hz, 1H), 8.10 (s, 1H), 7.73 (d, J = 5.7 Hz, 1H), 
7.57-7.53 (m, 3H), 7.46-7.43 (m, 2H)  
 
13C NMR (100 MHz, CDCl3) δ = 150.9, 147.1, 141.5, 134.9, 134.3, 129.7, 129.1, 128.7, 127.7, 
115.0 
 
FT-IR (NaCl, thin film) ν = 3054, 1605, 1556, 1240, 980, 821 cm-1 
 
EA: Calculated: C12H8ClN3; C, 62.76; H, 3.51; N, 18.30; found C, 62.54; H, 3.66; N, 18.26 
 
MP: 148-151°C 
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3-phenyl-3H-imidazo[4,5-c]pyridine-4-carbonitrile (44): To an oven dried 15 mL 
pressure tube containing a stir bar was added N-oxide 42 (53 mg, 0.25 mmol), 
acetonitrile (0.5 mL), Et3N (0.05 mL, 0.375 mmol), and trimethylsilylcyanide (0.11 
mL, 0.9 mmol). The reaction vessel was sealed with a teflon screw cap and heated in an oil bath 
at 110C for 12 h. The reaction mixture was cooled to room temp., diluted with 10 mL DCM and 
washed with 10mL NaHCO3 (sat. aq.). The organic layer was dried over MgSO4, filtered, 
concentrated in vacuo then purified on a silica gel column, eluted with 5% MeOH/ DCM to afford 
49 mg of nitrile 44 (89%) as an off-white solid. 
 
Rf = 0.50 (5% MeOH/DCM) 
 
1H NMR (400 MHz, CDCl3) δ = 8.63 (d, J = 5.6 Hz, 1H), 8.24 (s, 1H), 8.02 (d, J = 5.6 Hz, 1H), 
7.66-7.63 (m, 3H), 7.52-7.50 (m, 2H)  
 
13C NMR (100 MHz, CDCl3) δ = 150.1, 147.9, 143.4, 133.5, 133.4, 130.7, 130.0, 127.1, 119.2, 
117.4, 114.2 
 
FT-IR (NaCl, thin film) ν = 3115, 3057, 2222, 1595, 1501, 1222 cm-1 
 
EA: Calculated: C13H8N4; C, 70.90; H, 3.66; N, 25.44; found C, 70.81; H, 3.59; N, 25.07 
 
MP: 179-181°C 
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General Procedure E: Reductive Amination 
To a flame-dried round-bottom flask equipped with a magnetic stir-bar was added 3-amino-2-
chloropyridine (1 equiv.), ethyl acetate (0.78 M) and the appropriate aldehyde (1.2 equiv.). The 
mixture was allowed to stir until complete dissolution (about 5 min) at which time trifluoroacetic 
acid (2.0-3.0 equiv.) was added as a single portion via syringe to afford a yellow solution. After 
stirring at rt for 2 min sodium triacetoxyborohydride (1.2 equiv.) was added in two equal portions 
1 minute apart [CAUTION: vigorous gas evolution]; once the reaction was judged complete by 
TLC analysis, the reaction was quenched by the addition of 20% NaOH(aq). The pH was adjusted 
to about 8 by addition of NaOH(s). The layers were separated and the organic layer was washed 
with brine, dried over MgSO4, filtered and concentrated in vacuo to afford the crude pyridine 
which was purified as specified. 
 
4-(((2-chloropyridin-3-yl)amino)methyl)benzonitrile (1o): Adapted 
from general procedure E: 3-amino-2-chloropyridine (1.28 g, 10.0 
mmol), ethyl acetate (15 mL), 4-formylbenzonitrile (1.44 g, 11.0 mmol), 
TFA (2.3 mL, 30.0 mmol) and sodium triacetoxyborohydride (2.6 g, 12.0 
mmol) were combined and stirred for 1h. After the standard workup, the crude product was 
recrystallized with 80 mL of 2:1 hexanes:ethyl acetate to give 1o as colorless prisms (1.48 g, 61%). 
A second crop was obtained (0.64 g, 26%); total yield of 87%. 
Rf= 0.57 (5% MeOH/DCM) 
1H NMR (400 MHz, CDCl3) δ = 7.74 (dd, J = 4.8, 1.6 Hz, 1H), 7.64 (d, J = 8.4 Hz, 2H), 7.44 (d, 
J = 8.8 Hz, 2H), 7.01 (dd, J = 8.0, 4.4 Hz, 1H), 4.97 (s, NH), 4.50 (d, J = 6.0 Hz, 2H) 
13C NMR (100 MHz, CDCl3) δ = 143.5, 140.0, 137.4, 137.3, 132.8, 127.5, 123.4, 118.7, 117.9, 
111.6, 47.0 
FT-IR: (NaCl, thin film) ν = 3382, 2228, 1585 cm-1 
Anal. Calcd. for C13H10ClN3: C, 64.07; H, 4.14; N, 17.24; found C, 64.03; H, 4.07; N, 17.51 
MP: 151-152°C 
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General Procedure F: Cyclization of 2-Chloro-3-aminopyridines 
To an oven-dried 25 mL Schlenk tube equipped with a magnetic stir-bar was added 
Pd2(dba)3·CHCl3 (1 mol %), Xantphos (5 mol %), K3PO4 (1.5 equiv.) and the pyridine (1a-1t, 1 
equiv.). The reaction vessel was evacuated and refilled with Ar(g). 1,4-Dioxane:t-AmOH (10:1, 0.2 
M) and formamide (1.5 equiv.) were then added via syringe and the reaction mixture was degassed 
by three vacuum/Ar(g) purge cycles. The reaction vessel was equipped with a cold-finger, placed 
in a pre-heated 110 °C oil-bath and stirred for the specified time. Upon consumption of the pyridine 
(as judged by TLC analysis) the reaction was allowed to cool to RT, diluted with methanol, and 
passed through a Celite© plug. The solvent was removed in vacuo to afford the crude 
imidazopyridine which was purified as specified. 
 
4-((1H-imidazo[4,5-b]pyridin-1-yl)methyl)benzonitrile (2o) 
Adapted from general procedure F: Pd2(dba)3·CHCl3 (8.0 mg, 0.008 
mmol), Xantphos (23 mg, 0.04 mmol), K3PO4 (170 mg, 0.8 mmol) , 4-
(((2-chloropyridin-3-yl)amino)methyl)benzonitrile (1o) (97 mg, 0.4 
mmol), formamide (24 µL, 0.6 mmol) and 1,4-dioxane:t-AmOH (1.85 mL:0.15 mL) were 
combined and stirred for 19h. The crude product was purified by flash column chromatography 
(2-5% MeOH in CH2Cl2) to yield imidazopyridine 2o as a light yellow powder (66 mg, 70%).  
Rf = 0.12 (5% MeOH/DCM) 
1H NMR (400 MHz, CDCl3) δ = 8.52 (dd, J = 4.4 Hz, 1.6 Hz, 1H), 8.14 (s, 1H), 7.58 (d, J = 8.4 
Hz, 2H), 7.44 (dd, J = 8.0 Hz, 1.6 Hz, 1H), 7.19 (d, J = 8.0 Hz, 2H), 5.41 (s, 2H) 
13C NMR (100 MHz, CDCl3) δ = 156.5, 145.6, 145.3, 140.1, 133.1, 127.5, 125.9, 118.6, 118.1, 
118.1, 112.8, 48.9 
FT-IR: (NaCl, thin film) ν = 3391, 2228, 1610, 1494 cm-1 
Anal. Calcd. for C14H10N4: C, 71.78; H, 4.30; N, 23.92; found C, 71.63; H, 4.31; N, 23.94 
MP: 178-180C 
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2-cyclohexyl-1-(2,4-dimethoxybenzyl)-1H-imidazo[4,5-b]pyridine (7) 
Adapted from general procedure F: Pd2(dba)3·CHCl3 (8.0 mg, 0.008 
mmol), Xantphos (23 mg, 0.04 mmol), K3PO4 (170 mg, 0.8 mmol), 2-
chloro-N-(2,4-dimethoxybenzyl)pyridin-3-amine157 (134 mg, 0.48 mmol), 
cyclohexanecarboxamide (51 mg, 0.4 mmol, Limiting reagent) and 1,4-
dioxane:t-AmOH (1.85 mL:0.15 mL) were combined and stirred for 24h. 
The crude product was purified by flash column chromatography (1% MeOH in CH2Cl2) to yield 
imidazopyridine 7 as a yellow solid (110 mg, 79%).  
Rf = 0.46 (5% MeOH/DCM) 
1H NMR (400 MHz, CDCl3) δ = 8.43 (dd, J = 4.8, 1.2 Hz, 1H), 7.46 (dd, J = 8.0, 1.5 Hz, 1H), 
7.03 (dd, J = 8.0, 4.8 Hz, 1H), 6.55 (d, J = 8.4 Hz, 1H), 6.45 (d, J = 2.4 Hz, 1H), 6.31 (dd, J = 8.4 
Hz, 2.4 Hz, 1H), 5.24 (s, 2H), 3.80 (s, 3H), 3.74 (s, 3H), 2.92-2.85 (m, 1H), 1.86-1.84 (m, 6H), 
1.76-1.71 (m, 1H), 1.39-1.32 (m, 3H) 
13C NMR (100 MHz, CDCl3) δ = 162.2, 160.8, 157.7, 155.9, 144.1, 128.1, 127.5, 117.6, 117.0, 
116.2, 104.1, 98.6, 55.4, 55.4, 42.2, 36.5, 31.7, 26.3, 25.7 (29.7, “grease”) 
FT-IR: (NaCl, thin film) ν = 3419, 3054, 2997, 2933, 2847, 1610, 1584, 837 cm-1 
Anal. Calcd. for C21H25N3O2: C, 71.77; H, 7.17; N, 11.96; found C, 71.81; H, 7.11; N, 11.99 
MP: 134-136°C 
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5.0  APPENDIX III: SPECTRA 
5.1 VINYL SILICON TETHERED ALKYNES 
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5.2 ACRYLAMIDE AND ACRYLATE SPECTRA 
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5.3 VINYL BORONATE COUPLING SPECTRA 
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5.4 SILYLVINYLATION SPECTRA 
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5.5 IMIDAZOPYRIDINE SPECTRA 
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